ğ‹‡ Â¦severeÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ Â¦coronavirusÂ¦ Â¦2Â¦ â–( ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ )â– Â¦isÂ¦ Â¦aÂ¦ Â¦novelÂ¦ Â¦virusÂ¦ ,â– Â¦firstÂ¦ Â¦isolatedÂ¦ Â¦fromÂ¦ Â¦threeÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦pneumoniaÂ¦ Â¦conn ectedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦cl us terÂ¦ Â¦ofÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦illnessÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦thursdayÂ¦ ,â– Â¦theÂ¦ Â¦totalÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦coronavirusÂ¦ Â¦infectionsÂ¦ Â¦sur p as sedÂ¦ Â¦oneÂ¦ Â¦millionÂ¦ Â¦worldwideÂ¦ ,â– ğ‹‡Â¦joh nsÂ¦ ğ‹‡Â¦h op k insÂ¦ ğ‹‡Â¦universityÂ¦ Â¦dataÂ¦ Â¦indic atedÂ¦ .
ğ‹‡ Â¦beforeÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦isolationÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ Â¦strainÂ¦ ğ‹‡Â¦b 8 1 4Â¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦n as alÂ¦ Â¦disc har geÂ¦ Â¦ofÂ¦ Â¦patientsÂ¦ Â¦whoÂ¦ Â¦hadÂ¦ Â¦contractedÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ ,â– Â¦differentÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦isolatedÂ¦ Â¦inÂ¦ Â¦variousÂ¦ Â¦infectedÂ¦ Â¦animalsÂ¦ ,â– Â¦includingÂ¦ Â¦tur ke yÂ¦ ,â– Â¦mo useÂ¦ ,â– Â¦co wÂ¦ ,â– Â¦pi gÂ¦ ,â– Â¦c atÂ¦ Â¦andÂ¦ Â¦do gÂ¦ .
ğ‹‡ Â¦fe lineÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦f c ğŠ¼ o ğ‹‡ vÂ¦ )â– Â¦causesÂ¦ Â¦mildÂ¦ Â¦en teri tisÂ¦ Â¦inÂ¦ Â¦ca tsÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦severeÂ¦ ğ‹‡ Â¦fe lineÂ¦ Â¦infectiousÂ¦ Â¦pe ri to ni tisÂ¦ â–( Â¦otherÂ¦ Â¦variantsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦virusÂ¦ ).
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦governmentÂ¦ ' Â¦sÂ¦ Â¦seniorÂ¦ Â¦medicalÂ¦ Â¦adv is erÂ¦ ğ‹‡Â¦z h ongÂ¦ ğ‹‡Â¦na ns hanÂ¦ Â¦ar gu edÂ¦ Â¦thatÂ¦ â–" Â¦itÂ¦ Â¦couldÂ¦ Â¦beÂ¦ Â¦overÂ¦ Â¦byÂ¦ ğ‹‡Â¦juneÂ¦ "â– Â¦ifÂ¦ Â¦allÂ¦ Â¦countriesÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦mo bi lizedÂ¦ Â¦toÂ¦ Â¦followÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ ' Â¦sÂ¦ Â¦adviceÂ¦ Â¦onÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦stopÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦surveillanceÂ¦ Â¦isÂ¦ Â¦expectedÂ¦ Â¦toÂ¦ Â¦monitorÂ¦ Â¦epi dem io logicalÂ¦ Â¦tre ndsÂ¦ ,â– Â¦rapidlyÂ¦ Â¦det ectÂ¦ Â¦newÂ¦ Â¦casesÂ¦ ,â– Â¦andÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦thisÂ¦ Â¦informationÂ¦ ,â– Â¦provideÂ¦ Â¦epi dem io logicalÂ¦ Â¦informationÂ¦ Â¦toÂ¦ Â¦conduc tÂ¦ Â¦riskÂ¦ Â¦ass ess mentÂ¦ Â¦andÂ¦ Â¦gu ideÂ¦ Â¦diseaseÂ¦ Â¦prepar ed nessÂ¦ .
ğ‹‡ Â¦basedÂ¦ Â¦onÂ¦ Â¦clinicalÂ¦ Â¦studiesÂ¦ Â¦reportedÂ¦ Â¦th usÂ¦ Â¦farÂ¦ ,â– Â¦theÂ¦ Â¦followingÂ¦ Â¦factorsÂ¦ Â¦mayÂ¦ Â¦affectÂ¦ Â¦orÂ¦ Â¦beÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦pro gn osisÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦patientsÂ¦ â–( ğ‹‡Â¦t ableÂ¦ â– â€‹ ( ğ‹‡Â¦t ab le 3 3Â¦ ) :
ğ‹‡ Â¦givenÂ¦ Â¦suchÂ¦ Â¦rapidÂ¦ Â¦prog ressÂ¦ Â¦inÂ¦ Â¦researchÂ¦ Â¦onÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦severalÂ¦ Â¦criticalÂ¦ Â¦issuesÂ¦ Â¦remainÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦sol vedÂ¦ ,â– Â¦asÂ¦ Â¦f ol lo wsÂ¦ :
ğ‹‡Â¦onÂ¦ Â¦13Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦heÂ¦ Â¦declaredÂ¦ Â¦aÂ¦ Â¦nationalÂ¦ Â¦emergencyÂ¦ ,â– Â¦whichÂ¦ Â¦madeÂ¦ Â¦fe der alÂ¦ Â¦fun dsÂ¦ Â¦availableÂ¦ Â¦toÂ¦ Â¦respon dÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦crisisÂ¦ .
ğ‹‡Â¦chineseÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦andÂ¦ ğ‹‡Â¦sh en z h enÂ¦ Â¦claimedÂ¦ Â¦toÂ¦ Â¦showÂ¦ Â¦thatÂ¦ Â¦fa vi pi ra virÂ¦ Â¦wasÂ¦ â–" Â¦cle arlyÂ¦ Â¦effectiveÂ¦ ".
ğ‹‡Â¦ma u ri z i oÂ¦ ğ‹‡Â¦m ass ariÂ¦ ,â– ğ‹‡Â¦italyÂ¦ ' Â¦sÂ¦ Â¦a mb ass ad orÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğŠ£Â¦e u Â¦ğŠ¼ ,â– Â¦saidÂ¦ Â¦thatÂ¦ â–" ğ‹‡Â¦onlyÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦respon dedÂ¦ Â¦bi la ter allyÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦canÂ¦ Â¦k illÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦30Â¦ %â– Â¦ofÂ¦ Â¦thoseÂ¦ Â¦infectedÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦andÂ¦ Â¦someÂ¦ Â¦areÂ¦ Â¦rela tivelyÂ¦ Â¦har m lessÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦administrationÂ¦ Â¦ofÂ¦ ğ‹‡Â¦do na ldÂ¦ ğ‹‡Â¦trumpÂ¦ Â¦hasÂ¦ Â¦re fer redÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦asÂ¦ â–" ğ‹‡Â¦chineseÂ¦ Â¦virusÂ¦ "â– Â¦orÂ¦ â–" ğ‹‡Â¦wuhanÂ¦ Â¦virusÂ¦ "â– Â¦sayingÂ¦ Â¦thatÂ¦ ğ‹‡Â¦chinaÂ¦ ' Â¦sÂ¦ â–" Â¦ce ns or shipÂ¦ Â¦sup er c har gedÂ¦ Â¦aÂ¦ Â¦virusÂ¦ Â¦thatÂ¦ Â¦hasÂ¦ Â¦nowÂ¦ Â¦tur nedÂ¦ Â¦intoÂ¦ Â¦aÂ¦ Â¦globalÂ¦ Â¦pandemicÂ¦ " ,â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦inÂ¦ Â¦tur nÂ¦ Â¦beenÂ¦ Â¦criticizedÂ¦ Â¦byÂ¦ Â¦someÂ¦ Â¦crit icsÂ¦ Â¦asÂ¦ Â¦r ac ismÂ¦ Â¦andÂ¦ â–" Â¦dis tr actÂ¦ [ Â¦ ingÂ¦ ] â– Â¦fromÂ¦ Â¦hisÂ¦ Â¦administrationÂ¦ ' Â¦sÂ¦ Â¦fa ilureÂ¦ Â¦toÂ¦ Â¦con tainÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ".
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ Â¦toÂ¦ Â¦rep lic atingÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lowerÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦canÂ¦ Â¦eff ic ie ntlyÂ¦ Â¦rep lic ateÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦u pp erÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦andÂ¦ Â¦causesÂ¦ Â¦mildÂ¦ Â¦orÂ¦ Â¦noÂ¦ Â¦symptomsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ ,â– Â¦similarÂ¦ Â¦toÂ¦ Â¦otherÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦thatÂ¦ Â¦causeÂ¦ Â¦commonÂ¦ Â¦c ol dsÂ¦ .
ğ‹‡ Â¦cl ust eredÂ¦ Â¦onsetÂ¦ Â¦oftenÂ¦ Â¦happe nsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦familyÂ¦ Â¦orÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦ga th eringÂ¦ Â¦orÂ¦ Â¦vehic leÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦c ru iseÂ¦ Â¦ shipÂ¦ .
ğ‹‡ Â¦authoritiesÂ¦ Â¦worldwideÂ¦ Â¦haveÂ¦ Â¦respon dedÂ¦ Â¦byÂ¦ Â¦implement ingÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ ,â– Â¦qu ar ant inesÂ¦ ,â– Â¦cur fe wsÂ¦ ,â– Â¦work p l aceÂ¦ Â¦ha z ardÂ¦ Â¦controlsÂ¦ ,â– Â¦andÂ¦ Â¦facil ityÂ¦ Â¦closuresÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦moreÂ¦ Â¦recentÂ¦ Â¦studyÂ¦ ,â– Â¦asÂ¦ Â¦d escrib edÂ¦ Â¦aboveÂ¦ ,â– Â¦de mo nstr atesÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦inc ub ationÂ¦ Â¦periodÂ¦ Â¦wasÂ¦ Â¦4Â¦ . Â¦8Â¦ â–( Â¦3Â¦ . Â¦0Â¦ - Â¦7Â¦ . Â¦2Â¦ )â– Â¦daysÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦ dem ograph yÂ¦ Â¦ofÂ¦ Â¦8Â¦ , Â¦8 6 6Â¦ Â¦casesÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦severeÂ¦ Â¦casesÂ¦ ,â– Â¦patientsÂ¦ Â¦qu ick lyÂ¦ Â¦prog res sedÂ¦ Â¦toÂ¦ Â¦developÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ ,â– Â¦se p ticÂ¦ Â¦sh ockÂ¦ ,â– Â¦me t ab ol icÂ¦ Â¦ac id osisÂ¦ ,â– Â¦andÂ¦ Â¦co a g ul op a thyÂ¦ .
ğ‹‡ Â¦supp r essionÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦pre fer redÂ¦ Â¦butÂ¦ Â¦needsÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦main tainedÂ¦ Â¦forÂ¦ Â¦asÂ¦ Â¦longÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦circ ul atingÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦populationÂ¦ â–( Â¦orÂ¦ Â¦untilÂ¦ Â¦aÂ¦ Â¦vaccineÂ¦ Â¦b ec omesÂ¦ Â¦availableÂ¦ ,â– Â¦ifÂ¦ Â¦thatÂ¦ Â¦comesÂ¦ Â¦firstÂ¦ ),â– Â¦asÂ¦ Â¦transmissionÂ¦ Â¦o ther w iseÂ¦ Â¦qu ick lyÂ¦ Â¦re b ou ndsÂ¦ Â¦whenÂ¦ Â¦measuresÂ¦ Â¦areÂ¦ Â¦rela xedÂ¦ .
ğ‹‡ Â¦pres um ablyÂ¦ ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦alreadyÂ¦ Â¦beenÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦anotherÂ¦ Â¦hostÂ¦ Â¦closeÂ¦ Â¦toÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦studyÂ¦ ,â– Â¦weÂ¦ Â¦ass essÂ¦ Â¦theÂ¦ Â¦tre ndsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦c u mul ativeÂ¦ Â¦incidenceÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦inÂ¦ Â¦eachÂ¦ ğ‹‡Â¦europeanÂ¦ ğ‹‡Â¦unionÂ¦ / ğ‹‡Â¦europeanÂ¦ ğ‹‡ Â¦economicÂ¦ ğ‹‡ Â¦areaÂ¦ â–( ğŠ£Â¦e uÂ¦ / Â¦ ee aÂ¦ğŠ¼ )â– Â¦countryÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡ Â¦ki ng d omÂ¦ â–( ğŠ£Â¦ukÂ¦ğŠ¼ )â– Â¦andÂ¦ Â¦comp areÂ¦ Â¦themÂ¦ Â¦toÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğ‹‡Â¦h ub e iÂ¦ ğ‹‡ Â¦provi nceÂ¦ ,â– ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦twoÂ¦ Â¦typesÂ¦ Â¦ofÂ¦ Â¦c an ineÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦c c ğŠ¼ o ğ‹‡ vÂ¦ ) â–( Â¦oneÂ¦ Â¦cau singÂ¦ Â¦en teri tisÂ¦ ,â– Â¦theÂ¦ Â¦otherÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦respiratoryÂ¦ Â¦diseasesÂ¦ ).
ğ‹‡Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦wereÂ¦ Â¦ ea sedÂ¦ Â¦inÂ¦ ğ‹‡Â¦h ub e iÂ¦ ,â– Â¦a partÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– Â¦twoÂ¦ Â¦monthsÂ¦ Â¦afterÂ¦ Â¦theÂ¦ Â¦lockdownÂ¦ Â¦wasÂ¦ Â¦imposedÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ğ‹‡Â¦ministryÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦foreignÂ¦ ğ‹‡ Â¦af fa irsÂ¦ Â¦announcedÂ¦ Â¦onÂ¦ Â¦26Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ Â¦thatÂ¦ Â¦entryÂ¦ Â¦forÂ¦ Â¦v is aÂ¦ Â¦orÂ¦ Â¦re si de nceÂ¦ Â¦p erm itÂ¦ Â¦h ol dersÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦susp e ndedÂ¦ Â¦fromÂ¦ Â¦28Â¦ ğ‹‡Â¦marchÂ¦ Â¦ on w ardsÂ¦ ,â– Â¦withÂ¦ Â¦noÂ¦ Â¦specificÂ¦ Â¦deta ilsÂ¦ Â¦onÂ¦ Â¦whenÂ¦ Â¦thisÂ¦ Â¦policyÂ¦ Â¦willÂ¦ Â¦endÂ¦ .
ğ‹‡Â¦d am ageÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦economyÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦f el tÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ :â– Â¦accordingÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦mediaÂ¦ Â¦reportÂ¦ Â¦onÂ¦ Â¦16Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦theÂ¦ Â¦economyÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦wasÂ¦ Â¦veryÂ¦ Â¦h ardÂ¦ Â¦hitÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦twoÂ¦ Â¦monthsÂ¦ Â¦ofÂ¦ Â¦2020Â¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦measuresÂ¦ Â¦takenÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦governmentÂ¦ Â¦toÂ¦ Â¦cur ta ilÂ¦ Â¦virusÂ¦ Â¦spreadÂ¦ ,â– Â¦andÂ¦ Â¦re ta ilÂ¦ Â¦sa lesÂ¦ Â¦pl un gedÂ¦ Â¦20Â¦ . Â¦5Â¦ %.
ğ‹‡Â¦theÂ¦ Â¦2019Â¦ Â¦novelÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ â–( Â¦2019Â¦ - Â¦n ğ‹‡ co ğ‹‡ vÂ¦ ),â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦sub se que ntlyÂ¦ Â¦beenÂ¦ Â¦re na medÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦isÂ¦ Â¦theÂ¦ Â¦ca us ativeÂ¦ Â¦a gentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ongoingÂ¦ Â¦epidemicÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ Â¦2019Â¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ),â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦claimedÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦3Â¦ , Â¦12 0Â¦ Â¦livesÂ¦ Â¦andÂ¦ Â¦infectedÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦9 1Â¦ , Â¦000Â¦ Â¦peopleÂ¦ Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦marchÂ¦ Â¦3Â¦ ,â– Â¦2020Â¦ .
ğ‹‡ Â¦pres um ablyÂ¦ ,â– Â¦theÂ¦ Â¦interme di ateÂ¦ Â¦animalÂ¦ Â¦h ostsÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦amongÂ¦ Â¦theÂ¦ Â¦wi ld li f eÂ¦ Â¦speciesÂ¦ Â¦so ldÂ¦ Â¦andÂ¦ Â¦killedÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡ Â¦hu an anÂ¦ ğ‹‡Â¦s ea f o odÂ¦ ğ‹‡ Â¦wh ol es aleÂ¦ ğ‹‡ Â¦marketÂ¦ ,â– Â¦withÂ¦ Â¦whichÂ¦ Â¦manyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦initialÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wereÂ¦ Â¦associatedÂ¦ ,â– Â¦indic ativeÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦pro b ableÂ¦ Â¦animalÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦ev entÂ¦ .
ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ ' Â¦sÂ¦ Â¦progr am meÂ¦ Â¦isÂ¦ Â¦consideredÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦aÂ¦ Â¦success Â¦ Â¦inÂ¦ Â¦contro llingÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦despiteÂ¦ Â¦notÂ¦ Â¦qu ar anti ningÂ¦ Â¦entireÂ¦ Â¦citiesÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦southÂ¦ ğ‹‡Â¦ ko re anÂ¦ Â¦societyÂ¦ Â¦wasÂ¦ Â¦initiallyÂ¦ Â¦pol ari zedÂ¦ Â¦onÂ¦ ğ‹‡Â¦presidentÂ¦ ğ‹‡Â¦mo onÂ¦ ğ‹‡Â¦ja eÂ¦ - Â¦inÂ¦ ' Â¦sÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦crisisÂ¦ .
ğ‹‡Â¦ne ver t he lessÂ¦ ,â– Â¦theÂ¦ Â¦fe aturesÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦includingÂ¦ Â¦itsÂ¦ Â¦transm is sib il ityÂ¦ ,â– Â¦pathog en ic ityÂ¦ Â¦andÂ¦ Â¦s us ta in ableÂ¦ Â¦spreadingÂ¦ Â¦afterÂ¦ Â¦p ass a gesÂ¦ Â¦inÂ¦ Â¦humansÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦inf lu enti alÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦ ul tim ateÂ¦ Â¦f ateÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ongoingÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡Â¦mo re o verÂ¦ ,â– Â¦theÂ¦ Â¦highÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦re ac tiveÂ¦ Â¦oxygenÂ¦ Â¦speciesÂ¦ â–( ğŠ£Â¦r os Â¦ğŠ¼ )â– Â¦gener atedÂ¦ Â¦fromÂ¦ Â¦highÂ¦ Â¦me t ab ol icÂ¦ Â¦activityÂ¦ Â¦ofÂ¦ Â¦batsÂ¦ Â¦couldÂ¦ Â¦bothÂ¦ Â¦supp ressÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦rep lic ationÂ¦ Â¦andÂ¦ Â¦aff ectsÂ¦ Â¦pr oo f rea dingÂ¦ Â¦byÂ¦ Â¦ex o rib on ucle aseÂ¦ ,â– Â¦th usÂ¦ Â¦providingÂ¦ Â¦theÂ¦ Â¦sel ectionÂ¦ Â¦pressureÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦gener ationÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦stra insÂ¦ Â¦high lyÂ¦ Â¦pathog enicÂ¦ Â¦whenÂ¦ Â¦in tr od uc edÂ¦ Â¦intoÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦hostÂ¦ .
ğ‹‡ Â¦severalÂ¦ Â¦trainÂ¦ Â¦st ationsÂ¦ Â¦andÂ¦ Â¦ fer ryÂ¦ Â¦ por tsÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦closedÂ¦ .
ğ‹‡ Â¦coronavirusesÂ¦ Â¦v aryÂ¦ Â¦signific a ntlyÂ¦ Â¦inÂ¦ Â¦riskÂ¦ Â¦fa ctorÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦clari tyÂ¦ ,â– Â¦theÂ¦ Â¦currentÂ¦ Â¦ knowled geÂ¦ Â¦onÂ¦ Â¦animalÂ¦ Â¦origin sÂ¦ Â¦ofÂ¦ Â¦knownÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦isÂ¦ Â¦s um m ari zedÂ¦ Â¦inÂ¦ ğ‹‡Â¦fi g ureÂ¦ â– â€‹ Â¦1Â¦ Â¦andÂ¦ ğ‹‡Â¦t ableÂ¦ Â¦2Â¦ .
ğ‹‡Â¦inÂ¦ Â¦bothÂ¦ Â¦casesÂ¦ ,â– Â¦theÂ¦ Â¦h ostsÂ¦ Â¦areÂ¦ Â¦n at ur allyÂ¦ Â¦infectedÂ¦ Â¦andÂ¦ Â¦areÂ¦ Â¦theÂ¦ Â¦naturalÂ¦ Â¦h ostsÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦orÂ¦ Â¦itsÂ¦ Â¦par entalÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ ,â– Â¦2 1 5Â¦ ğ‹‡Â¦cana di ansÂ¦ â–( Â¦1 7 6Â¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦pl aneÂ¦ ,â– Â¦andÂ¦ Â¦3 9Â¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦secondÂ¦ Â¦pl aneÂ¦ Â¦ch art eredÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦governmentÂ¦ )â– Â¦wereÂ¦ Â¦ev ac u atedÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦toÂ¦ ğŠ£Â¦c f b Â¦ğŠ¼ ğ‹‡ Â¦tre nt onÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦quarantinedÂ¦ Â¦forÂ¦ Â¦twoÂ¦ Â¦weeksÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦pol yp ro te inÂ¦ Â¦hasÂ¦ Â¦itsÂ¦ Â¦ownÂ¦ Â¦prot ea sesÂ¦ Â¦whichÂ¦ Â¦clea veÂ¦ Â¦theÂ¦ Â¦pol yp ro te inÂ¦ Â¦intoÂ¦ Â¦multipleÂ¦ Â¦no nstruc t uralÂ¦ Â¦proteinsÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦b har ati yaÂ¦ ğ‹‡Â¦ja na taÂ¦ ğ‹‡ Â¦partyÂ¦ ' Â¦sÂ¦ ğ‹‡Â¦stateÂ¦ Â¦unitÂ¦ Â¦presidentÂ¦ Â¦inÂ¦ ğ‹‡Â¦westÂ¦ ğ‹‡Â¦bengalÂ¦ ğ‹‡Â¦di li pÂ¦ ğ‹‡Â¦ gh os hÂ¦ Â¦st atedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦hadÂ¦ Â¦d est ro yedÂ¦ Â¦n atureÂ¦ Â¦andÂ¦ â–" Â¦thatÂ¦ ' Â¦sÂ¦ Â¦whyÂ¦ Â¦theÂ¦ ğ‹‡Â¦g odÂ¦ Â¦tookÂ¦ Â¦rev en geÂ¦ Â¦againstÂ¦ Â¦themÂ¦ ."
ğ‹‡ Â¦studiesÂ¦ Â¦haveÂ¦ Â¦foundÂ¦ Â¦thatÂ¦ Â¦anÂ¦ Â¦u nc ov eredÂ¦ Â¦c oug hingÂ¦ Â¦canÂ¦ Â¦leadÂ¦ Â¦toÂ¦ Â¦dr op letsÂ¦ Â¦trave llingÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦4Â¦ . Â¦5Â¦ Â¦me tr esÂ¦ â–( Â¦15Â¦ Â¦feetÂ¦ )â– Â¦toÂ¦ Â¦8Â¦ . Â¦2Â¦ Â¦me tr esÂ¦ â–( Â¦27Â¦ Â¦feetÂ¦ ).
ğ‹‡Â¦inÂ¦ Â¦ch ic ke nsÂ¦ ,â– Â¦theÂ¦ Â¦infectiousÂ¦ Â¦bro nc hi tisÂ¦ Â¦virusÂ¦ â–( ğŠ£Â¦i b vÂ¦ğŠ¼ ),â– Â¦aÂ¦ Â¦coronavirusÂ¦ ,â– Â¦tar ge tsÂ¦ Â¦notÂ¦ Â¦onlyÂ¦ Â¦theÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦butÂ¦ Â¦alsoÂ¦ Â¦theÂ¦ Â¦u ro ge ni talÂ¦ Â¦tr actÂ¦ .
ğ‹‡Â¦in te res ti nglyÂ¦ ,â– Â¦theÂ¦ Â¦n ucle ot ideÂ¦ Â¦an al og ueÂ¦ ğ‹‡ Â¦rem desivirÂ¦ Â¦isÂ¦ Â¦knownÂ¦ Â¦toÂ¦ Â¦supp ressÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦rep lic ationÂ¦ Â¦throughÂ¦ Â¦in hib itionÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦ex o rib on ucle aseÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ - Â¦depe ndentÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦pol y mer aseÂ¦ .
ğ‹‡ Â¦takingÂ¦ Â¦overÂ¦ - Â¦theÂ¦ - Â¦coun terÂ¦ Â¦coldÂ¦ Â¦medic ationsÂ¦ ,â– Â¦dr in kingÂ¦ Â¦f lu i dsÂ¦ ,â– Â¦andÂ¦ Â¦res tingÂ¦ Â¦mayÂ¦ Â¦helpÂ¦ Â¦alle vi ateÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦th usÂ¦ ,â– Â¦ifÂ¦ Â¦neededÂ¦ ,â– Â¦s ter oi dsÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦atÂ¦ Â¦lowÂ¦ Â¦d os ageÂ¦ Â¦andÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦shortÂ¦ Â¦timeÂ¦ Â¦inÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦patientsÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦septemberÂ¦ Â¦201 2Â¦ ,â– Â¦aÂ¦ Â¦newÂ¦ Â¦typeÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦wasÂ¦ Â¦identifiedÂ¦ ,â– Â¦initiallyÂ¦ Â¦calledÂ¦ ğ‹‡ Â¦novelÂ¦ ğ‹‡ Â¦coronavirusÂ¦ Â¦201 2Â¦ ,â– Â¦andÂ¦ Â¦nowÂ¦ Â¦off ici allyÂ¦ Â¦na medÂ¦ ğ‹‡Â¦m iddleÂ¦ ğ‹‡Â¦eastÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ).
ğ‹‡Â¦aÂ¦ ğŠ£Â¦c n n Â¦ğŠ¼ Â¦reportÂ¦ Â¦indic atedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦comb inationÂ¦ Â¦ofÂ¦ ğ‹‡Â¦italyÂ¦ ' Â¦sÂ¦ Â¦largeÂ¦ Â¦elder lyÂ¦ Â¦populationÂ¦ Â¦andÂ¦ Â¦in abilityÂ¦ Â¦toÂ¦ Â¦testÂ¦ Â¦allÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦toÂ¦ Â¦dateÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦cont rib u tingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦highÂ¦ Â¦f at alityÂ¦ Â¦rateÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦januaryÂ¦ Â¦20Â¦ ,â– Â¦theÂ¦ Â¦infectionÂ¦ Â¦ofÂ¦ Â¦healthÂ¦ - Â¦careÂ¦ Â¦provi dersÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ ,â– Â¦sugges tingÂ¦ Â¦thatÂ¦ Â¦humanÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦wasÂ¦ Â¦possibleÂ¦ .
ğ‹‡ Â¦surg icalÂ¦ Â¦masksÂ¦ Â¦areÂ¦ Â¦recommendedÂ¦ Â¦forÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦infectedÂ¦ ,â– Â¦asÂ¦ Â¦wearingÂ¦ Â¦aÂ¦ Â¦maskÂ¦ Â¦canÂ¦ Â¦limitÂ¦ Â¦theÂ¦ Â¦vo lu meÂ¦ Â¦andÂ¦ Â¦travelÂ¦ Â¦distanceÂ¦ Â¦ofÂ¦ Â¦exp ir atoryÂ¦ Â¦dr op letsÂ¦ Â¦disp er sedÂ¦ Â¦whenÂ¦ Â¦talkingÂ¦ ,â– Â¦snee zingÂ¦ ,â– Â¦andÂ¦ Â¦c oug hingÂ¦ .
ğ‹‡Â¦weÂ¦ Â¦alsoÂ¦ Â¦reviewÂ¦ Â¦theÂ¦ Â¦tr endÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦ev o lutionÂ¦ Â¦inÂ¦ Â¦whichÂ¦ Â¦theÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦transm is sib il ityÂ¦ Â¦oftenÂ¦ Â¦comesÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦decrea seÂ¦ Â¦inÂ¦ Â¦pathog en ic ityÂ¦ .
ğ‹‡Â¦sinceÂ¦ Â¦casesÂ¦ Â¦haveÂ¦ Â¦soÂ¦ Â¦farÂ¦ Â¦cl ust eredÂ¦ Â¦inÂ¦ Â¦certainÂ¦ Â¦regi onsÂ¦ Â¦inÂ¦ ğŠ£Â¦e uÂ¦ / Â¦ ee aÂ¦ğŠ¼ Â¦countriesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼ ,â– Â¦andÂ¦ Â¦hospitalsÂ¦ Â¦andÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦uni tsÂ¦ Â¦usuallyÂ¦ Â¦ser veÂ¦ Â¦aÂ¦ Â¦def inedÂ¦ Â¦regi onalÂ¦ Â¦c at ch mentÂ¦ Â¦populationÂ¦ ,â– Â¦informationÂ¦ Â¦aboutÂ¦ Â¦casesÂ¦ Â¦andÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦bedsÂ¦ Â¦shouldÂ¦ Â¦pre fer ablyÂ¦ Â¦beÂ¦ Â¦madeÂ¦ Â¦availableÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğ‹‡Â¦no me nc l atureÂ¦ Â¦ofÂ¦ Â¦ter ri to rialÂ¦ Â¦uni tsÂ¦ Â¦forÂ¦ Â¦statisticsÂ¦ Â¦2Â¦ â–( ğŠ£Â¦n ut s Â¦ğŠ¼ - Â¦2Â¦ )â– Â¦levelÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦the re f oreÂ¦ Â¦notÂ¦ Â¦tooÂ¦ Â¦sur pri singÂ¦ Â¦thatÂ¦ Â¦batsÂ¦ Â¦mightÂ¦ Â¦transm itÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦directlyÂ¦ .
ğ‹‡ Â¦threeÂ¦ Â¦majorÂ¦ Â¦riskÂ¦ Â¦factorsÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wereÂ¦ Â¦se xÂ¦ â–( Â¦m aleÂ¦ ),â– Â¦ageÂ¦ â–( â‰¥ Â¦60Â¦ ),â– Â¦andÂ¦ Â¦severeÂ¦ Â¦pneumoniaÂ¦ .
ğ‹‡Â¦accordingÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦humanÂ¦ Â¦v ol un te erÂ¦ Â¦studyÂ¦ ,â– Â¦he al thyÂ¦ Â¦individualsÂ¦ Â¦infectedÂ¦ Â¦withÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ Â¦developedÂ¦ Â¦mildÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦art istsÂ¦ Â¦haveÂ¦ Â¦exp lo redÂ¦ Â¦ waysÂ¦ Â¦toÂ¦ Â¦continueÂ¦ Â¦toÂ¦ Â¦produceÂ¦ Â¦andÂ¦ Â¦sh areÂ¦ Â¦workÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦in tern etÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦al tern ativeÂ¦ Â¦toÂ¦ Â¦tra di ti onalÂ¦ Â¦liveÂ¦ Â¦per form anceÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦liveÂ¦ Â¦st rea mingÂ¦ Â¦concer tsÂ¦ Â¦orÂ¦ Â¦cre atingÂ¦ Â¦we bÂ¦ - Â¦basedÂ¦ â–" Â¦f es ti v alsÂ¦ "â– Â¦forÂ¦ Â¦art istsÂ¦ Â¦toÂ¦ Â¦per formÂ¦ ,â– Â¦distribu teÂ¦ ,â– Â¦andÂ¦ Â¦p ub l ici zeÂ¦ Â¦theirÂ¦ Â¦workÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦18Â¦ ,â– Â¦2020Â¦ ,â– ğ‹‡Â¦b ol iÂ¦ ğ‹‡Â¦z han gÂ¦ Â¦andÂ¦ Â¦co wor kersÂ¦ Â¦publishedÂ¦ Â¦aÂ¦ Â¦studyÂ¦ Â¦toÂ¦ Â¦comp areÂ¦ Â¦w est ernÂ¦ Â¦medicineÂ¦ â–( ğŠ£ Â¦w mÂ¦ğŠ¼ )â– Â¦treatmentÂ¦ Â¦aloneÂ¦ Â¦withÂ¦ Â¦comb inedÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ ğŠ£ Â¦w mÂ¦ğŠ¼ Â¦andÂ¦ ğŠ£Â¦t c mÂ¦ğŠ¼ .
ğ‹‡Â¦theÂ¦ Â¦casesÂ¦ Â¦mo st lyÂ¦ Â¦hadÂ¦ Â¦lin ksÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡ Â¦hu an anÂ¦ ğ‹‡Â¦s ea f o odÂ¦ ğ‹‡ Â¦wh ol es aleÂ¦ ğ‹‡ Â¦marketÂ¦ Â¦andÂ¦ Â¦soÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦z oo no ticÂ¦ Â¦originÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦ex o rib on ucle aseÂ¦ Â¦no nstruc t uralÂ¦ Â¦proteinÂ¦ ,â– Â¦forÂ¦ Â¦in st anceÂ¦ ,â– Â¦providesÂ¦ Â¦ext raÂ¦ Â¦f id el ityÂ¦ Â¦toÂ¦ Â¦rep lic ationÂ¦ Â¦byÂ¦ Â¦providingÂ¦ Â¦aÂ¦ Â¦pr oo f rea dingÂ¦ Â¦fun ctionÂ¦ Â¦whichÂ¦ Â¦theÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ - Â¦depe ndentÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦pol y mer aseÂ¦ Â¦l ac ksÂ¦ . ğ‹‡Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦mainÂ¦ Â¦fun c tionsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦comple xÂ¦ Â¦isÂ¦ Â¦toÂ¦ Â¦rep lic ateÂ¦ Â¦theÂ¦ Â¦viralÂ¦ Â¦genomeÂ¦ .
ğ‹‡ Â¦sevenÂ¦ Â¦trialsÂ¦ Â¦wereÂ¦ Â¦e va lu atingÂ¦ Â¦rep ur p osedÂ¦ Â¦drugsÂ¦ Â¦alreadyÂ¦ Â¦approvedÂ¦ Â¦toÂ¦ Â¦treatÂ¦ Â¦m al ari aÂ¦ ,â– Â¦includingÂ¦ Â¦fourÂ¦ Â¦studiesÂ¦ Â¦onÂ¦ Â¦hydro xy ch loroquineÂ¦ Â¦orÂ¦ Â¦ch loroquineÂ¦ Â¦ph os ph ateÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦rapidlyÂ¦ Â¦increasingÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦p ub licationsÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦emer gingÂ¦ Â¦diseaseÂ¦ ,â– Â¦thisÂ¦ Â¦art ic leÂ¦ Â¦atte mp tsÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦aÂ¦ Â¦ti melyÂ¦ Â¦andÂ¦ Â¦comp re h ensiveÂ¦ Â¦reviewÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦sw i f t lyÂ¦ Â¦developingÂ¦ Â¦researchÂ¦ Â¦subj ectÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦directlyÂ¦ Â¦involvedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦rep lic ationÂ¦ Â¦andÂ¦ Â¦trans c r ip tionÂ¦ Â¦ofÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦fromÂ¦ Â¦anÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦str andÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦epidemicÂ¦ Â¦resul tedÂ¦ Â¦inÂ¦ Â¦8Â¦ , Â¦0 9 6Â¦ Â¦reportedÂ¦ Â¦casesÂ¦ Â¦withÂ¦ Â¦7 7 4Â¦ Â¦deathsÂ¦ ,â– Â¦spreadingÂ¦ Â¦acrossÂ¦ Â¦manyÂ¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦con ti ne ntsÂ¦ .
ğ‹‡Â¦mostÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦origin atedÂ¦ Â¦fromÂ¦ Â¦batsÂ¦ Â¦whereÂ¦ Â¦theyÂ¦ Â¦areÂ¦ Â¦nonÂ¦ - Â¦pathog enicÂ¦ .
ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦al th oughÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦severalÂ¦ Â¦batÂ¦ Â¦coronavirusÂ¦ Â¦speciesÂ¦ ,â– Â¦appe arsÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦di ver gedÂ¦ Â¦fromÂ¦ Â¦theseÂ¦ Â¦severalÂ¦ Â¦ce nt ur iesÂ¦ Â¦agoÂ¦ .
ğ‹‡ Â¦physicalÂ¦ Â¦distancingÂ¦ Â¦measuresÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦recommendedÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦transmissionÂ¦ . ğ‹‡Â¦manyÂ¦ Â¦governmentsÂ¦ Â¦haveÂ¦ Â¦restric tedÂ¦ Â¦orÂ¦ Â¦advisedÂ¦ Â¦againstÂ¦ Â¦allÂ¦ Â¦nonÂ¦ - Â¦essentialÂ¦ Â¦travelÂ¦ Â¦toÂ¦ Â¦andÂ¦ Â¦fromÂ¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦areasÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦theÂ¦ Â¦situationÂ¦ Â¦isÂ¦ Â¦rapidlyÂ¦ Â¦ev ol vingÂ¦ ,â– Â¦theÂ¦ Â¦fin alÂ¦ Â¦sc opeÂ¦ Â¦andÂ¦ Â¦severityÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦remainÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦determ inedÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ ,â– Â¦overÂ¦ Â¦2 4 4Â¦ Â¦thousandÂ¦ Â¦coronavirusÂ¦ Â¦casesÂ¦ Â¦wereÂ¦ Â¦recordedÂ¦ ,â– Â¦lin kingÂ¦ Â¦toÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦5Â¦ , Â¦9 00Â¦ Â¦deathsÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦st ar kÂ¦ Â¦cont ra stÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦r b d ğŠ¼sÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼ 1 3Â¦ Â¦areÂ¦ Â¦moreÂ¦ Â¦di ver gentÂ¦ ,â– Â¦al b e itÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦de g re eÂ¦ Â¦ofÂ¦ Â¦se que nceÂ¦ Â¦ho mo logyÂ¦ Â¦genomeÂ¦ - Â¦ wideÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦earlyÂ¦ ğ‹‡Â¦aprilÂ¦ Â¦2020Â¦ ,â– Â¦1 0 3Â¦ Â¦candid ateÂ¦ Â¦the rap e ut icsÂ¦ Â¦wereÂ¦ Â¦inÂ¦ Â¦pr ec lin icalÂ¦ Â¦orÂ¦ Â¦aÂ¦ Â¦stageÂ¦ Â¦ofÂ¦ ğ‹‡Â¦phaseÂ¦ ğ‹‡Â¦iÂ¦ - ğŠ£Â¦i vÂ¦ğŠ¼ Â¦developmentÂ¦ ,â– Â¦withÂ¦ Â¦trialÂ¦ Â¦resultsÂ¦ Â¦forÂ¦ Â¦29Â¦ Â¦drugÂ¦ Â¦candidatesÂ¦ Â¦expectedÂ¦ Â¦duringÂ¦ ğ‹‡Â¦aprilÂ¦ .
ğ‹‡ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 4Â¦ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦u ti li zeÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦hostÂ¦ Â¦recept orÂ¦ ,â– Â¦d ip e pt id y lÂ¦ Â¦pe pt id aseÂ¦ Â¦4Â¦ â–( ğŠ£Â¦d pp ğŠ¼ 4Â¦ ),â– Â¦forÂ¦ Â¦virusÂ¦ Â¦entryÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– ğ‹‡Â¦coğ‹‡vÂ¦ Â¦canÂ¦ Â¦in hib itÂ¦ ğ‹‡ Â¦tÂ¦ Â¦cellÂ¦ Â¦fun c tionsÂ¦ Â¦byÂ¦ Â¦ind uc ingÂ¦ Â¦a po pt osisÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦tÂ¦ Â¦cellsÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦areÂ¦ Â¦en v el op edÂ¦ Â¦virusesÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦positiveÂ¦ - Â¦s enseÂ¦ Â¦singleÂ¦ - Â¦stra ndedÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦genomeÂ¦ Â¦andÂ¦ Â¦aÂ¦ Â¦n ucle oc ap s idÂ¦ Â¦ofÂ¦ Â¦hel icalÂ¦ Â¦s ym me tryÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦f at al itiesÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦dayÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦evidenceÂ¦ Â¦toÂ¦ Â¦dateÂ¦ Â¦isÂ¦ Â¦thatÂ¦ Â¦c aÂ¦ Â¦80Â¦ %â– Â¦ofÂ¦ Â¦individualsÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦mildÂ¦ Â¦diseaseÂ¦ ,â– Â¦ iÂ¦ . Â¦eÂ¦ .â– Â¦aÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦infectionÂ¦ Â¦withÂ¦ Â¦orÂ¦ Â¦withoutÂ¦ Â¦pneumoniaÂ¦ ,â– Â¦andÂ¦ Â¦mostÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦reco verÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦14Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦aÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ - Â¦ledÂ¦ ğ‹‡ Â¦jo intÂ¦ ğ‹‡Â¦ missionÂ¦ ğ‹‡ Â¦teamÂ¦ Â¦withÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦wasÂ¦ Â¦activ atedÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦internationalÂ¦ Â¦andÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦expertsÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦gr oundÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦toÂ¦ Â¦ass istÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦dom es ticÂ¦ Â¦managementÂ¦ Â¦andÂ¦ Â¦e va lu ateÂ¦ â–" Â¦theÂ¦ Â¦severityÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦transm is sib il ityÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ "â– Â¦byÂ¦ Â¦h os tingÂ¦ Â¦work s ho psÂ¦ Â¦andÂ¦ Â¦m eetingsÂ¦ Â¦withÂ¦ Â¦ke yÂ¦ Â¦nationalÂ¦ - Â¦levelÂ¦ Â¦institu tionsÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦conduc tÂ¦ Â¦f ieldÂ¦ Â¦visi tsÂ¦ Â¦toÂ¦ Â¦ass essÂ¦ Â¦theÂ¦ â–" Â¦impactÂ¦ Â¦ofÂ¦ Â¦responseÂ¦ Â¦activ itiesÂ¦ Â¦atÂ¦ Â¦provi n cialÂ¦ Â¦andÂ¦ Â¦coun tyÂ¦ Â¦levelsÂ¦ ,â– Â¦includingÂ¦ Â¦urbanÂ¦ Â¦andÂ¦ Â¦ruralÂ¦ Â¦set ti ngsÂ¦ ". ğ‹‡Â¦onÂ¦ Â¦25Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦declaredÂ¦ Â¦thatÂ¦ â–" Â¦theÂ¦ Â¦worldÂ¦ Â¦shouldÂ¦ Â¦doÂ¦ Â¦moreÂ¦ Â¦toÂ¦ Â¦prep areÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦possibleÂ¦ Â¦coronavirusÂ¦ Â¦pandemicÂ¦ ,"â– Â¦st atingÂ¦ Â¦thatÂ¦ Â¦whileÂ¦ Â¦itÂ¦ Â¦wasÂ¦ Â¦stillÂ¦ Â¦tooÂ¦ Â¦earlyÂ¦ Â¦toÂ¦ Â¦callÂ¦ Â¦itÂ¦ Â¦aÂ¦ Â¦pandemicÂ¦ ,â– Â¦countriesÂ¦ Â¦shouldÂ¦ Â¦no ne t he lessÂ¦ Â¦beÂ¦ â–" Â¦inÂ¦ Â¦aÂ¦ Â¦phaseÂ¦ Â¦ofÂ¦ Â¦prepar ed nessÂ¦ ".
ğ‹‡ Â¦casesÂ¦ Â¦beganÂ¦ Â¦toÂ¦ Â¦riseÂ¦ Â¦s har p lyÂ¦ ,â– Â¦whichÂ¦ Â¦pro mp tedÂ¦ Â¦theÂ¦ ğ‹‡Â¦i ta lianÂ¦ Â¦governmentÂ¦ Â¦toÂ¦ Â¦susp endÂ¦ Â¦allÂ¦ Â¦flightsÂ¦ Â¦toÂ¦ Â¦andÂ¦ Â¦fromÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦dec l areÂ¦ Â¦aÂ¦ Â¦stateÂ¦ Â¦ofÂ¦ Â¦emergencyÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦v ar ie tyÂ¦ Â¦ofÂ¦ Â¦z oo no ticÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦circ ul atingÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦wi ldÂ¦ .
ğ‹‡ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦experienceÂ¦ Â¦fromÂ¦ ğ‹‡Â¦italyÂ¦ ,â– Â¦countriesÂ¦ ,â– Â¦hospitalsÂ¦ Â¦andÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦uni tsÂ¦ Â¦shouldÂ¦ Â¦increaseÂ¦ Â¦theirÂ¦ Â¦prepar ed nessÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦sur geÂ¦ Â¦ofÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦whoÂ¦ Â¦willÂ¦ Â¦requireÂ¦ Â¦healthcareÂ¦ ,â– Â¦andÂ¦ Â¦inÂ¦ Â¦partic ularÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ .
ğ‹‡Â¦toÂ¦ Â¦conc lu deÂ¦ ,â– Â¦weÂ¦ Â¦h opeÂ¦ Â¦moreÂ¦ Â¦directÂ¦ Â¦evidenceÂ¦ Â¦comingÂ¦ Â¦upÂ¦ Â¦andÂ¦ Â¦callÂ¦ Â¦forÂ¦ Â¦rea dersÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦theirÂ¦ Â¦com mentsÂ¦ .
ğ‹‡ Â¦individualsÂ¦ Â¦mayÂ¦ Â¦app lyÂ¦ Â¦socialÂ¦ Â¦distancingÂ¦ Â¦meth odsÂ¦ Â¦byÂ¦ Â¦sta yingÂ¦ Â¦atÂ¦ Â¦homeÂ¦ ,â– Â¦limi tingÂ¦ Â¦travelÂ¦ ,â– Â¦avoi dingÂ¦ Â¦crowdedÂ¦ Â¦areasÂ¦ ,â– Â¦usingÂ¦ Â¦noÂ¦ - Â¦contactÂ¦ Â¦gr eetingsÂ¦ ,â– Â¦andÂ¦ Â¦phys icallyÂ¦ Â¦distancingÂ¦ Â¦the ms el vesÂ¦ Â¦fromÂ¦ Â¦othersÂ¦ .
ğ‹‡ Â¦diagn osingÂ¦ Â¦theÂ¦ Â¦confirmedÂ¦ Â¦caseÂ¦ Â¦shouldÂ¦ Â¦b aseÂ¦ Â¦onÂ¦ Â¦suspectedÂ¦ Â¦caseÂ¦ Â¦withÂ¦ Â¦anyÂ¦ Â¦oneÂ¦ Â¦i te mÂ¦ Â¦ofÂ¦ Â¦pathog enicÂ¦ Â¦orÂ¦ Â¦sero logicalÂ¦ Â¦evidenceÂ¦ Â¦asÂ¦ Â¦followingÂ¦ : â–( Â¦1Â¦ )â– Â¦realÂ¦ - Â¦timeÂ¦ ğŠ£ Â¦pcrÂ¦ğŠ¼ Â¦testÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ; â–( Â¦2Â¦ )â– Â¦viralÂ¦ Â¦wholeÂ¦ Â¦genomeÂ¦ Â¦sequencingÂ¦ Â¦sh owingÂ¦ Â¦highÂ¦ Â¦ho mo ge ne ityÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦knownÂ¦ Â¦novelÂ¦ Â¦coronavirusesÂ¦ ; â–( Â¦3Â¦ )â– Â¦positiveÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦specificÂ¦ ğ‹‡Â¦i g ğ‹‡ mÂ¦ Â¦antibodyÂ¦ Â¦andÂ¦ ğ‹‡Â¦i g ğ‹‡ gÂ¦ Â¦antibodyÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦inÂ¦ Â¦ser umÂ¦ Â¦testÂ¦ ;â– Â¦orÂ¦ Â¦aÂ¦ Â¦changeÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦specificÂ¦ ğ‹‡Â¦i g ğ‹‡ gÂ¦ Â¦antibodyÂ¦ Â¦fromÂ¦ Â¦negativeÂ¦ Â¦toÂ¦ Â¦positiveÂ¦ ,â– Â¦orÂ¦ Â¦ti terÂ¦ Â¦r isingÂ¦ â– â‰¥ Â¦4Â¦ Â¦timesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦recoveryÂ¦ Â¦phaseÂ¦ Â¦aboveÂ¦ Â¦thatÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦acuteÂ¦ Â¦phaseÂ¦ .
ğ‹‡ Â¦eightÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦doctorsÂ¦ ,â– Â¦includingÂ¦ ğ‹‡Â¦l iÂ¦ ğ‹‡Â¦w en li an gÂ¦ ,â– Â¦wereÂ¦ Â¦ad mon ish edÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦policeÂ¦ Â¦forÂ¦ Â¦spreadingÂ¦ Â¦f alseÂ¦ Â¦r um our sÂ¦ ,â– Â¦andÂ¦ Â¦anotherÂ¦ ,â– ğ‹‡Â¦a iÂ¦ ğ‹‡Â¦f enÂ¦ ,â– Â¦wasÂ¦ Â¦re pri ma ndedÂ¦ Â¦byÂ¦ Â¦herÂ¦ Â¦sup e ri orsÂ¦ Â¦forÂ¦ Â¦ra isingÂ¦ Â¦theÂ¦ Â¦al ar mÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦wasÂ¦ Â¦informedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦thisÂ¦ Â¦chestÂ¦ Â¦painÂ¦ Â¦startedÂ¦ ?
ğ‹‡Â¦shi aÂ¦ Â¦sh r inesÂ¦ Â¦inÂ¦ ğ‹‡Â¦ q omÂ¦ Â¦rema inedÂ¦ Â¦openÂ¦ Â¦toÂ¦ Â¦p il g ri msÂ¦ Â¦untilÂ¦ Â¦16Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ . ğ‹‡Â¦ iranÂ¦ Â¦becameÂ¦ Â¦aÂ¦ Â¦c entr eÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦afterÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦duringÂ¦ ğ‹‡Â¦februaryÂ¦ .
ğ‹‡ Â¦longÂ¦ - Â¦termÂ¦ Â¦interv en tionÂ¦ Â¦toÂ¦ Â¦supp ressÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦causesÂ¦ Â¦socialÂ¦ Â¦andÂ¦ Â¦economicÂ¦ Â¦c ostsÂ¦ .
ğ‹‡Â¦iÂ¦ ' Â¦ veÂ¦ Â¦veryÂ¦ Â¦concernedÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğŠ£Â¦usÂ¦ğŠ¼ Â¦authoritiesÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦acc usedÂ¦ Â¦ofÂ¦ Â¦di ver tingÂ¦ Â¦a idÂ¦ Â¦me antÂ¦ Â¦forÂ¦ Â¦otherÂ¦ Â¦n ationsÂ¦ Â¦toÂ¦ Â¦theirÂ¦ Â¦ownÂ¦ Â¦countryÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦det ectionÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦viaÂ¦ Â¦re verseÂ¦ - Â¦trans c ri pt aseÂ¦ Â¦pol y mer aseÂ¦ Â¦chainÂ¦ Â¦rea ctionÂ¦ â–( ğŠ£Â¦rtÂ¦ - Â¦pcrÂ¦ğŠ¼ )â– Â¦wasÂ¦ Â¦usedÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦c ri teri aÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diagn osisÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡ Â¦emer gingÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦ â– â€“ â– ğ‹‡ Â¦infectiousÂ¦ Â¦diseaseÂ¦ Â¦ofÂ¦ Â¦emer gingÂ¦ Â¦pathog enÂ¦ ,â– Â¦oftenÂ¦ Â¦novelÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦outbreakÂ¦ Â¦ran geÂ¦ Â¦orÂ¦ Â¦transmissionÂ¦ Â¦mo deÂ¦
ğ‹‡ Â¦ki mb er lyÂ¦ - ğ‹‡ Â¦cl ar kÂ¦ ,â– Â¦whichÂ¦ Â¦ma kesÂ¦ ğ‹‡Â¦k l ee ne xÂ¦ ğ‹‡ Â¦to il etÂ¦ ğ‹‡Â¦t iss ueÂ¦ ,â– Â¦andÂ¦ ğ‹‡ Â¦sol ari sÂ¦ ğ‹‡ Â¦paperÂ¦ Â¦whichÂ¦ Â¦ma kesÂ¦ ğ‹‡Â¦s or b entÂ¦ ,â– Â¦emp ha si zedÂ¦ Â¦theyÂ¦ Â¦wereÂ¦ Â¦workingÂ¦ Â¦24Â¦ / Â¦7Â¦ Â¦toÂ¦ Â¦main tainÂ¦ Â¦theÂ¦ Â¦supplyÂ¦ ,â– Â¦accordingÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡ Â¦newsÂ¦ . Â¦c omÂ¦ . Â¦a uÂ¦ Â¦reportÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦a ust ri anÂ¦ Â¦governmentÂ¦ Â¦ma nd atedÂ¦ Â¦thatÂ¦ Â¦everyoneÂ¦ Â¦ent eringÂ¦ Â¦aÂ¦ Â¦groc eryÂ¦ Â¦storeÂ¦ Â¦mustÂ¦ Â¦wearÂ¦ Â¦aÂ¦ Â¦faceÂ¦ Â¦maskÂ¦ .
ğ‹‡ Â¦basedÂ¦ Â¦onÂ¦ Â¦theseÂ¦ ,â– ğ‹‡ Â¦gi le adÂ¦ Â¦hasÂ¦ Â¦providedÂ¦ Â¦theÂ¦ Â¦comp oundÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦toÂ¦ Â¦conduc tÂ¦ Â¦aÂ¦ Â¦pa irÂ¦ Â¦ofÂ¦ Â¦trialsÂ¦ Â¦onÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦infectedÂ¦ Â¦individualsÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦resultsÂ¦ Â¦areÂ¦ Â¦high lyÂ¦ Â¦anti cip atedÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦22Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦amongÂ¦ Â¦9Â¦ , Â¦3 3 6Â¦ Â¦fo ll ow ersÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ch ur chÂ¦ ,â– Â¦1Â¦ , Â¦2 6 1Â¦ Â¦orÂ¦ Â¦aboutÂ¦ Â¦13Â¦ %â– Â¦reportedÂ¦ Â¦symptomsÂ¦ . ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ Â¦declaredÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦al er tÂ¦ Â¦onÂ¦ Â¦23Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ .
ğ‹‡ Â¦glo b a liz ationÂ¦ Â¦andÂ¦ Â¦diseaseÂ¦ â– â€“ â– ğ‹‡ Â¦over v ie wÂ¦ Â¦ofÂ¦ Â¦glo b a liz ationÂ¦ Â¦andÂ¦ Â¦diseaseÂ¦ Â¦transmissionÂ¦
ğ‹‡Â¦atÂ¦ Â¦leastÂ¦ Â¦12Â¦ Â¦s ittingÂ¦ Â¦orÂ¦ Â¦formerÂ¦ ğ‹‡Â¦i ra ni anÂ¦ Â¦polit i ciansÂ¦ Â¦andÂ¦ Â¦governmentÂ¦ Â¦officialsÂ¦ Â¦hadÂ¦ Â¦diedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦byÂ¦ Â¦17Â¦ ğ‹‡Â¦marchÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦the re f oreÂ¦ Â¦imp os si bleÂ¦ Â¦toÂ¦ Â¦s ac ri f iceÂ¦ Â¦allÂ¦ Â¦cam elsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦controlÂ¦ Â¦ofÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ ,â– Â¦asÂ¦ Â¦whatÂ¦ Â¦wasÂ¦ Â¦doneÂ¦ Â¦inÂ¦ Â¦wi ldÂ¦ Â¦animalÂ¦ Â¦marketsÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦theÂ¦ Â¦spreadingÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦becauseÂ¦ Â¦outsideÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦bodyÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦killedÂ¦ Â¦byÂ¦ Â¦house ho ldÂ¦ Â¦soapÂ¦ ,â– Â¦whichÂ¦ Â¦bur s tsÂ¦ Â¦itsÂ¦ Â¦protectiveÂ¦ Â¦b ub bleÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦cdcÂ¦ğŠ¼ Â¦recommendsÂ¦ Â¦thatÂ¦ Â¦peopleÂ¦ Â¦washÂ¦ Â¦handsÂ¦ Â¦oftenÂ¦ Â¦withÂ¦ Â¦soapÂ¦ Â¦andÂ¦ Â¦waterÂ¦ Â¦forÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦tw en tyÂ¦ Â¦se co ndsÂ¦ ,â– Â¦especiallyÂ¦ Â¦afterÂ¦ Â¦goingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦to il etÂ¦ Â¦orÂ¦ Â¦whenÂ¦ Â¦handsÂ¦ Â¦areÂ¦ Â¦vi sib lyÂ¦ Â¦dir tyÂ¦ ;â– Â¦beforeÂ¦ Â¦e atingÂ¦ ;â– Â¦andÂ¦ Â¦afterÂ¦ Â¦bl owingÂ¦ Â¦oneÂ¦ ' Â¦sÂ¦ Â¦noseÂ¦ ,â– Â¦c oug hingÂ¦ ,â– Â¦orÂ¦ Â¦snee zingÂ¦ .
ğ‹‡ Â¦rapidlyÂ¦ Â¦increasingÂ¦ Â¦c u mul ativeÂ¦ Â¦incidenceÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ )â– Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦europeanÂ¦ ğ‹‡Â¦unionÂ¦ / ğ‹‡Â¦europeanÂ¦ ğ‹‡ Â¦economicÂ¦ ğ‹‡ Â¦areaÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡ Â¦ki ng d omÂ¦ ,â– Â¦1Â¦ ğ‹‡Â¦januaryÂ¦ Â¦toÂ¦ Â¦15Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦
ğ‹‡Â¦theÂ¦ Â¦highÂ¦ - Â¦thr ou gh p utÂ¦ Â¦aut om atedÂ¦ Â¦systemsÂ¦ Â¦inÂ¦ Â¦manyÂ¦ Â¦clinicalÂ¦ Â¦laboratoriesÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦ableÂ¦ Â¦toÂ¦ Â¦per formÂ¦ Â¦theseÂ¦ Â¦ass a ysÂ¦ Â¦butÂ¦ Â¦theirÂ¦ Â¦availabilityÂ¦ Â¦willÂ¦ Â¦dep endÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦rateÂ¦ Â¦ofÂ¦ Â¦productionÂ¦ Â¦forÂ¦ Â¦eachÂ¦ Â¦systemÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦averageÂ¦ Â¦timeÂ¦ Â¦fromÂ¦ Â¦onsetÂ¦ Â¦toÂ¦ Â¦deathÂ¦ Â¦wasÂ¦ Â¦9Â¦ . Â¦5Â¦ â–( Â¦4Â¦ . Â¦8Â¦ - Â¦13Â¦ )â– Â¦daysÂ¦ .
ğ‹‡Â¦peopleÂ¦ Â¦haveÂ¦ Â¦testedÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦threeÂ¦ Â¦daysÂ¦ Â¦beforeÂ¦ Â¦onsetÂ¦ Â¦ofÂ¦ Â¦symptomsÂ¦ Â¦sugges tingÂ¦ Â¦transmissionÂ¦ Â¦isÂ¦ Â¦possibleÂ¦ Â¦beforeÂ¦ Â¦developingÂ¦ Â¦significantÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦virusÂ¦ Â¦canÂ¦ Â¦spreadÂ¦ Â¦toÂ¦ Â¦differentÂ¦ Â¦organ sÂ¦ Â¦thr oug ho utÂ¦ Â¦theÂ¦ Â¦ch ic kenÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦authoritiesÂ¦ Â¦alsoÂ¦ Â¦announcedÂ¦ Â¦theÂ¦ Â¦con structionÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦tempor aryÂ¦ Â¦hospitalÂ¦ ,â– ğ‹‡ Â¦hu os he ns hanÂ¦ ğ‹‡Â¦hospitalÂ¦ ,â– Â¦whichÂ¦ Â¦wasÂ¦ Â¦completedÂ¦ Â¦inÂ¦ Â¦10Â¦ Â¦daysÂ¦ .
ğ‹‡ Â¦int ri gu i nglyÂ¦ ,â– Â¦se raÂ¦ Â¦ofÂ¦ Â¦con v al esc entÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦patientsÂ¦ Â¦wereÂ¦ Â¦c ap ableÂ¦ Â¦ofÂ¦ Â¦ne ut ra li zingÂ¦ ğŠ£ Â¦wi v ğŠ¼ 1Â¦ .
ğ‹‡Â¦toÂ¦ Â¦furtherÂ¦ Â¦alle vi ateÂ¦ Â¦theÂ¦ Â¦shortageÂ¦ ,â– ğ‹‡Â¦co lesÂ¦ Â¦orderedÂ¦ Â¦bi gg erÂ¦ Â¦p ac ka gesÂ¦ Â¦fromÂ¦ Â¦suppli ersÂ¦ Â¦andÂ¦ Â¦increasedÂ¦ Â¦deliveryÂ¦ Â¦fre que ncyÂ¦ ,â– ğ‹‡Â¦w o ol wor th sÂ¦ Â¦orderedÂ¦ Â¦ext raÂ¦ Â¦stockÂ¦ ,â– Â¦whileÂ¦ ğŠ£Â¦a ld iÂ¦ğŠ¼ Â¦madeÂ¦ Â¦stocksÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦plannedÂ¦ ğ‹‡Â¦wednesdayÂ¦ Â¦specialÂ¦ Â¦availableÂ¦ Â¦earlyÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦areÂ¦ Â¦twoÂ¦ Â¦typesÂ¦ Â¦ofÂ¦ Â¦c an ineÂ¦ Â¦coronavirusÂ¦ â–( ğŠ£Â¦c c ğŠ¼ o ğ‹‡ vÂ¦ ),â– Â¦oneÂ¦ Â¦thatÂ¦ Â¦causesÂ¦ Â¦mildÂ¦ Â¦g as tr oi nt est in alÂ¦ Â¦diseaseÂ¦ Â¦andÂ¦ Â¦oneÂ¦ Â¦thatÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦respiratoryÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦whileÂ¦ Â¦int actÂ¦ ğŠ£ Â¦or f ğŠ¼ 4Â¦ Â¦couldÂ¦ Â¦beÂ¦ Â¦observedÂ¦ Â¦inÂ¦ Â¦batÂ¦ Â¦andÂ¦ Â¦cam elÂ¦ Â¦virusesÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ ,â– Â¦theÂ¦ Â¦al p ac aÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦disp la ysÂ¦ Â¦aÂ¦ Â¦singleÂ¦ Â¦n ucle ot ideÂ¦ Â¦ins er tionÂ¦ ,â– Â¦resul tingÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦fr am es hi ftÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦countriesÂ¦ Â¦inÂ¦ ğ‹‡Â¦africaÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦seenÂ¦ Â¦aÂ¦ Â¦riseÂ¦ Â¦inÂ¦ Â¦antiÂ¦ - ğ‹‡Â¦chineseÂ¦ Â¦s enti mentÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦cam elsÂ¦ Â¦ser veÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦importantÂ¦ Â¦to olÂ¦ Â¦forÂ¦ Â¦transportationÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦mainÂ¦ Â¦s ourceÂ¦ Â¦ofÂ¦ Â¦me atÂ¦ ,â– Â¦mil kÂ¦ ,â– Â¦lea therÂ¦ Â¦andÂ¦ Â¦w o olÂ¦ Â¦produc tsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦localÂ¦ Â¦peopleÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theirÂ¦ Â¦workÂ¦ Â¦alsoÂ¦ Â¦needsÂ¦ Â¦upd ateÂ¦ Â¦accordingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦l at estÂ¦ ğ‹‡ Â¦diagn osisÂ¦ Â¦andÂ¦ ğ‹‡ Â¦treatmentÂ¦ ğ‹‡ Â¦guidelinesÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ â–( ğ‹‡ Â¦trialÂ¦ Â¦se v en thÂ¦ Â¦ ver sionÂ¦ )â– Â¦andÂ¦ Â¦recentlyÂ¦ Â¦studiesÂ¦ .
ğ‹‡ Â¦coronavirusesÂ¦ Â¦canÂ¦ Â¦causeÂ¦ Â¦c ol dsÂ¦ Â¦withÂ¦ Â¦majorÂ¦ Â¦symptomsÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦feverÂ¦ ,â– Â¦andÂ¦ Â¦aÂ¦ Â¦s oreÂ¦ Â¦throatÂ¦ Â¦fromÂ¦ Â¦sw o ll enÂ¦ Â¦ad en oi dsÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦studyÂ¦ Â¦publishedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ ğ‹‡Â¦centerÂ¦ Â¦forÂ¦ ğ‹‡Â¦diseaseÂ¦ ğ‹‡Â¦controlÂ¦ Â¦andÂ¦ ğ‹‡Â¦preventionÂ¦ Â¦hasÂ¦ Â¦conc lu dedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦5Â¦ . Â¦7Â¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦moreÂ¦ Â¦pathog enicÂ¦ Â¦thanÂ¦ Â¦communityÂ¦ - Â¦acqu iredÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦andÂ¦ Â¦lessÂ¦ Â¦pathog enicÂ¦ Â¦thanÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦orÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦atÂ¦ Â¦leastÂ¦ Â¦5 2Â¦ Â¦thousandÂ¦ Â¦deathsÂ¦ Â¦wereÂ¦ Â¦lin kedÂ¦ Â¦toÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡ Â¦fourÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦coronavirusesÂ¦ Â¦continu allyÂ¦ Â¦circ ul ateÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦populationÂ¦ Â¦andÂ¦ Â¦produceÂ¦ Â¦theÂ¦ Â¦gener allyÂ¦ Â¦mildÂ¦ Â¦symptomsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ Â¦inÂ¦ Â¦adultsÂ¦ Â¦andÂ¦ Â¦childrenÂ¦ Â¦worldwideÂ¦ : â–- ğŠ£Â¦ oc 43Â¦ , â–- Â¦h k u 1Â¦ ,â– Â¦h c ğŠ¼ o ğ‹‡ vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ , â–- ğŠ£Â¦n l ğŠ¼ 6 3Â¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦aprilÂ¦ Â¦7Â¦ ,â– Â¦2020Â¦ ,â– Â¦onlyÂ¦ Â¦aÂ¦ Â¦singleÂ¦ Â¦testÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦approvedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğŠ£Â¦f daÂ¦ğŠ¼ Â¦underÂ¦ Â¦anÂ¦ Â¦emergencyÂ¦ Â¦useÂ¦ Â¦aut ho ri z ationÂ¦ . ğ‹‡Â¦inÂ¦ Â¦lateÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– ğ‹‡Â¦e ur oi m m u nÂ¦ ğ‹‡Â¦medicalÂ¦ ğ‹‡ Â¦laboratoryÂ¦ ğ‹‡ Â¦diagn o st icsÂ¦ Â¦andÂ¦ ğ‹‡Â¦e p it opeÂ¦ ğ‹‡ Â¦diagn o st icsÂ¦ Â¦receivedÂ¦ ğ‹‡Â¦europeanÂ¦ Â¦appro v alsÂ¦ Â¦forÂ¦ Â¦theirÂ¦ Â¦testÂ¦ Â¦kitsÂ¦ ,â– Â¦whichÂ¦ Â¦canÂ¦ Â¦det ectÂ¦ ğ‹‡Â¦i g ğ‹‡ gÂ¦ Â¦andÂ¦ ğ‹‡Â¦i g ğ‹‡ aÂ¦ Â¦antibodiesÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦inÂ¦ Â¦bloodÂ¦ Â¦samplesÂ¦ .
ğ‹‡Â¦z oo no ticÂ¦ Â¦origin sÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ Â¦coronavirusesÂ¦
ğ‹‡ Â¦anyoneÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦familyÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦heartÂ¦ Â¦problemÂ¦ Â¦heartÂ¦ Â¦diseaseÂ¦ Â¦heartÂ¦ Â¦att ackÂ¦ Â¦highÂ¦ Â¦ch ol es ter olÂ¦ Â¦highÂ¦ Â¦bloodÂ¦ Â¦pressureÂ¦
ğ‹‡ Â¦showÂ¦ Â¦meÂ¦ Â¦onÂ¦ Â¦thisÂ¦ Â¦i m ageÂ¦ Â¦whereÂ¦ Â¦youÂ¦ Â¦feelÂ¦ Â¦theÂ¦ Â¦painÂ¦
ğ‹‡Â¦allÂ¦ Â¦ofÂ¦ Â¦themÂ¦ Â¦hadÂ¦ Â¦liveÂ¦ Â¦bir thÂ¦ Â¦p reg na nciesÂ¦ Â¦andÂ¦ Â¦noÂ¦ Â¦severeÂ¦ Â¦ne o na talÂ¦ Â¦as ph y xiaÂ¦ Â¦wasÂ¦ Â¦observedÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦cont ra stÂ¦ ,â– Â¦high lyÂ¦ Â¦pathog enicÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦haveÂ¦ Â¦notÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦wellÂ¦ Â¦andÂ¦ Â¦theirÂ¦ Â¦transmissionÂ¦ Â¦withinÂ¦ Â¦humansÂ¦ Â¦cannotÂ¦ Â¦beÂ¦ Â¦s us tainedÂ¦ .
ğ‹‡Â¦bÂ¦ ' ğ‹‡ Â¦coronavirusesÂ¦ Â¦areÂ¦ Â¦aÂ¦ Â¦groupÂ¦ Â¦ofÂ¦ Â¦relatedÂ¦ Â¦virusesÂ¦ Â¦thatÂ¦ Â¦causeÂ¦ Â¦diseasesÂ¦ Â¦inÂ¦ Â¦m amm alsÂ¦ Â¦andÂ¦ Â¦bir dsÂ¦ .
ğ‹‡ Â¦threeÂ¦ Â¦feetÂ¦ Â¦isÂ¦ Â¦consideredÂ¦ Â¦anÂ¦ Â¦appropriateÂ¦ Â¦distanceÂ¦ Â¦forÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦stayÂ¦ Â¦awayÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦patientÂ¦ .
ğ‹‡Â¦fromÂ¦ Â¦anotherÂ¦ Â¦per sp ectiveÂ¦ ,â– Â¦itÂ¦ Â¦mightÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦tr ueÂ¦ Â¦thatÂ¦ Â¦humansÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦wellÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦theseÂ¦ Â¦fourÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦thursdayÂ¦ ,â– ğ‹‡ Â¦associatedÂ¦ ğ‹‡ Â¦pressÂ¦ Â¦reportedÂ¦ Â¦thereÂ¦ Â¦wereÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦12 6Â¦ , Â¦000Â¦ Â¦casesÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦worldwideÂ¦ ,â– Â¦resul tingÂ¦ Â¦inÂ¦ Â¦overÂ¦ Â¦4Â¦ , Â¦6 00Â¦ Â¦deathsÂ¦ .
ğ‹‡Â¦chinaÂ¦ Â¦hasÂ¦ Â¦alsoÂ¦ Â¦calledÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦toÂ¦ Â¦li ftÂ¦ Â¦itsÂ¦ Â¦sa nc tionsÂ¦ Â¦offÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦sy ri aÂ¦ ,â– ğ‹‡ Â¦ve ne z u el aÂ¦ Â¦andÂ¦ ğ‹‡Â¦ iranÂ¦ ,â– Â¦whileÂ¦ Â¦rep ort ed lyÂ¦ Â¦s endingÂ¦ Â¦a idÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦la tterÂ¦ Â¦twoÂ¦ Â¦countriesÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦causesÂ¦ Â¦severeÂ¦ Â¦respiratoryÂ¦ Â¦infectionÂ¦ Â¦likeÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦pres entedÂ¦ Â¦asÂ¦ Â¦feverÂ¦ ,â– Â¦coughÂ¦ Â¦andÂ¦ Â¦d y sp ne aÂ¦ .
ğ‹‡Â¦meanwhileÂ¦ ,â– Â¦theÂ¦ Â¦epidemicÂ¦ Â¦rapidlyÂ¦ Â¦spreadÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦ne i gh bo ringÂ¦ Â¦citiesÂ¦ ,â– Â¦provi n cesÂ¦ ,â– Â¦andÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦s por tsÂ¦ Â¦eventsÂ¦ Â¦andÂ¦ Â¦se as onsÂ¦ Â¦wereÂ¦ Â¦cance lledÂ¦ . ğ‹‡Â¦onÂ¦ Â¦11Â¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦trumpÂ¦ Â¦announcedÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ Â¦forÂ¦ Â¦mostÂ¦ Â¦ofÂ¦ ğ‹‡Â¦europeÂ¦ ,â– Â¦exclu dingÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡ Â¦ki ng d omÂ¦ ,â– Â¦forÂ¦ Â¦30Â¦ Â¦daysÂ¦ ,â– Â¦effectiveÂ¦ Â¦13Â¦ ğ‹‡Â¦marchÂ¦ .
ğ‹‡Â¦byÂ¦ Â¦13Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦moreÂ¦ Â¦thanÂ¦ Â¦for tyÂ¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦ter rit oriesÂ¦ Â¦hadÂ¦ Â¦reportedÂ¦ Â¦deathsÂ¦ ,â– Â¦onÂ¦ Â¦everyÂ¦ Â¦cont in entÂ¦ Â¦exceptÂ¦ ğ‹‡Â¦ ant ar ct icaÂ¦ . ğ‹‡ Â¦severalÂ¦ Â¦measuresÂ¦ Â¦areÂ¦ Â¦com mon lyÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦qu anti fyÂ¦ Â¦mortalityÂ¦ .
ğ‹‡Â¦i raÂ¦ ğ‹‡Â¦lo ng in iÂ¦ ,â– Â¦ etÂ¦ Â¦ alÂ¦ . ,â– Â¦establishedÂ¦ Â¦aÂ¦ Â¦mod elÂ¦ Â¦toÂ¦ Â¦pr edic tÂ¦ Â¦theÂ¦ Â¦out comeÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦andÂ¦ Â¦suggestedÂ¦ Â¦thatÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦couldÂ¦ Â¦inf ectÂ¦ Â¦twoÂ¦ - Â¦th ir dsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦31Â¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ ,â– Â¦theÂ¦ Â¦outbreakÂ¦ Â¦wasÂ¦ Â¦tr acedÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦novelÂ¦ Â¦strainÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ ,â– Â¦whichÂ¦ Â¦wasÂ¦ Â¦givenÂ¦ Â¦theÂ¦ Â¦in teri mÂ¦ Â¦nameÂ¦ Â¦2019Â¦ - Â¦n ğ‹‡ co ğ‹‡ vÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ â–( ğŠ£Â¦whoÂ¦ğŠ¼ ),â– Â¦laterÂ¦ Â¦re na medÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦internationalÂ¦ ğ‹‡Â¦comm itteeÂ¦ Â¦onÂ¦ ğ‹‡Â¦ta x on om yÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦virusesÂ¦ .
ğ‹‡ Â¦followÂ¦ - Â¦upÂ¦ Â¦i ma gesÂ¦ Â¦afterÂ¦ Â¦deliveryÂ¦ Â¦showedÂ¦ Â¦noÂ¦ Â¦progr essionÂ¦ Â¦ofÂ¦ Â¦pneumoniaÂ¦ . ğ‹‡ Â¦mediaÂ¦ Â¦reportsÂ¦ Â¦indic ateÂ¦ Â¦thatÂ¦ Â¦overÂ¦ Â¦100Â¦ Â¦womenÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦mightÂ¦ Â¦haveÂ¦ Â¦deli v eredÂ¦ ,â– Â¦andÂ¦ Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦noÂ¦ Â¦ma tern alÂ¦ Â¦deathsÂ¦ Â¦wereÂ¦ Â¦reportedÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦main landÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦majorÂ¦ Â¦economyÂ¦ Â¦andÂ¦ Â¦manufacturingÂ¦ Â¦hu bÂ¦ ,â– Â¦theÂ¦ Â¦viralÂ¦ Â¦outbreakÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦seenÂ¦ Â¦toÂ¦ Â¦p oseÂ¦ Â¦aÂ¦ Â¦majorÂ¦ Â¦d es ta bi li zingÂ¦ Â¦th re atÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦economyÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦estim atesÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦deathÂ¦ - Â¦toÂ¦ - Â¦caseÂ¦ Â¦r ati oÂ¦ Â¦decreasedÂ¦ Â¦fromÂ¦ Â¦17Â¦ . Â¦3Â¦ % â–( Â¦forÂ¦ Â¦thoseÂ¦ Â¦withÂ¦ Â¦s ym pt omÂ¦ Â¦onsetÂ¦ Â¦1Â¦ â€“ Â¦10Â¦ ğ‹‡Â¦januaryÂ¦ Â¦2020Â¦ )â– Â¦toÂ¦ Â¦0Â¦ . Â¦7Â¦ % â–( Â¦forÂ¦ Â¦thoseÂ¦ Â¦withÂ¦ Â¦s ym pt omÂ¦ Â¦onsetÂ¦ Â¦afterÂ¦ Â¦1Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ ). ğ‹‡Â¦otherÂ¦ Â¦measuresÂ¦ Â¦includeÂ¦ Â¦theÂ¦ Â¦caseÂ¦ Â¦f at alityÂ¦ Â¦rateÂ¦ â–( ğŠ£Â¦c f rÂ¦ğŠ¼ ),â– Â¦whichÂ¦ Â¦ref l ectsÂ¦ Â¦theÂ¦ Â¦percentÂ¦ Â¦ofÂ¦ Â¦diagnosedÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦dieÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦infectionÂ¦ Â¦f at alityÂ¦ Â¦rateÂ¦ â–( ğŠ£Â¦i f rÂ¦ğŠ¼ ),â– Â¦whichÂ¦ Â¦ref l ectsÂ¦ Â¦theÂ¦ Â¦percentÂ¦ Â¦ofÂ¦ Â¦infectedÂ¦ â–( Â¦diagnosedÂ¦ Â¦andÂ¦ Â¦un dia gn osedÂ¦ )â– Â¦whoÂ¦ Â¦dieÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦currentlyÂ¦ ,â– Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦lackÂ¦ Â¦ofÂ¦ Â¦effectiveÂ¦ Â¦andÂ¦ Â¦specificÂ¦ Â¦therapyÂ¦ Â¦forÂ¦ ğŠ£ Â¦covidÂ¦ - Â¦19Â¦ ,â– Â¦t c mÂ¦ğŠ¼ Â¦hasÂ¦ Â¦becomeÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦al tern ativeÂ¦ Â¦tre at mentsÂ¦ Â¦forÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦ lightÂ¦ Â¦toÂ¦ Â¦mo der ateÂ¦ Â¦symptomsÂ¦ Â¦orÂ¦ Â¦forÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦recoveredÂ¦ Â¦fromÂ¦ Â¦severeÂ¦ Â¦stagesÂ¦ .
ğ‹‡Â¦th ai landÂ¦ Â¦isÂ¦ Â¦usingÂ¦ Â¦anÂ¦ Â¦appÂ¦ Â¦andÂ¦ ğŠ£ Â¦si mÂ¦ğŠ¼ Â¦c ardsÂ¦ Â¦forÂ¦ Â¦allÂ¦ Â¦trave l ersÂ¦ Â¦toÂ¦ Â¦enfor ceÂ¦ Â¦theirÂ¦ Â¦quarantineÂ¦ .
ğ‹‡Â¦moreÂ¦ Â¦thanÂ¦ Â¦30Â¦ %â– Â¦ofÂ¦ Â¦patientsÂ¦ Â¦presentÂ¦ Â¦withÂ¦ Â¦g as tr oi nt est in alÂ¦ Â¦symptomsÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦diarrheaÂ¦ Â¦andÂ¦ Â¦vo mi tingÂ¦ .
ğ‹‡ Â¦mis in form ationÂ¦ Â¦aboutÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦hasÂ¦ Â¦spreadÂ¦ Â¦onlineÂ¦ ,â– Â¦andÂ¦ Â¦thereÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦in ci dentsÂ¦ Â¦ofÂ¦ Â¦ x en op ho bi aÂ¦ Â¦andÂ¦ Â¦disc ri m inationÂ¦ Â¦againstÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦peopleÂ¦ ,â– Â¦otherÂ¦ Â¦peopleÂ¦ Â¦ofÂ¦ ğ‹‡Â¦eastÂ¦ Â¦andÂ¦ ğ‹‡Â¦s ou th eastÂ¦ ğ‹‡Â¦a si anÂ¦ Â¦d esc entÂ¦ Â¦andÂ¦ Â¦appe ar anceÂ¦ ,â– Â¦andÂ¦ Â¦othersÂ¦ Â¦fromÂ¦ Â¦areasÂ¦ Â¦withÂ¦ Â¦significantÂ¦ Â¦virusÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦ad ap tiveÂ¦ Â¦desi gnsÂ¦ Â¦withinÂ¦ Â¦ongoingÂ¦ ğ‹‡Â¦phaseÂ¦ ğŠ£Â¦i iÂ¦ - Â¦i i iÂ¦ğŠ¼ Â¦clinicalÂ¦ Â¦trialsÂ¦ Â¦onÂ¦ Â¦candid ateÂ¦ Â¦the rap e ut icsÂ¦ Â¦mayÂ¦ Â¦sh ort enÂ¦ Â¦trialÂ¦ Â¦d ur ationsÂ¦ Â¦andÂ¦ Â¦useÂ¦ Â¦fe w erÂ¦ Â¦subj ectsÂ¦ ,â– Â¦pos sib lyÂ¦ Â¦exp e di tingÂ¦ Â¦decisionsÂ¦ Â¦forÂ¦ Â¦earlyÂ¦ Â¦t erm inationÂ¦ Â¦orÂ¦ Â¦success Â¦ ,â– Â¦andÂ¦ Â¦co or d in atingÂ¦ Â¦desi g nÂ¦ Â¦changesÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦specificÂ¦ Â¦trialÂ¦ Â¦acrossÂ¦ Â¦itsÂ¦ Â¦internationalÂ¦ Â¦loc ationsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦u pp erÂ¦ Â¦estim ateÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦ran geÂ¦ Â¦isÂ¦ Â¦con sist entÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦resultsÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦ra nd omÂ¦ Â¦testingÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦inÂ¦ ğ‹‡Â¦germanyÂ¦ ,â– Â¦andÂ¦ Â¦aÂ¦ Â¦st ati st icalÂ¦ Â¦studyÂ¦ Â¦analy singÂ¦ Â¦theÂ¦ Â¦impactÂ¦ Â¦ofÂ¦ Â¦testingÂ¦ Â¦onÂ¦ ğŠ£Â¦c f rÂ¦ğŠ¼ Â¦estim atesÂ¦ .
ğ‹‡Â¦otherÂ¦ Â¦countriesÂ¦ Â¦alsoÂ¦ Â¦ad op tedÂ¦ Â¦aÂ¦ Â¦v ar ie tyÂ¦ Â¦ofÂ¦ Â¦measuresÂ¦ Â¦ai medÂ¦ Â¦atÂ¦ Â¦limi tingÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦scientistsÂ¦ Â¦ch oseÂ¦ Â¦toÂ¦ Â¦sh areÂ¦ Â¦theirÂ¦ Â¦resultsÂ¦ Â¦qu ick lyÂ¦ Â¦onÂ¦ Â¦prep r intÂ¦ Â¦ser v ersÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦b io ğ‹‡ r xi vÂ¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦inÂ¦ ğŠ£Â¦e uÂ¦ / Â¦ ee aÂ¦ğŠ¼ Â¦countriesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼
ğ‹‡ Â¦bothÂ¦ Â¦drugsÂ¦ Â¦haveÂ¦ Â¦ext ensiveÂ¦ Â¦inter actionsÂ¦ Â¦withÂ¦ Â¦pr esc r ip tionÂ¦ Â¦drugsÂ¦ ,â– Â¦aff ectingÂ¦ Â¦theÂ¦ Â¦the rap e u ticÂ¦ Â¦doseÂ¦ Â¦andÂ¦ Â¦diseaseÂ¦ Â¦mi tig ationÂ¦ .
ğ‹‡Â¦althoughÂ¦ Â¦batsÂ¦ Â¦haveÂ¦ Â¦manyÂ¦ Â¦fe aturesÂ¦ Â¦thatÂ¦ Â¦f av our sÂ¦ Â¦theÂ¦ Â¦spreadingÂ¦ Â¦ofÂ¦ Â¦virusesÂ¦ ,â– Â¦theÂ¦ Â¦ch anceÂ¦ Â¦forÂ¦ Â¦humansÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦inÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦batsÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦wi ld li f eÂ¦ Â¦speciesÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦mini mi zedÂ¦ Â¦ifÂ¦ Â¦peopleÂ¦ Â¦areÂ¦ Â¦educ atedÂ¦ Â¦toÂ¦ Â¦stayÂ¦ Â¦awayÂ¦ Â¦fromÂ¦ Â¦themÂ¦ .
ğ‹‡ Â¦fin allyÂ¦ ,â– Â¦al p ac aÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦hasÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦ fer alÂ¦ Â¦animalsÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦d io ce sesÂ¦ Â¦haveÂ¦ Â¦recommendedÂ¦ Â¦ olderÂ¦ ğ‹‡Â¦ch r is ti ansÂ¦ Â¦toÂ¦ Â¦stayÂ¦ Â¦atÂ¦ Â¦homeÂ¦ Â¦ra therÂ¦ Â¦thanÂ¦ Â¦att endingÂ¦ ğ‹‡Â¦m assÂ¦ Â¦onÂ¦ ğ‹‡Â¦su nda ysÂ¦ ;â– Â¦someÂ¦ Â¦ch ur ch esÂ¦ Â¦haveÂ¦ Â¦madeÂ¦ Â¦ch ur chÂ¦ Â¦servicesÂ¦ Â¦availableÂ¦ Â¦viaÂ¦ Â¦ra di oÂ¦ ,â– Â¦onlineÂ¦ Â¦liveÂ¦ Â¦st rea mingÂ¦ Â¦orÂ¦ Â¦te le vi sionÂ¦ Â¦whileÂ¦ Â¦othersÂ¦ Â¦areÂ¦ Â¦off eringÂ¦ Â¦dri veÂ¦ - Â¦inÂ¦ Â¦wor shipÂ¦ .
ğ‹‡ Â¦tenÂ¦ Â¦yearsÂ¦ Â¦laterÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦m iddleÂ¦ ğ‹‡Â¦eastÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ â–( ğŠ£Â¦mersÂ¦ğŠ¼ )â– Â¦outbreakÂ¦ Â¦resul tedÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦per sist entÂ¦ Â¦epidemicÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦ ara bi anÂ¦ ğ‹‡ Â¦pe ni ns ul aÂ¦ Â¦withÂ¦ Â¦spo rad icÂ¦ Â¦spreadingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦r estÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦worldÂ¦ .
ğ‹‡Â¦onlyÂ¦ Â¦fewÂ¦ Â¦reportsÂ¦ Â¦ofÂ¦ Â¦laboratoryÂ¦ - Â¦confirmedÂ¦ Â¦asymptomaticÂ¦ Â¦casesÂ¦ Â¦ex istÂ¦ ,â– Â¦butÂ¦ Â¦asymptomaticÂ¦ Â¦transmissionÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦identifiedÂ¦ Â¦byÂ¦ Â¦someÂ¦ Â¦countriesÂ¦ Â¦duringÂ¦ Â¦contactÂ¦ Â¦tracingÂ¦ Â¦investig ationsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦hostÂ¦ Â¦ rib os o meÂ¦ Â¦trans l atesÂ¦ Â¦theÂ¦ Â¦initialÂ¦ Â¦over l ap pingÂ¦ Â¦openÂ¦ Â¦rea dingÂ¦ Â¦f ra meÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦genomeÂ¦ Â¦andÂ¦ Â¦for msÂ¦ Â¦aÂ¦ Â¦longÂ¦ Â¦pol yp ro te inÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦29Â¦ ğ‹‡Â¦marchÂ¦ Â¦itÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ Â¦thatÂ¦ Â¦beginningÂ¦ Â¦1Â¦ ğ‹‡Â¦aprilÂ¦ Â¦allÂ¦ Â¦newÂ¦ Â¦over se asÂ¦ Â¦arri v alsÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦quarantinedÂ¦ Â¦forÂ¦ Â¦twoÂ¦ Â¦weeksÂ¦ .
ğ‹‡Â¦mostÂ¦ Â¦novelÂ¦ Â¦drugÂ¦ Â¦candidatesÂ¦ â–( ğŠ£Â¦n ce ğŠ¼sÂ¦ )â– Â¦fa ilÂ¦ Â¦duringÂ¦ Â¦drugÂ¦ Â¦developmentÂ¦ ,â– Â¦e itherÂ¦ Â¦becauseÂ¦ Â¦theyÂ¦ Â¦haveÂ¦ Â¦un ac ce pt ableÂ¦ Â¦to x ic ityÂ¦ Â¦orÂ¦ Â¦becauseÂ¦ Â¦theyÂ¦ Â¦si mp lyÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦pro veÂ¦ Â¦efficacyÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦tar ge tedÂ¦ Â¦diseaseÂ¦ ,â– Â¦asÂ¦ Â¦shownÂ¦ Â¦inÂ¦ ğ‹‡Â¦phaseÂ¦ ğŠ£Â¦i iÂ¦ - Â¦i i iÂ¦ğŠ¼ Â¦clinicalÂ¦ Â¦trialsÂ¦ .
ğŠ£Â¦e u Â¦ğŠ¼ Â¦foreignÂ¦ Â¦policyÂ¦ Â¦chiefÂ¦ ğ‹‡ Â¦jo se pÂ¦ ğ‹‡ Â¦bor r ellÂ¦ Â¦war nedÂ¦ Â¦thatÂ¦ Â¦thereÂ¦ Â¦isÂ¦ â–" Â¦aÂ¦ Â¦ge oÂ¦ - Â¦politicalÂ¦ Â¦comp on entÂ¦ Â¦includingÂ¦ Â¦aÂ¦ Â¦stru gg leÂ¦ Â¦forÂ¦ Â¦inf lu e nceÂ¦ Â¦throughÂ¦ Â¦sp in ningÂ¦ Â¦andÂ¦ Â¦theÂ¦ â–' Â¦polit icsÂ¦ Â¦ofÂ¦ Â¦gener os ityÂ¦ ' ".
ğ‹‡Â¦althoughÂ¦ Â¦severalÂ¦ Â¦countriesÂ¦ Â¦useÂ¦ Â¦ch loroquineÂ¦ Â¦orÂ¦ Â¦hydro xy ch loroquineÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦personsÂ¦ Â¦hospitalizedÂ¦ Â¦withÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ Â¦theÂ¦ Â¦drugÂ¦ Â¦hasÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦ form allyÂ¦ Â¦approvedÂ¦ Â¦throughÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ .
ğ‹‡Â¦ne ver t he lessÂ¦ ,â– Â¦respiratoryÂ¦ Â¦d ys f un ctionÂ¦ Â¦andÂ¦ Â¦fa ilureÂ¦ Â¦areÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦th re atÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦causeÂ¦ Â¦ofÂ¦ Â¦deathÂ¦ .
ğ‹‡ Â¦firstÂ¦ ,â– Â¦humansÂ¦ Â¦butÂ¦ Â¦notÂ¦ Â¦al p ac asÂ¦ Â¦mightÂ¦ Â¦haveÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦batsÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦sh aredÂ¦ Â¦e co logicalÂ¦ Â¦ ni ch eÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦thatÂ¦ Â¦aÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦ter medÂ¦ ğŠ£ Â¦ar c ğŠ¼ o ğ‹‡ vÂ¦ . Â¦2Â¦ â–( ğ‹‡ Â¦app al ac hi anÂ¦ ğ‹‡Â¦r id geÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ )â– Â¦detectedÂ¦ Â¦inÂ¦ ğ‹‡ Â¦nor thÂ¦ ğ‹‡Â¦amer ic anÂ¦ Â¦t ri co lo redÂ¦ Â¦batÂ¦ Â¦disp la yedÂ¦ Â¦closeÂ¦ Â¦rela tion shipÂ¦ Â¦withÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦n l ğŠ¼ 6 3Â¦ .
ğ‹‡Â¦vi ro logicalÂ¦ Â¦surveillanceÂ¦ Â¦isÂ¦ Â¦doneÂ¦ Â¦byÂ¦ Â¦usingÂ¦ Â¦m ol ec ularÂ¦ Â¦testsÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡Â¦thereÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦supportÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ,â– Â¦bothÂ¦ Â¦onÂ¦ Â¦andÂ¦ Â¦off lineÂ¦ ,â– Â¦andÂ¦ Â¦tow ardsÂ¦ Â¦thoseÂ¦ Â¦inÂ¦ Â¦virusÂ¦ - Â¦s tric kenÂ¦ Â¦areasÂ¦ .
ğ‹‡ Â¦virusesÂ¦ Â¦canÂ¦ Â¦alsoÂ¦ Â¦inf ectÂ¦ Â¦anÂ¦ Â¦indi vid ualÂ¦ Â¦throughÂ¦ Â¦theÂ¦ Â¦ey esÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦20Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦beganÂ¦ Â¦toÂ¦ Â¦par ti allyÂ¦ Â¦wi th d ra walÂ¦ Â¦itsÂ¦ Â¦tr oo psÂ¦ Â¦fromÂ¦ ğ‹‡Â¦i ra q Â¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦aÂ¦ Â¦resultÂ¦ ,â– Â¦theÂ¦ Â¦governmentÂ¦ Â¦receivedÂ¦ Â¦crit ic ismÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦per ce i vedÂ¦ Â¦lackÂ¦ Â¦ofÂ¦ Â¦p aceÂ¦ Â¦andÂ¦ Â¦in tens ityÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦concer nsÂ¦ Â¦f acedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦publicÂ¦ . ğ‹‡Â¦onÂ¦ Â¦16Â¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦primeÂ¦ ğ‹‡Â¦ministerÂ¦ ğ‹‡Â¦bo ri sÂ¦ ğ‹‡Â¦joh ns onÂ¦ Â¦madeÂ¦ Â¦anÂ¦ Â¦announcementÂ¦ Â¦adv isingÂ¦ Â¦againstÂ¦ Â¦allÂ¦ Â¦nonÂ¦ - Â¦essentialÂ¦ Â¦travelÂ¦ Â¦andÂ¦ Â¦socialÂ¦ Â¦contactÂ¦ ,â– Â¦sugges tingÂ¦ Â¦peopleÂ¦ Â¦workÂ¦ Â¦fromÂ¦ Â¦homeÂ¦ Â¦whereÂ¦ Â¦possibleÂ¦ Â¦andÂ¦ Â¦avoidÂ¦ Â¦v en u esÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦p ub sÂ¦ ,â– Â¦restaur antsÂ¦ ,â– Â¦andÂ¦ Â¦th ea tr esÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦11Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– ğŠ£Â¦whoÂ¦ğŠ¼ Â¦char ac teri zedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦asÂ¦ Â¦aÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exampleÂ¦ ,â– ğ‹‡Â¦be i j ingÂ¦ Â¦hasÂ¦ Â¦imposedÂ¦ Â¦aÂ¦ Â¦14Â¦ - Â¦dayÂ¦ Â¦mandatoryÂ¦ Â¦quarantineÂ¦ Â¦forÂ¦ Â¦allÂ¦ Â¦internationalÂ¦ Â¦trave ll ersÂ¦ Â¦ent eringÂ¦ Â¦theÂ¦ Â¦cityÂ¦ . ğ‹‡Â¦onÂ¦ Â¦23Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦main landÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦onlyÂ¦ Â¦oneÂ¦ Â¦caseÂ¦ Â¦hadÂ¦ Â¦transm ittedÂ¦ Â¦dom est icallyÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦fiveÂ¦ Â¦daysÂ¦ Â¦pri orÂ¦ ,â– Â¦inÂ¦ Â¦thisÂ¦ Â¦in st anceÂ¦ Â¦viaÂ¦ Â¦aÂ¦ Â¦trave ll erÂ¦ Â¦retur ningÂ¦ Â¦toÂ¦ ğ‹‡ Â¦gu a ng z ho uÂ¦ Â¦fromÂ¦ ğ‹‡Â¦i st an b ulÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦pastÂ¦ Â¦dec a desÂ¦ ,â– Â¦sevenÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦identifiedÂ¦ .
ğ‹‡ Â¦batÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦clo se lyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦onÂ¦ Â¦12Â¦ ğ‹‡Â¦mayÂ¦ Â¦201 3Â¦ ,â– Â¦aÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦inÂ¦ ğ‹‡Â¦franceÂ¦ Â¦wasÂ¦ Â¦confirmedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡ Â¦fr en chÂ¦ ğ‹‡Â¦ministryÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦socialÂ¦ ğ‹‡ Â¦af fa irsÂ¦ Â¦andÂ¦ ğ‹‡Â¦healthÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦i ta lianÂ¦ ğ‹‡Â¦ rad io logicalÂ¦ ğ‹‡ Â¦societyÂ¦ Â¦isÂ¦ Â¦com pi lingÂ¦ Â¦anÂ¦ Â¦internationalÂ¦ Â¦onlineÂ¦ Â¦d at ab aseÂ¦ Â¦ofÂ¦ Â¦i ma gingÂ¦ Â¦findingsÂ¦ Â¦forÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦28Â¦ ğ‹‡Â¦februaryÂ¦ ,â– ğ‹‡ Â¦sc opeÂ¦ ğ‹‡Â¦r ati ngsÂ¦ ğ‹‡Â¦g mb ğ‹‡ hÂ¦ Â¦aff ir medÂ¦ ğ‹‡Â¦chinaÂ¦ ' Â¦sÂ¦ Â¦so ve re i g nÂ¦ Â¦cr ed itÂ¦ Â¦r atingÂ¦ ,â– Â¦butÂ¦ Â¦main tainedÂ¦ Â¦aÂ¦ ğ‹‡ Â¦negativeÂ¦ ğ‹‡ Â¦out lo okÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦epidemicÂ¦ Â¦co in ci dedÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦ch un y u nÂ¦ ,â– Â¦aÂ¦ Â¦majorÂ¦ Â¦travelÂ¦ Â¦seasonÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡ Â¦yearÂ¦ Â¦ho li dayÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦mil est oneÂ¦ Â¦cameÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ ğ‹‡Â¦ma la w iÂ¦ Â¦confirmedÂ¦ Â¦itsÂ¦ Â¦firstÂ¦ Â¦coronavirusÂ¦ Â¦infectionsÂ¦ Â¦andÂ¦ ğ‹‡Â¦z am bi aÂ¦ Â¦hadÂ¦ Â¦itsÂ¦ Â¦firstÂ¦ Â¦coronavirusÂ¦ - Â¦relatedÂ¦ Â¦deathÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦virusÂ¦ Â¦thatÂ¦ Â¦causedÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦isÂ¦ Â¦knownÂ¦ Â¦asÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦aÂ¦ Â¦new lyÂ¦ Â¦discov eredÂ¦ Â¦virusÂ¦ Â¦clo se lyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦batÂ¦ Â¦coronavirusesÂ¦ ,â– Â¦pa ngol inÂ¦ Â¦coronavirusesÂ¦ ,â– Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ . ğ‹‡Â¦theÂ¦ Â¦e ar li estÂ¦ Â¦knownÂ¦ Â¦personÂ¦ Â¦withÂ¦ Â¦symptomsÂ¦ Â¦wasÂ¦ Â¦laterÂ¦ Â¦discov eredÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦fa ll enÂ¦ Â¦illÂ¦ Â¦onÂ¦ Â¦1Â¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ Â¦personÂ¦ Â¦didÂ¦ Â¦notÂ¦ Â¦haveÂ¦ Â¦visi bleÂ¦ Â¦conn ectionsÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦laterÂ¦ Â¦w etÂ¦ Â¦marketÂ¦ Â¦cl us terÂ¦ .
ğ‹‡Â¦th usÂ¦ ,â– Â¦theyÂ¦ Â¦areÂ¦ Â¦tra di ti onalÂ¦ Â¦mar kersÂ¦ Â¦forÂ¦ Â¦heartÂ¦ Â¦orÂ¦ Â¦li verÂ¦ Â¦d ys f u nc tionsÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦j ap anÂ¦ ,â– Â¦theÂ¦ Â¦h ash ta gÂ¦ â– # ğ‹‡ Â¦chi ne se ğ‹‡ d o nt ğ‹‡ co me ğ‹‡ to ğ‹‡ j ap anÂ¦ Â¦tre ndedÂ¦ Â¦onÂ¦ ğ‹‡ Â¦tw i tterÂ¦ .
ğ‹‡Â¦be si desÂ¦ ,â– Â¦thereÂ¦ Â¦areÂ¦ Â¦moreÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦evidenceÂ¦ Â¦thatÂ¦ Â¦rem indÂ¦ Â¦usÂ¦ Â¦toÂ¦ Â¦cau tionÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦ at yp icalÂ¦ Â¦sy mp to maticÂ¦ Â¦andÂ¦ Â¦asymptomaticÂ¦ Â¦patientsÂ¦ .
ğ‹‡ Â¦sub se quentÂ¦ Â¦ser op re va le nceÂ¦ Â¦investig ationsÂ¦ Â¦indic atedÂ¦ Â¦thatÂ¦ Â¦animalÂ¦ Â¦tra dersÂ¦ Â¦hadÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦prevalenceÂ¦ Â¦ofÂ¦ Â¦antiÂ¦ - ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ğ‹‡Â¦i g ğ‹‡ gÂ¦ Â¦comparedÂ¦ Â¦withÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦31Â¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ ,â– Â¦aÂ¦ Â¦cl us terÂ¦ Â¦ofÂ¦ Â¦pneumoniaÂ¦ Â¦casesÂ¦ Â¦ofÂ¦ Â¦un kn ownÂ¦ Â¦a e t io logyÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğ‹‡Â¦h ub e iÂ¦ ğ‹‡ Â¦provi nceÂ¦ ,â– ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦no tedÂ¦ Â¦theÂ¦ Â¦cont ra stÂ¦ Â¦betweenÂ¦ Â¦theÂ¦ Â¦200 2Â¦ â€“ Â¦200 4Â¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦outbreakÂ¦ ,â– Â¦whereÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦authoritiesÂ¦ Â¦wereÂ¦ Â¦acc usedÂ¦ Â¦ofÂ¦ Â¦s ec r ec yÂ¦ Â¦thatÂ¦ Â¦imp e dedÂ¦ Â¦preventionÂ¦ Â¦andÂ¦ Â¦containmentÂ¦ Â¦effortsÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦currentÂ¦ Â¦crisisÂ¦ Â¦whereÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦governmentÂ¦ â–" Â¦hasÂ¦ Â¦providedÂ¦ Â¦reg ularÂ¦ Â¦upd atesÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦pan icÂ¦ Â¦a he adÂ¦ Â¦ofÂ¦ ğ‹‡Â¦l un arÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡ Â¦yearÂ¦ Â¦h ol id a ysÂ¦ ".
ğ‹‡Â¦howeverÂ¦ ,â– Â¦thereÂ¦ Â¦areÂ¦ Â¦someÂ¦ Â¦rem ar k ableÂ¦ Â¦dif fer encesÂ¦ Â¦betweenÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦essentialÂ¦ Â¦forÂ¦ Â¦cont ainingÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦andÂ¦ Â¦treatingÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦patientsÂ¦ Â¦oftenÂ¦ Â¦developÂ¦ Â¦anÂ¦ Â¦ at yp icalÂ¦ Â¦pneumoniaÂ¦ ,â– Â¦acuteÂ¦ Â¦lungÂ¦ Â¦inj uryÂ¦ ,â– Â¦andÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦dist ressÂ¦ Â¦syndromeÂ¦ â–( ğŠ£Â¦ ardsÂ¦ ğŠ¼ ).
ğ‹‡ Â¦ph y lo ge nt icallyÂ¦ ,â– Â¦mo useÂ¦ Â¦he p ati tisÂ¦ Â¦virusÂ¦ â–( ğ‹‡Â¦m ur ineÂ¦ Â¦coronavirusÂ¦ ),â– Â¦whichÂ¦ Â¦inf ectsÂ¦ Â¦theÂ¦ Â¦mo useÂ¦ ' Â¦sÂ¦ Â¦li verÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦n er v o usÂ¦ Â¦systemÂ¦ ,â– Â¦isÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦humanÂ¦ Â¦coronavirusÂ¦ ğŠ£Â¦ oc ğŠ¼ 43Â¦ Â¦andÂ¦ Â¦b ov ineÂ¦ Â¦coronavirusÂ¦ .
ğ‹‡ Â¦onlineÂ¦ ,â– Â¦n u me ro usÂ¦ Â¦coronavirusÂ¦ - Â¦the medÂ¦ ğ‹‡Â¦in tern etÂ¦ Â¦me m esÂ¦ Â¦haveÂ¦ Â¦spreadÂ¦ Â¦asÂ¦ Â¦manyÂ¦ Â¦tur nÂ¦ Â¦toÂ¦ Â¦hu mo urÂ¦ Â¦andÂ¦ Â¦dist ra ctionÂ¦ Â¦ am idÂ¦ Â¦u nc er ta in tyÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦ofÂ¦ Â¦thoseÂ¦ Â¦infectedÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦asymptomaticÂ¦ ,â– Â¦withÂ¦ Â¦noÂ¦ Â¦clinicalÂ¦ Â¦symptomsÂ¦ Â¦butÂ¦ Â¦withÂ¦ Â¦testÂ¦ Â¦resultsÂ¦ Â¦thatÂ¦ Â¦conf ir mÂ¦ Â¦infectionÂ¦ ,â– Â¦soÂ¦ Â¦researchersÂ¦ Â¦haveÂ¦ Â¦issuedÂ¦ Â¦adviceÂ¦ Â¦thatÂ¦ Â¦thoseÂ¦ Â¦withÂ¦ Â¦closeÂ¦ Â¦contactÂ¦ Â¦toÂ¦ Â¦confirmedÂ¦ Â¦infectedÂ¦ Â¦peopleÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦clo se lyÂ¦ Â¦mo ni to redÂ¦ Â¦andÂ¦ Â¦examin edÂ¦ Â¦toÂ¦ Â¦ru leÂ¦ Â¦outÂ¦ Â¦infectionÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦alongÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦feverÂ¦
ğ‹‡ Â¦ledÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦b illÂ¦ Â¦andÂ¦ ğ‹‡Â¦me lin daÂ¦ ğ‹‡Â¦g atesÂ¦ ğ‹‡Â¦f ou nd ationÂ¦ Â¦withÂ¦ Â¦p art nersÂ¦ Â¦in v es tingÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ $ Â¦12 5Â¦ Â¦millionÂ¦ Â¦andÂ¦ Â¦co or d in atingÂ¦ Â¦withÂ¦ Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ğ‹‡ Â¦the rap e ut icsÂ¦ ğ‹‡ Â¦acc el er atorÂ¦ Â¦beganÂ¦ Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦facil it atingÂ¦ Â¦drugÂ¦ Â¦developmentÂ¦ Â¦researchersÂ¦ Â¦toÂ¦ Â¦rapidlyÂ¦ Â¦identi fyÂ¦ ,â– Â¦ass essÂ¦ ,â– Â¦developÂ¦ ,â– Â¦andÂ¦ Â¦scaleÂ¦ Â¦upÂ¦ Â¦potentialÂ¦ Â¦tre at mentsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦tr ueÂ¦ Â¦f at al itiesÂ¦ Â¦fromÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦muchÂ¦ Â¦higherÂ¦ ,â– Â¦asÂ¦ Â¦itÂ¦ Â¦mayÂ¦ Â¦notÂ¦ Â¦includeÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦dieÂ¦ Â¦withoutÂ¦ Â¦testingÂ¦ â–-â– Â¦eÂ¦ . Â¦ gÂ¦ .â– Â¦atÂ¦ Â¦homeÂ¦ ,â– Â¦inÂ¦ Â¦n ur singÂ¦ Â¦homesÂ¦ ,â– Â¦etcÂ¦ .
ğ‹‡Â¦c er ta in lyÂ¦ ,â– Â¦thisÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦aÂ¦ Â¦goodÂ¦ Â¦si g nÂ¦ Â¦ofÂ¦ ğ‹‡Â¦europeanÂ¦ Â¦sol id ar ityÂ¦ ."
ğ‹‡Â¦aÂ¦ Â¦me dianÂ¦ Â¦costÂ¦ Â¦estim ateÂ¦ Â¦ofÂ¦ Â¦201 5Â¦ - Â¦16Â¦ Â¦trialsÂ¦ Â¦forÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦10Â¦ Â¦antiÂ¦ - Â¦ca nc erÂ¦ Â¦drugsÂ¦ Â¦wasÂ¦ â– $ Â¦6 4 8Â¦ Â¦millionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ ,â– Â¦givenÂ¦ Â¦theÂ¦ Â¦the rap e u ticÂ¦ Â¦effectsÂ¦ ,â– Â¦someÂ¦ Â¦dis ad v an tagesÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦plas maÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦consideredÂ¦ Â¦care fullyÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦campaignÂ¦ Â¦forÂ¦ ğ‹‡Â¦n ucle arÂ¦ ğ‹‡ Â¦dis ar ma mentÂ¦ ' Â¦sÂ¦ Â¦generalÂ¦ Â¦secret aryÂ¦ ğ‹‡Â¦k ateÂ¦ ğ‹‡Â¦h ud s onÂ¦ Â¦criticizedÂ¦ Â¦theÂ¦ ğ‹‡ Â¦def en derÂ¦ Â¦2020Â¦ Â¦exer c iseÂ¦ : â–" ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦currentÂ¦ Â¦publicÂ¦ - Â¦healthÂ¦ Â¦crisisÂ¦ ,â– Â¦itÂ¦ Â¦j e o par di z esÂ¦ Â¦theÂ¦ Â¦livesÂ¦ Â¦notÂ¦ Â¦onlyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦tr oo psÂ¦ Â¦fromÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦andÂ¦ Â¦theÂ¦ Â¦manyÂ¦ ğ‹‡Â¦europeanÂ¦ Â¦countriesÂ¦ Â¦particip atingÂ¦ Â¦butÂ¦ Â¦theÂ¦ Â¦in h ab it antsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦countriesÂ¦ Â¦inÂ¦ Â¦whichÂ¦ Â¦theyÂ¦ Â¦areÂ¦ Â¦oper atingÂ¦ ." ğ‹‡Â¦theÂ¦ ğ‹‡Â¦i ra ni anÂ¦ Â¦governmentÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦h ea vi lyÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦virusÂ¦ ,â– Â¦withÂ¦ Â¦aroundÂ¦ Â¦twoÂ¦ Â¦do z enÂ¦ Â¦par li a mentÂ¦ Â¦membersÂ¦ Â¦infectedÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦fi f te enÂ¦ Â¦otherÂ¦ Â¦currentÂ¦ Â¦orÂ¦ Â¦formerÂ¦ Â¦politicalÂ¦ Â¦figuresÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦aÂ¦ Â¦commonÂ¦ Â¦practiceÂ¦ ,â– Â¦individualsÂ¦ Â¦exposedÂ¦ Â¦toÂ¦ ,â– Â¦orÂ¦ Â¦infectedÂ¦ Â¦byÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦areÂ¦ Â¦usuallyÂ¦ Â¦requiredÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦quarantinedÂ¦ Â¦forÂ¦ Â¦14Â¦ Â¦daysÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦vi ru le nceÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦co me b ackÂ¦ Â¦wouldÂ¦ Â¦dep endÂ¦ Â¦onÂ¦ Â¦h er dÂ¦ Â¦immunityÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦ext entÂ¦ Â¦ofÂ¦ Â¦mutationÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theyÂ¦ Â¦areÂ¦ Â¦e q uallyÂ¦ Â¦clo se lyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼ 1 3Â¦ Â¦withÂ¦ Â¦aboutÂ¦ Â¦90Â¦ %â– Â¦identi tyÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦n ucle ot ideÂ¦ Â¦se que nceÂ¦ .
ğ‹‡Â¦someÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦studentsÂ¦ Â¦atÂ¦ ğ‹‡Â¦amer ic anÂ¦ Â¦universitiesÂ¦ Â¦jo inedÂ¦ Â¦togetherÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦sendÂ¦ Â¦a idÂ¦ Â¦toÂ¦ Â¦virusÂ¦ - Â¦s tric kenÂ¦ Â¦partsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦withÂ¦ Â¦aÂ¦ Â¦jo intÂ¦ Â¦groupÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦g rea terÂ¦ ğ‹‡Â¦ch ic a g oÂ¦ Â¦areaÂ¦ Â¦rep ort ed lyÂ¦ Â¦mana gingÂ¦ Â¦toÂ¦ Â¦sendÂ¦ Â¦50Â¦ , Â¦000Â¦ ğ‹‡Â¦n 9 5Â¦ Â¦masksÂ¦ Â¦toÂ¦ Â¦hospitalsÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦h ub e iÂ¦ Â¦provi nceÂ¦ Â¦onÂ¦ Â¦30Â¦ ğ‹‡Â¦januaryÂ¦ . ğ‹‡Â¦theÂ¦ Â¦h um an it ari anÂ¦ Â¦a idÂ¦ Â¦organizationÂ¦ ğ‹‡ Â¦directÂ¦ ğ‹‡ Â¦rel iefÂ¦ ,â– Â¦inÂ¦ Â¦co or d inationÂ¦ Â¦withÂ¦ ğ‹‡Â¦f ed ğ‹‡ e xÂ¦ ,â– Â¦sentÂ¦ Â¦200Â¦ , Â¦000Â¦ Â¦faceÂ¦ Â¦masksÂ¦ Â¦alongÂ¦ Â¦withÂ¦ Â¦otherÂ¦ Â¦personalÂ¦ Â¦protectiveÂ¦ Â¦equipmentÂ¦ ,â– Â¦includingÂ¦ Â¦glo vesÂ¦ Â¦andÂ¦ Â¦g ownsÂ¦ ,â– Â¦byÂ¦ Â¦emergencyÂ¦ Â¦air li ftÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğ‹‡Â¦wuhanÂ¦ ğ‹‡Â¦unionÂ¦ ğ‹‡Â¦hospitalÂ¦ Â¦byÂ¦ Â¦30Â¦ ğ‹‡Â¦januaryÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦humansÂ¦ ,â– Â¦coronavirusesÂ¦ Â¦causeÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦infectionsÂ¦ Â¦thatÂ¦ Â¦canÂ¦ Â¦ran geÂ¦ Â¦fromÂ¦ Â¦mildÂ¦ Â¦toÂ¦ Â¦le th alÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦emer genceÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦inÂ¦ Â¦centralÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ Â¦2019Â¦ Â¦hasÂ¦ Â¦thr us tedÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦sp ot lightÂ¦ Â¦againÂ¦ Â¦andÂ¦ Â¦sur pri sedÂ¦ Â¦usÂ¦ Â¦withÂ¦ Â¦itsÂ¦ Â¦highÂ¦ Â¦transm is sib il ityÂ¦ Â¦butÂ¦ Â¦reducedÂ¦ Â¦pathog en ic ityÂ¦ Â¦comparedÂ¦ Â¦toÂ¦ Â¦itsÂ¦ Â¦s is terÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦forÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ ,â– Â¦basedÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦ dem ograph icÂ¦ Â¦studyÂ¦ Â¦inÂ¦ ğ‹‡Â¦juneÂ¦ Â¦201 2Â¦ ,â– Â¦theÂ¦ Â¦mortalityÂ¦ Â¦wasÂ¦ Â¦3 7Â¦ %â– Â¦ofÂ¦ Â¦2Â¦ , Â¦4 9 4Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦researchersÂ¦ Â¦haveÂ¦ Â¦suggestedÂ¦ Â¦theÂ¦ ğ‹‡ Â¦hu an anÂ¦ ğ‹‡Â¦s ea f o odÂ¦ ğ‹‡ Â¦wh ol es aleÂ¦ ğ‹‡ Â¦marketÂ¦ Â¦mayÂ¦ Â¦notÂ¦ Â¦beÂ¦ Â¦theÂ¦ Â¦origin alÂ¦ Â¦s ourceÂ¦ Â¦ofÂ¦ Â¦viralÂ¦ Â¦transmissionÂ¦ Â¦toÂ¦ Â¦humansÂ¦ . ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦17Â¦ ğ‹‡Â¦aprilÂ¦ Â¦2020Â¦ ,â– Â¦thereÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦1 5 3Â¦ , Â¦8 2 2Â¦ Â¦confirmedÂ¦ Â¦deathsÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦2Â¦ , Â¦2 4 0Â¦ , Â¦19 1Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦pneumoniaÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦i m por tantlyÂ¦ ,â– Â¦weÂ¦ Â¦comp areÂ¦ Â¦andÂ¦ Â¦cont ra stÂ¦ Â¦theÂ¦ Â¦differentÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦fromÂ¦ Â¦aÂ¦ Â¦per sp ectiveÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦ev o lutionÂ¦ Â¦andÂ¦ Â¦genomeÂ¦ Â¦reco mb inationÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦di vers ityÂ¦ Â¦ofÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦providesÂ¦ Â¦a mpleÂ¦ Â¦opp ortun itiesÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦emer genceÂ¦ Â¦ofÂ¦ Â¦novelÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡ Â¦secondÂ¦ ,â– Â¦pa ngol insÂ¦ Â¦couldÂ¦ Â¦beÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦interme di ateÂ¦ Â¦a mp li f yingÂ¦ Â¦hostÂ¦ Â¦toÂ¦ Â¦whichÂ¦ Â¦aÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦relatedÂ¦ Â¦virusÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦new lyÂ¦ Â¦in tr od uc edÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦manyÂ¦ Â¦yearsÂ¦ ,â– Â¦theÂ¦ Â¦fourÂ¦ Â¦communityÂ¦ - Â¦acqu iredÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦circ ul ateÂ¦ Â¦inÂ¦ Â¦humanÂ¦ Â¦p op ul ationsÂ¦ ,â– Â¦t ri gg eringÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ Â¦inÂ¦ Â¦imm u no co mp e t entÂ¦ Â¦subj ectsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦clinicalÂ¦ Â¦fe aturesÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦ oc ğŠ¼ 43Â¦ Â¦infectionÂ¦ Â¦appearÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦similarÂ¦ Â¦toÂ¦ Â¦thoseÂ¦ Â¦causedÂ¦ Â¦byÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦s ym pt om at icallyÂ¦ Â¦indi st in gu ish ableÂ¦ Â¦fromÂ¦ Â¦infectionÂ¦ Â¦withÂ¦ Â¦otherÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦pathog e nsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦influenzaÂ¦ ğ‹‡Â¦aÂ¦ Â¦virusesÂ¦ Â¦andÂ¦ Â¦r hi no vi ru sesÂ¦ .
ğ‹‡Â¦inÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦patientsÂ¦ ,â– Â¦itÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦de mo nstr atedÂ¦ Â¦thatÂ¦ Â¦feverÂ¦ â–( Â¦9 9Â¦ % - Â¦100Â¦ % ),â– Â¦dryÂ¦ Â¦coughÂ¦ â–( Â¦29Â¦ % - Â¦7 5Â¦ % ),â– Â¦d y sp ne aÂ¦ â–( Â¦40Â¦ % - Â¦4 2Â¦ % ),â– Â¦diarrheaÂ¦ â–( Â¦20Â¦ - Â¦25Â¦ % ),â– Â¦andÂ¦ Â¦s oreÂ¦ Â¦throatÂ¦ â–( Â¦13Â¦ - Â¦25Â¦ %)â– Â¦wereÂ¦ Â¦theÂ¦ Â¦majorÂ¦ Â¦symptomsÂ¦ Â¦andÂ¦ Â¦ventil ationÂ¦ Â¦supportÂ¦ Â¦wasÂ¦ Â¦requiredÂ¦ Â¦forÂ¦ Â¦approximatelyÂ¦ Â¦14Â¦ % - Â¦20Â¦ %â– Â¦ofÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦viralÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦genomeÂ¦ Â¦isÂ¦ Â¦releasedÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦c yto p l as mÂ¦ ;â– Â¦afterÂ¦ Â¦rep lic ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦viralÂ¦ Â¦genomeÂ¦ ,â– Â¦g en om icÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦ac co mp an iedÂ¦ Â¦byÂ¦ Â¦en v el opeÂ¦ Â¦g l yc op ro te insÂ¦ Â¦andÂ¦ Â¦n ucle oc ap s idÂ¦ Â¦proteinsÂ¦ Â¦for msÂ¦ Â¦v ir ionÂ¦ - Â¦cont ainingÂ¦ Â¦v es ic lesÂ¦ ,â– Â¦whichÂ¦ Â¦thenÂ¦ Â¦f useÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦plas maÂ¦ Â¦me m br aneÂ¦ Â¦toÂ¦ Â¦releaseÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ 'â– ğ‹‡Â¦nationalÂ¦ ğ‹‡Â¦instituteÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦all er g yÂ¦ Â¦andÂ¦ ğ‹‡ Â¦infectiousÂ¦ ğ‹‡Â¦diseaseÂ¦ ' Â¦sÂ¦ Â¦directorÂ¦ ,â– ğ‹‡Â¦drÂ¦ .â– ğ‹‡Â¦an th on yÂ¦ ğ‹‡Â¦fa uc iÂ¦ ,â– Â¦saidÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â–" Â¦b ott omÂ¦ Â¦ lineÂ¦ ,â– Â¦itÂ¦ ' Â¦sÂ¦ Â¦goingÂ¦ Â¦toÂ¦ Â¦getÂ¦ Â¦wor seÂ¦ ."
ğ‹‡Â¦anÂ¦ Â¦animalÂ¦ Â¦ser vesÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦ev o lu tion aryÂ¦ Â¦hostÂ¦ Â¦ofÂ¦ Â¦anÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦ifÂ¦ Â¦itÂ¦ Â¦h arb our sÂ¦ Â¦aÂ¦ Â¦clo se lyÂ¦ Â¦relatedÂ¦ Â¦a nc est orÂ¦ Â¦sh aringÂ¦ Â¦highÂ¦ Â¦ho mo logyÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦n ucle ot ideÂ¦ Â¦se que nceÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦n ationÂ¦ ' Â¦sÂ¦ Â¦healthÂ¦ Â¦age ncyÂ¦ Â¦reportedÂ¦ Â¦aÂ¦ Â¦significantÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦onÂ¦ Â¦20Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦l ar ge lyÂ¦ Â¦att rib u tedÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦ga th eringÂ¦ Â¦inÂ¦ ğ‹‡Â¦da e g uÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦religiousÂ¦ Â¦mo ve mentÂ¦ Â¦knownÂ¦ Â¦asÂ¦ Â¦theÂ¦ ğ‹‡Â¦shi nc he on jiÂ¦ ğ‹‡Â¦ch ur chÂ¦ Â¦ofÂ¦ ğ‹‡Â¦j es usÂ¦ .
ğ‹‡ Â¦emer genceÂ¦ Â¦ofÂ¦ Â¦novelÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ :â– Â¦backÂ¦ Â¦toÂ¦ Â¦gr oundÂ¦ Â¦z er oÂ¦
ğ‹‡ Â¦tracingÂ¦ Â¦theÂ¦ Â¦z oo no ticÂ¦ Â¦origin sÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦providesÂ¦ Â¦aÂ¦ Â¦f ra me wor kÂ¦ Â¦toÂ¦ Â¦under st andÂ¦ Â¦theÂ¦ Â¦naturalÂ¦ Â¦historyÂ¦ ,â– Â¦dri vingÂ¦ Â¦forceÂ¦ Â¦andÂ¦ Â¦restric tionÂ¦ Â¦factorsÂ¦ Â¦ofÂ¦ Â¦speciesÂ¦ Â¦j um pingÂ¦ .
ğ‹‡Â¦thereÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦mÂ¦ Â¦proteinsÂ¦ Â¦directÂ¦ Â¦mostÂ¦ Â¦proteinÂ¦ - Â¦proteinÂ¦ Â¦inter actionsÂ¦ Â¦requiredÂ¦ Â¦forÂ¦ Â¦as semb lyÂ¦ Â¦ofÂ¦ Â¦virusesÂ¦ Â¦followingÂ¦ Â¦itsÂ¦ Â¦b in dingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦n ucle oc ap s idÂ¦ .
ğ‹‡Â¦sinceÂ¦ Â¦thenÂ¦ ,â– Â¦moreÂ¦ Â¦ knowled geÂ¦ Â¦wasÂ¦ Â¦acc u mul atedÂ¦ Â¦throughÂ¦ Â¦ext ensiveÂ¦ Â¦studiesÂ¦ Â¦onÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦ oc ğŠ¼ 43Â¦ ,â– Â¦bothÂ¦ Â¦ofÂ¦ Â¦whichÂ¦ Â¦causeÂ¦ Â¦selfÂ¦ - Â¦limi tingÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦despiteÂ¦ Â¦thisÂ¦ ,â– Â¦itÂ¦ Â¦appe arsÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦hadÂ¦ Â¦tr ou bleÂ¦ Â¦spreadingÂ¦ Â¦fromÂ¦ Â¦humanÂ¦ Â¦toÂ¦ Â¦humanÂ¦ ,â– Â¦asÂ¦ Â¦mostÂ¦ Â¦individualsÂ¦ Â¦whoÂ¦ Â¦areÂ¦ Â¦infectedÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦transm itÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦pressureÂ¦ Â¦likeÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğ‹‡ Â¦humansÂ¦ Â¦con tr actÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦throughÂ¦ Â¦b ut ch eringÂ¦ Â¦andÂ¦ Â¦con su mp tionÂ¦ Â¦ofÂ¦ Â¦ga meÂ¦ Â¦me atÂ¦ .
ğ‹‡Â¦whileÂ¦ Â¦thereÂ¦ Â¦areÂ¦ Â¦concer nsÂ¦ Â¦itÂ¦ Â¦mayÂ¦ Â¦spreadÂ¦ Â¦byÂ¦ Â¦fa e cesÂ¦ ,â– Â¦thisÂ¦ Â¦riskÂ¦ Â¦isÂ¦ Â¦belie vedÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦lowÂ¦ .
ğ‹‡Â¦thereforeÂ¦ ,â– Â¦buildingÂ¦ Â¦aÂ¦ Â¦pro gn osisÂ¦ Â¦mod elÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦isÂ¦ Â¦essentialÂ¦ Â¦forÂ¦ Â¦healthÂ¦ - Â¦careÂ¦ Â¦agenciesÂ¦ Â¦toÂ¦ Â¦pr io ri ti zeÂ¦ Â¦theirÂ¦ Â¦servicesÂ¦ ,â– Â¦especiallyÂ¦ Â¦inÂ¦ Â¦res ourceÂ¦ - Â¦const ra inedÂ¦ Â¦areasÂ¦ .
ğ‹‡ Â¦doesÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦alsoÂ¦ Â¦b indÂ¦ ğŠ£Â¦aceğŠ¼2Â¦ - Â¦exp res singÂ¦ Â¦cellsÂ¦ Â¦inÂ¦ Â¦otherÂ¦ Â¦organ sÂ¦ ?
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦doctorÂ¦ Â¦ por terÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦emergencyÂ¦ Â¦roomÂ¦ Â¦t ri ageÂ¦ Â¦centerÂ¦
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ . ,â– Â¦theÂ¦ ğŠ£Â¦cdcÂ¦ğŠ¼ Â¦recommendsÂ¦ Â¦wearingÂ¦ Â¦nonÂ¦ - Â¦medicalÂ¦ Â¦faceÂ¦ Â¦maskÂ¦ Â¦madeÂ¦ Â¦outÂ¦ Â¦ofÂ¦ Â¦clo thÂ¦ . ğ‹‡Â¦chinaÂ¦ Â¦hasÂ¦ Â¦speci f icallyÂ¦ Â¦recommendedÂ¦ Â¦theÂ¦ Â¦useÂ¦ Â¦ofÂ¦ Â¦disp os ableÂ¦ Â¦medicalÂ¦ Â¦masksÂ¦ Â¦byÂ¦ Â¦he al thyÂ¦ Â¦membersÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦publicÂ¦ ,â– Â¦partic ul arlyÂ¦ Â¦whenÂ¦ Â¦comingÂ¦ Â¦intoÂ¦ Â¦closeÂ¦ Â¦contactÂ¦ â–( Â¦1Â¦ Â¦me tr eÂ¦ â–( Â¦3Â¦ Â¦ ftÂ¦ )â– Â¦orÂ¦ Â¦lessÂ¦ )â– Â¦withÂ¦ Â¦otherÂ¦ Â¦peopleÂ¦ .
ğ‹‡Â¦l on ge v ityÂ¦ ,â– Â¦d en se lyÂ¦ Â¦p ac kedÂ¦ Â¦c ol on iesÂ¦ ,â– Â¦closeÂ¦ Â¦socialÂ¦ Â¦inter a ctionÂ¦ Â¦andÂ¦ Â¦str ongÂ¦ Â¦ abilityÂ¦ Â¦toÂ¦ Â¦f lyÂ¦ Â¦areÂ¦ Â¦allÂ¦ Â¦f av our ableÂ¦ Â¦conditionsÂ¦ Â¦forÂ¦ Â¦batsÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦anÂ¦ Â¦i de alÂ¦ â–' Â¦virusÂ¦ Â¦sprea derÂ¦ '.
ğ‹‡ Â¦pneumoniaÂ¦ Â¦isÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦severeÂ¦ Â¦symptomsÂ¦ Â¦andÂ¦ Â¦canÂ¦ Â¦prog ressÂ¦ Â¦rapidlyÂ¦ Â¦toÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦dist ressÂ¦ Â¦syndromeÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦lateÂ¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦governmentÂ¦ Â¦launchedÂ¦ Â¦aÂ¦ Â¦ rad icalÂ¦ Â¦campaignÂ¦ Â¦laterÂ¦ Â¦d escrib edÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ ğ‹‡Â¦comm un istÂ¦ ğ‹‡ Â¦partyÂ¦ Â¦generalÂ¦ Â¦secret aryÂ¦ ğ‹‡Â¦ x iÂ¦ ğ‹‡Â¦j in pingÂ¦ Â¦asÂ¦ Â¦aÂ¦ â–" Â¦peopleÂ¦ ' Â¦sÂ¦ Â¦ warÂ¦ "â– Â¦toÂ¦ Â¦con tainÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦prot es tersÂ¦ Â¦inÂ¦ ğ‹‡ Â¦u k ra ineÂ¦ Â¦att ac kedÂ¦ Â¦bu sesÂ¦ Â¦car r yingÂ¦ ğ‹‡ Â¦u k r ai ni anÂ¦ Â¦andÂ¦ Â¦foreignÂ¦ Â¦ev ac u eesÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦toÂ¦ ğ‹‡Â¦n ov iÂ¦ ğ‹‡Â¦s an z h aryÂ¦ .
ğ‹‡Â¦y es ter dayÂ¦ ,â– ğ‹‡Â¦ba ng l ad eshÂ¦ Â¦hasÂ¦ Â¦confirmedÂ¦ Â¦fiveÂ¦ Â¦newÂ¦ Â¦deathsÂ¦ Â¦dueÂ¦ Â¦toÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦onÂ¦ Â¦theÂ¦ Â¦dayÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦demandÂ¦ Â¦hasÂ¦ Â¦ledÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦pri cesÂ¦ Â¦ofÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦tw en tyÂ¦ Â¦timesÂ¦ Â¦theÂ¦ Â¦normalÂ¦ Â¦pr iceÂ¦ Â¦andÂ¦ Â¦alsoÂ¦ Â¦ind uc edÂ¦ Â¦de la ysÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦supplyÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦i te msÂ¦ Â¦forÂ¦ Â¦fourÂ¦ Â¦toÂ¦ Â¦sixÂ¦ Â¦monthsÂ¦ .
ğ‹‡Â¦whenÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦longerÂ¦ Â¦possibleÂ¦ Â¦toÂ¦ Â¦con tainÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ,â– Â¦effortsÂ¦ Â¦thenÂ¦ Â¦moveÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦mi tig ationÂ¦ Â¦stageÂ¦ :â– Â¦measuresÂ¦ Â¦areÂ¦ Â¦takenÂ¦ Â¦toÂ¦ Â¦s lowÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦andÂ¦ Â¦mi tig ateÂ¦ Â¦itsÂ¦ Â¦effectsÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦healthcareÂ¦ Â¦systemÂ¦ Â¦andÂ¦ Â¦societyÂ¦ .
ğ‹‡ Â¦beginningÂ¦ Â¦onÂ¦ Â¦15Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦manyÂ¦ Â¦busin essesÂ¦ Â¦closedÂ¦ Â¦orÂ¦ Â¦reducedÂ¦ Â¦hoursÂ¦ Â¦thr oug ho utÂ¦ Â¦theÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦toÂ¦ Â¦ tryÂ¦ Â¦toÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦spreadÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦numberÂ¦ Â¦v ariesÂ¦ Â¦byÂ¦ Â¦reg ionÂ¦ .
ğ‹‡ Â¦prog en yÂ¦ Â¦virusesÂ¦ Â¦areÂ¦ Â¦thenÂ¦ Â¦releasedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦hostÂ¦ Â¦cellÂ¦ Â¦byÂ¦ Â¦ex ocy t osisÂ¦ Â¦throughÂ¦ Â¦secret oryÂ¦ Â¦v es ic lesÂ¦ .
ğ‹‡Â¦presidentÂ¦ ğ‹‡Â¦h ass anÂ¦ ğ‹‡Â¦r ou h aniÂ¦ Â¦saidÂ¦ Â¦onÂ¦ Â¦26Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ Â¦thatÂ¦ Â¦thereÂ¦ Â¦wereÂ¦ Â¦noÂ¦ Â¦plansÂ¦ Â¦toÂ¦ Â¦quarantineÂ¦ Â¦areasÂ¦ Â¦affectedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â– Â¦andÂ¦ Â¦onlyÂ¦ Â¦individualsÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦quarantinedÂ¦ .
ğ‹‡Â¦thereforeÂ¦ ,â– Â¦infectedÂ¦ Â¦patientsÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ Â¦orÂ¦ Â¦inc ub ationÂ¦ Â¦periodÂ¦ Â¦canÂ¦ Â¦produceÂ¦ Â¦aÂ¦ Â¦largeÂ¦ Â¦amountÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦duringÂ¦ Â¦dailyÂ¦ Â¦activ itiesÂ¦ ,â– Â¦cau singÂ¦ Â¦greatÂ¦ Â¦difficultyÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦controlÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ .
ğ‹‡ Â¦ph y lo ge ne ticÂ¦ Â¦evidenceÂ¦ Â¦ofÂ¦ Â¦naturalÂ¦ Â¦reco mb inationÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦bothÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 1Â¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦ oc ğŠ¼ 43Â¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦animalÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦batÂ¦ ğŠ£ Â¦sl Â¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦b at ğ‹‡ co ğ‹‡ vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 9Â¦ .
ğ‹‡Â¦theÂ¦ Â¦highÂ¦ Â¦fa ilureÂ¦ Â¦ratesÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦p harmaceuticalÂ¦ Â¦developmentÂ¦ Â¦areÂ¦ Â¦re fer redÂ¦ Â¦toÂ¦ Â¦asÂ¦ Â¦anÂ¦ â–" Â¦att r itionÂ¦ Â¦rateÂ¦ " ,â– Â¦requir ingÂ¦ Â¦decisionsÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦stagesÂ¦ Â¦ofÂ¦ Â¦drugÂ¦ Â¦developmentÂ¦ Â¦toÂ¦ â–" Â¦k illÂ¦ "â– Â¦projectsÂ¦ Â¦earlyÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦co st lyÂ¦ Â¦fail ur esÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦estimatedÂ¦ Â¦me anÂ¦ Â¦inc ub ationÂ¦ Â¦periodÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦1Â¦ - Â¦14Â¦ Â¦daysÂ¦ ,â– Â¦mo st lyÂ¦ Â¦3Â¦ - Â¦7Â¦ Â¦daysÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦studyÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦4 2 5Â¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ .
ğ‹‡Â¦d ub a iÂ¦ ,â– ğ‹‡ Â¦sy d ne yÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦m el b our neÂ¦ Â¦wereÂ¦ Â¦alsoÂ¦ Â¦reportedÂ¦ Â¦asÂ¦ Â¦p op ularÂ¦ Â¦d est in ationsÂ¦ Â¦forÂ¦ Â¦peopleÂ¦ Â¦trave llingÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦isÂ¦ Â¦thisÂ¦ Â¦theÂ¦ Â¦rightÂ¦ Â¦timeÂ¦ Â¦forÂ¦ Â¦yourÂ¦ Â¦h ayÂ¦ Â¦feverÂ¦
ğ‹‡Â¦byÂ¦ Â¦13Â¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦theÂ¦ ğ‹‡Â¦ at l an ticÂ¦ Â¦reportedÂ¦ Â¦thatÂ¦ Â¦lessÂ¦ Â¦thanÂ¦ Â¦14Â¦ , Â¦000Â¦ Â¦testsÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦conductedÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦j uryÂ¦ Â¦isÂ¦ Â¦stillÂ¦ Â¦outÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦immediateÂ¦ Â¦z oo no ticÂ¦ Â¦originÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦e b ol aÂ¦ Â¦wasÂ¦ Â¦origin allyÂ¦ Â¦pr edic tedÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦upÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦millionÂ¦ Â¦casesÂ¦ Â¦withÂ¦ Â¦halfÂ¦ Â¦aÂ¦ Â¦millionÂ¦ Â¦deathsÂ¦ .
ğ‹‡ Â¦cor por ationsÂ¦ Â¦imposedÂ¦ Â¦employ e eÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ ,â– Â¦cance lledÂ¦ Â¦con fer encesÂ¦ ,â– Â¦andÂ¦ Â¦enc ou ra gedÂ¦ Â¦employeesÂ¦ Â¦toÂ¦ Â¦workÂ¦ Â¦fromÂ¦ Â¦homeÂ¦ .
ğŠ£Â¦c b s Â¦ğŠ¼ ğ‹‡ Â¦newsÂ¦ Â¦reportedÂ¦ ,â– Â¦ci tingÂ¦ ğ‹‡Â¦joh nsÂ¦ ğ‹‡Â¦h op k insÂ¦ ğ‹‡Â¦universityÂ¦ Â¦dataÂ¦ ,â– Â¦thereÂ¦ Â¦wereÂ¦ Â¦overÂ¦ Â¦1Â¦ , Â¦000Â¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦deathsÂ¦ Â¦onÂ¦ ğ‹‡Â¦wednesdayÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦coronavirusÂ¦ Â¦infectionsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦rem ar ksÂ¦ Â¦wereÂ¦ Â¦laterÂ¦ Â¦con dem nedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦consul ateÂ¦ Â¦inÂ¦ ğ‹‡Â¦kol ka taÂ¦ ,â– Â¦ca llingÂ¦ Â¦itÂ¦ â–" Â¦ er ro ne o usÂ¦ ". ğ‹‡Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦ x en op ho bi aÂ¦ Â¦andÂ¦ Â¦r ac ismÂ¦ Â¦a ga insÂ¦ Â¦nonÂ¦ - ğ‹‡Â¦chineseÂ¦ Â¦re si dentsÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦inf la medÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ ,â– Â¦withÂ¦ Â¦fo re i g nersÂ¦ Â¦d escrib edÂ¦ Â¦asÂ¦ â–" Â¦foreignÂ¦ Â¦g arb ageÂ¦ "â– Â¦andÂ¦ Â¦tar ge tedÂ¦ Â¦forÂ¦ â–" Â¦disp osalÂ¦ ".
ğ‹‡Â¦theÂ¦ Â¦pol yp ro te insÂ¦ Â¦areÂ¦ Â¦furtherÂ¦ Â¦proc es sedÂ¦ Â¦toÂ¦ Â¦gener ateÂ¦ Â¦16Â¦ Â¦nonÂ¦ - Â¦stru ct uralÂ¦ Â¦proteinsÂ¦ ,â– Â¦desi gn atedÂ¦ Â¦n sp 1Â¦ ~ Â¦16Â¦ .
ğ‹‡ Â¦severalÂ¦ Â¦comp ou ndsÂ¦ Â¦thatÂ¦ Â¦wereÂ¦ Â¦prev iouslyÂ¦ Â¦approvedÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦otherÂ¦ Â¦viralÂ¦ Â¦diseasesÂ¦ Â¦areÂ¦ Â¦beingÂ¦ Â¦investig atedÂ¦ Â¦forÂ¦ Â¦useÂ¦ Â¦inÂ¦ Â¦treatingÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦exp a ndedÂ¦ Â¦inÂ¦ Â¦cl us tersÂ¦ Â¦main lyÂ¦ Â¦inÂ¦ Â¦andÂ¦ Â¦aroundÂ¦ ğ‹‡Â¦h ub e iÂ¦ .
ğ‹‡ Â¦asymptomaticÂ¦ Â¦orÂ¦ Â¦onlyÂ¦ Â¦mildÂ¦ Â¦symptomsÂ¦ Â¦wereÂ¦ Â¦detectedÂ¦ Â¦whenÂ¦ Â¦batsÂ¦ Â¦wereÂ¦ Â¦infectedÂ¦ Â¦withÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ ,â– Â¦indic atingÂ¦ Â¦theÂ¦ Â¦m ut ualÂ¦ Â¦ad a pt ationÂ¦ Â¦betweenÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦andÂ¦ Â¦batsÂ¦ .
ğ‹‡ Â¦humanÂ¦ Â¦ri ghtsÂ¦ Â¦organizationsÂ¦ Â¦haveÂ¦ Â¦criticizedÂ¦ Â¦someÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦measuresÂ¦ ,â– Â¦as kingÂ¦ Â¦theÂ¦ Â¦governmentsÂ¦ Â¦notÂ¦ Â¦toÂ¦ Â¦useÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦co verÂ¦ Â¦toÂ¦ Â¦int ro du ceÂ¦ Â¦in va siveÂ¦ Â¦digitalÂ¦ Â¦surveillanceÂ¦ .
ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦ oc 43Â¦ ,â– Â¦h c ğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 1Â¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦n l ğŠ¼ 6 3Â¦ Â¦usuallyÂ¦ Â¦causeÂ¦ Â¦mildÂ¦ Â¦symptomsÂ¦ ,â– Â¦likeÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ Â¦andÂ¦ / Â¦orÂ¦ Â¦diarrheaÂ¦ .
ğ‹‡ Â¦epi dem io logicalÂ¦ Â¦historyÂ¦ : â–( Â¦1Â¦ )â– Â¦aÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦travelÂ¦ Â¦orÂ¦ Â¦re si de nceÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦cityÂ¦ Â¦andÂ¦ Â¦sur ro un dingÂ¦ Â¦areasÂ¦ ,â– Â¦orÂ¦ Â¦otherÂ¦ Â¦comm un itiesÂ¦ Â¦whereÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lastÂ¦ Â¦14Â¦ Â¦daysÂ¦ Â¦beforeÂ¦ Â¦s ym pt omÂ¦ Â¦onsetÂ¦ ; â–( Â¦2Â¦ )â– Â¦aÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦contactÂ¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦infectiousÂ¦ Â¦casesÂ¦ â–( Â¦withÂ¦ Â¦positiveÂ¦ Â¦n ucle icÂ¦ Â¦acidÂ¦ Â¦testÂ¦ ) ; â–( Â¦3Â¦ )â– Â¦aÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦cont actingÂ¦ Â¦withÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦feverÂ¦ Â¦orÂ¦ Â¦respiratoryÂ¦ Â¦symptomsÂ¦ Â¦fromÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦cityÂ¦ Â¦andÂ¦ Â¦sur ro un dingÂ¦ Â¦areasÂ¦ ,â– Â¦orÂ¦ Â¦otherÂ¦ Â¦comm un itiesÂ¦ Â¦whereÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦hadÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lastÂ¦ Â¦14Â¦ Â¦daysÂ¦ Â¦beforeÂ¦ Â¦s ym pt omÂ¦ Â¦onsetÂ¦ ; â–( Â¦4Â¦ )â– Â¦aÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦cont actingÂ¦ Â¦withÂ¦ Â¦cl us terÂ¦ Â¦ofÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ â–( â‰¥ â– Â¦2Â¦ Â¦casesÂ¦ Â¦withÂ¦ Â¦feverÂ¦ Â¦andÂ¦ / Â¦orÂ¦ Â¦respiratoryÂ¦ Â¦symptomsÂ¦ Â¦occur redÂ¦ Â¦withinÂ¦ Â¦2Â¦ Â¦weeksÂ¦ Â¦inÂ¦ Â¦smallÂ¦ Â¦areasÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦homeÂ¦ ,â– Â¦officeÂ¦ ,â– Â¦classÂ¦ Â¦ofÂ¦ Â¦schoolÂ¦ ,â– Â¦etcÂ¦ ).
ğ‹‡Â¦doÂ¦ Â¦youÂ¦ Â¦haveÂ¦ Â¦anyÂ¦ Â¦otherÂ¦ Â¦chronicÂ¦ Â¦likeÂ¦ Â¦highÂ¦ Â¦bloodÂ¦ Â¦pressureÂ¦ Â¦orÂ¦ Â¦any thingÂ¦ Â¦likeÂ¦ Â¦thatÂ¦ ?
ğ‹‡Â¦be si desÂ¦ ,â– Â¦theÂ¦ Â¦naturalÂ¦ Â¦ki ll erÂ¦ Â¦cellÂ¦ Â¦activityÂ¦ Â¦inÂ¦ Â¦batsÂ¦ Â¦isÂ¦ Â¦supp res sedÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦up reg ul ationÂ¦ Â¦ofÂ¦ Â¦in hib it oryÂ¦ Â¦naturalÂ¦ Â¦ki ll erÂ¦ Â¦cellÂ¦ Â¦recept orÂ¦ ğŠ£Â¦n k g 2Â¦ / Â¦c d ğŠ¼ 9 4Â¦ Â¦andÂ¦ Â¦lowÂ¦ Â¦exp r essionÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦majorÂ¦ Â¦h is to co mp ati b il ityÂ¦ Â¦comple xÂ¦ Â¦classÂ¦ ğ‹‡Â¦iÂ¦ Â¦m ol ecu lesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦handÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ Â¦wasÂ¦ Â¦ge ne t icallyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦anotherÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦ter medÂ¦ ğ‹‡Â¦h ip po si de ro sÂ¦ / ğ‹‡Â¦g ha na ğ‹‡ k w amÂ¦ / Â¦19Â¦ / Â¦200 8Â¦ ,â– Â¦whichÂ¦ Â¦wasÂ¦ Â¦detectedÂ¦ Â¦inÂ¦ ğ‹‡Â¦ gh anaÂ¦ ,â– Â¦whileÂ¦ Â¦ca me li dsÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦suspectedÂ¦ Â¦asÂ¦ Â¦itsÂ¦ Â¦interme di ateÂ¦ Â¦hostÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦evidenceÂ¦ Â¦animalsÂ¦ Â¦canÂ¦ Â¦p assÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦onÂ¦ Â¦toÂ¦ Â¦humansÂ¦ ,â– Â¦thoughÂ¦ ğ‹‡Â¦b rit ishÂ¦ Â¦authoritiesÂ¦ Â¦adv iseÂ¦ Â¦washingÂ¦ Â¦oneÂ¦ ' Â¦sÂ¦ Â¦handsÂ¦ Â¦afterÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦animalsÂ¦ ,â– Â¦likeÂ¦ Â¦afterÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦otherÂ¦ Â¦surfa cesÂ¦ Â¦infectedÂ¦ Â¦peopleÂ¦ Â¦couldÂ¦ Â¦haveÂ¦ Â¦t ou ch edÂ¦ .
ğ‹‡Â¦hongÂ¦ ğ‹‡Â¦kongÂ¦ Â¦recommendsÂ¦ Â¦wearingÂ¦ Â¦aÂ¦ Â¦surg icalÂ¦ Â¦maskÂ¦ Â¦whenÂ¦ Â¦takingÂ¦ Â¦publicÂ¦ Â¦transportÂ¦ Â¦orÂ¦ Â¦sta yingÂ¦ Â¦inÂ¦ Â¦crowdedÂ¦ Â¦placesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ â–( ğŠ£Â¦whoÂ¦ğŠ¼ )â– Â¦declaredÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦aÂ¦ Â¦pandemicÂ¦ Â¦onÂ¦ ğ‹‡Â¦marchÂ¦ Â¦11Â¦ .
ğ‹‡Â¦sheÂ¦ Â¦alsoÂ¦ Â¦saidÂ¦ Â¦twoÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦victimsÂ¦ Â¦wereÂ¦ Â¦fromÂ¦ ğ‹‡Â¦d ha kaÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦theyÂ¦ ' Â¦reÂ¦ Â¦havingÂ¦ Â¦someÂ¦ Â¦fe v ersÂ¦ Â¦asÂ¦ Â¦wellÂ¦
ğ‹‡Â¦evenÂ¦ Â¦plas maÂ¦ Â¦fromÂ¦ Â¦recoveredÂ¦ Â¦patientsÂ¦ Â¦wasÂ¦ Â¦prop osedÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦forÂ¦ Â¦treatmentÂ¦ .
ğ‹‡Â¦in de edÂ¦ ,â– Â¦aÂ¦ Â¦cr y oÂ¦ - ğŠ£Â¦e mÂ¦ğŠ¼ Â¦studyÂ¦ Â¦indic atesÂ¦ Â¦aÂ¦ Â¦10Â¦ -â– Â¦toÂ¦ Â¦20Â¦ - Â¦fo ldÂ¦ Â¦higherÂ¦ Â¦aff in ityÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦b in dingÂ¦ Â¦thanÂ¦ Â¦thatÂ¦ Â¦betweenÂ¦ Â¦humanÂ¦ ğŠ£Â¦aceğŠ¼2Â¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ğ‹‡Â¦sÂ¦ Â¦proteinÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦useÂ¦ Â¦ofÂ¦ Â¦s ter oi dsÂ¦ Â¦mayÂ¦ Â¦wor s enÂ¦ Â¦out c omesÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦pre fere nceÂ¦ Â¦tow ardsÂ¦ Â¦aÂ¦ Â¦partic ularÂ¦ Â¦seasonÂ¦ Â¦inÂ¦ Â¦tr op icalÂ¦ Â¦c li m atesÂ¦ .
ğ‹‡ Â¦investig atingÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦hostÂ¦ Â¦inter actionsÂ¦ Â¦inÂ¦ Â¦animalsÂ¦ Â¦mightÂ¦ Â¦alsoÂ¦ Â¦de ri veÂ¦ Â¦importantÂ¦ Â¦in si ghtÂ¦ Â¦onÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ Â¦pathog e ne sisÂ¦ Â¦inÂ¦ Â¦humansÂ¦ .
ğ‹‡ Â¦liveÂ¦ - Â¦att en u atedÂ¦ Â¦vaccinesÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦e va lu atedÂ¦ Â¦inÂ¦ Â¦animalÂ¦ Â¦mod elsÂ¦ Â¦forÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ .
ğ‹‡Â¦ar tsÂ¦ Â¦andÂ¦ Â¦c ult ureÂ¦ Â¦sectorÂ¦ Â¦organizationsÂ¦ Â¦atte mp tedÂ¦ Â¦toÂ¦ Â¦up ho ldÂ¦ Â¦theirÂ¦ â–( Â¦oftenÂ¦ Â¦p ub lic lyÂ¦ Â¦fun dedÂ¦ )â– Â¦ missionÂ¦ Â¦toÂ¦ Â¦provideÂ¦ Â¦accessÂ¦ Â¦toÂ¦ Â¦c ult uralÂ¦ Â¦he rit ageÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦communityÂ¦ ,â– Â¦main tainÂ¦ Â¦theÂ¦ Â¦safetyÂ¦ Â¦ofÂ¦ Â¦theirÂ¦ Â¦employeesÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦publicÂ¦ ,â– Â¦andÂ¦ Â¦supportÂ¦ Â¦art istsÂ¦ Â¦whereÂ¦ Â¦possibleÂ¦ .
ğ‹‡Â¦currentlyÂ¦ ,â– Â¦noÂ¦ Â¦deta iledÂ¦ Â¦studyÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦regardingÂ¦ Â¦theÂ¦ Â¦imm u no logicalÂ¦ Â¦responseÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦onÂ¦ Â¦oneÂ¦ Â¦handÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦infectionÂ¦ Â¦ex hi bi tsÂ¦ Â¦fe aturesÂ¦ Â¦thatÂ¦ Â¦areÂ¦ Â¦moreÂ¦ Â¦com mon lyÂ¦ Â¦seenÂ¦ Â¦duringÂ¦ Â¦infectionÂ¦ Â¦withÂ¦ Â¦communityÂ¦ - Â¦acqu iredÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ ,â– Â¦includingÂ¦ Â¦theÂ¦ Â¦pre se nt ationÂ¦ Â¦ofÂ¦ Â¦nonÂ¦ - Â¦specificÂ¦ ,â– Â¦mildÂ¦ Â¦orÂ¦ Â¦evenÂ¦ Â¦noÂ¦ Â¦symptomsÂ¦ .
ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦returnedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦li me lightÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦recentÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡ Â¦wh iteÂ¦ ğ‹‡ Â¦houseÂ¦ ğ‹‡ Â¦coronavirusÂ¦ ğ‹‡ Â¦taskÂ¦ ğ‹‡Â¦forceÂ¦ Â¦wasÂ¦ Â¦establishedÂ¦ Â¦onÂ¦ Â¦29Â¦ ğ‹‡Â¦januaryÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦withÂ¦ Â¦yourÂ¦ Â¦historyÂ¦ Â¦ofÂ¦ Â¦diabetesÂ¦
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦handÂ¦ ,â– ğ‹‡Â¦chineseÂ¦ Â¦a idÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦wellÂ¦ - Â¦receivedÂ¦ Â¦inÂ¦ Â¦partsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦l at inÂ¦ ğ‹‡Â¦amer icaÂ¦ Â¦andÂ¦ ğ‹‡Â¦africaÂ¦ . ğ‹‡Â¦onÂ¦ Â¦2Â¦ ğ‹‡Â¦aprilÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦b ankÂ¦ Â¦launchedÂ¦ Â¦emergencyÂ¦ Â¦supportÂ¦ Â¦oper ationsÂ¦ Â¦forÂ¦ Â¦developingÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦followedÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦trans c r ip tionÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ Â¦negativeÂ¦ - Â¦s enseÂ¦ Â¦sub g en om icÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦m ol ecu lesÂ¦ Â¦toÂ¦ Â¦theirÂ¦ Â¦cor r esp on dingÂ¦ Â¦positiveÂ¦ - Â¦s enseÂ¦ Â¦m ğŠ£ r na ğŠ¼sÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦globalÂ¦ ğ‹‡ Â¦sol id ar ityÂ¦ Â¦andÂ¦ ğ‹‡Â¦europeanÂ¦ ğ‹‡ Â¦discov eryÂ¦ Â¦trialsÂ¦ Â¦ofÂ¦ Â¦hospitalizedÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦severeÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionÂ¦ Â¦app lyÂ¦ Â¦ad ap tiveÂ¦ Â¦desi g nÂ¦ Â¦toÂ¦ Â¦rapidlyÂ¦ Â¦al terÂ¦ Â¦trialÂ¦ Â¦p ara me tersÂ¦ Â¦asÂ¦ Â¦resultsÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦fourÂ¦ Â¦exper i m entalÂ¦ Â¦the rap e u ticÂ¦ Â¦strategiesÂ¦ Â¦emer geÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦statisticsÂ¦ Â¦areÂ¦ Â¦notÂ¦ Â¦ti me b oundÂ¦ Â¦andÂ¦ Â¦followÂ¦ Â¦aÂ¦ Â¦specificÂ¦ Â¦populationÂ¦ Â¦fromÂ¦ Â¦infectionÂ¦ Â¦throughÂ¦ Â¦caseÂ¦ Â¦res o lutionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦outbreakÂ¦ ,â– Â¦aÂ¦ Â¦ran geÂ¦ Â¦ofÂ¦ Â¦ps yc hi a tr icÂ¦ Â¦m orbid itiesÂ¦ Â¦includingÂ¦ Â¦per sist entÂ¦ Â¦dep r essionÂ¦ ,â– Â¦an x ie tyÂ¦ ,â– Â¦pan icÂ¦ Â¦att ac ksÂ¦ ,â– Â¦ps y ch om ot orÂ¦ Â¦ex ci te mentÂ¦ ,â– Â¦ps yc ho ticÂ¦ Â¦symptomsÂ¦ ,â– Â¦deli ri umÂ¦ ,â– Â¦andÂ¦ Â¦evenÂ¦ Â¦su ic id alityÂ¦ Â¦wereÂ¦ Â¦reportedÂ¦ .
ğ‹‡ Â¦wh en everÂ¦ Â¦possibleÂ¦ ,â– Â¦weÂ¦ Â¦willÂ¦ Â¦ tryÂ¦ Â¦toÂ¦ Â¦comp areÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦andÂ¦ Â¦anotherÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦causedÂ¦ Â¦diseaseÂ¦ ,â– ğ‹‡Â¦m iddleÂ¦ ğ‹‡Â¦eastÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ â–( ğŠ£Â¦mersÂ¦ğŠ¼ ,â– Â¦anÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ Â¦201 2Â¦ ).
ğ‹‡Â¦itÂ¦ Â¦hasÂ¦ Â¦att r actedÂ¦ Â¦aÂ¦ Â¦greatÂ¦ Â¦attentionÂ¦ Â¦sinceÂ¦ Â¦publishedÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦enz y meÂ¦ Â¦isÂ¦ Â¦essentialÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦hostÂ¦ Â¦cellÂ¦ Â¦toÂ¦ Â¦rep ro du ceÂ¦ Â¦theÂ¦ Â¦ rib on ucle icÂ¦ Â¦acidÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦aff ectsÂ¦ Â¦moreÂ¦ Â¦elder lyÂ¦ Â¦individualsÂ¦ Â¦thanÂ¦ Â¦you thÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦menÂ¦ Â¦thanÂ¦ Â¦womenÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ Â¦severityÂ¦ Â¦andÂ¦ Â¦deathÂ¦ Â¦rateÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦higherÂ¦ Â¦inÂ¦ Â¦elder lyÂ¦ Â¦indi vid ualÂ¦ Â¦thanÂ¦ Â¦inÂ¦ Â¦you thÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theÂ¦ Â¦transmissionÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦wasÂ¦ Â¦consideredÂ¦ Â¦toÂ¦ Â¦occ urÂ¦ Â¦whenÂ¦ Â¦theÂ¦ Â¦patientsÂ¦ Â¦areÂ¦ Â¦se ve relyÂ¦ Â¦illÂ¦ ,â– Â¦whileÂ¦ Â¦mostÂ¦ Â¦transmissionÂ¦ Â¦didÂ¦ Â¦notÂ¦ Â¦happenÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦phaseÂ¦ .
ğ‹‡ Â¦rep ur p osedÂ¦ Â¦antiviralÂ¦ Â¦drugsÂ¦ Â¦makeÂ¦ Â¦upÂ¦ Â¦mostÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦researchÂ¦ ,â– Â¦withÂ¦ Â¦9Â¦ ğ‹‡Â¦phaseÂ¦ ğŠ£Â¦i i iÂ¦ğŠ¼ Â¦trialsÂ¦ Â¦onÂ¦ Â¦rem desivirÂ¦ Â¦acrossÂ¦ Â¦severalÂ¦ Â¦countriesÂ¦ Â¦dueÂ¦ Â¦toÂ¦ Â¦reportÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ ğ‹‡Â¦aprilÂ¦ .
ğ‹‡Â¦j ap anÂ¦ Â¦d on atedÂ¦ Â¦oneÂ¦ Â¦millionÂ¦ Â¦faceÂ¦ Â¦masksÂ¦ Â¦toÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğ‹‡ Â¦tur ke yÂ¦ Â¦disp at ch edÂ¦ Â¦medicalÂ¦ Â¦equipmentÂ¦ ,â– ğ‹‡Â¦russiaÂ¦ Â¦sentÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦13Â¦ Â¦tonnesÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦suppli esÂ¦ Â¦toÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğ‹‡Â¦ma la y siaÂ¦ Â¦announcedÂ¦ Â¦aÂ¦ Â¦d on ationÂ¦ Â¦ofÂ¦ Â¦18Â¦ Â¦millionÂ¦ Â¦medicalÂ¦ Â¦glo vesÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– ğ‹‡Â¦germanyÂ¦ Â¦deli v eredÂ¦ Â¦variousÂ¦ Â¦medicalÂ¦ Â¦suppli esÂ¦ Â¦includingÂ¦ Â¦10Â¦ , Â¦000Â¦ ğ‹‡ Â¦ha z m atÂ¦ Â¦su i tsÂ¦ ,â– Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦d on atedÂ¦ Â¦17Â¦ . Â¦8Â¦ Â¦t onsÂ¦ Â¦ofÂ¦ Â¦medicalÂ¦ Â¦suppli esÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦pro mi sedÂ¦ Â¦anÂ¦ Â¦additionalÂ¦ â– $ Â¦100Â¦ Â¦millionÂ¦ Â¦inÂ¦ Â¦financialÂ¦ Â¦supportÂ¦ Â¦toÂ¦ Â¦affectedÂ¦ Â¦countriesÂ¦ . ğ‹‡Â¦afterÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦see medÂ¦ Â¦toÂ¦ Â¦sta bi li zeÂ¦ ,â– Â¦theÂ¦ Â¦countryÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦s endingÂ¦ Â¦a idÂ¦ Â¦toÂ¦ Â¦variousÂ¦ Â¦n ationsÂ¦ Â¦hitÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦22Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦associatedÂ¦ ğ‹‡ Â¦pressÂ¦ Â¦reportedÂ¦ : â–" ğ‹‡Â¦manyÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦symptomsÂ¦ Â¦andÂ¦ Â¦aÂ¦ Â¦doctorÂ¦ ' Â¦sÂ¦ Â¦orderÂ¦ Â¦haveÂ¦ Â¦wai tedÂ¦ Â¦hoursÂ¦ Â¦orÂ¦ Â¦daysÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦testÂ¦ ." ğ‹‡Â¦afterÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦deathÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦wasÂ¦ Â¦reportedÂ¦ Â¦inÂ¦ ğ‹‡Â¦w as hi ng t onÂ¦ Â¦stateÂ¦ Â¦onÂ¦ Â¦29Â¦ ğ‹‡Â¦februaryÂ¦ ,â– ğ‹‡Â¦go ver n orÂ¦ ğ‹‡Â¦ jayÂ¦ ğ‹‡ Â¦ins le eÂ¦ Â¦declaredÂ¦ Â¦aÂ¦ Â¦stateÂ¦ Â¦ofÂ¦ Â¦emergencyÂ¦ ,â– Â¦anÂ¦ Â¦actionÂ¦ Â¦thatÂ¦ Â¦wasÂ¦ Â¦soonÂ¦ Â¦followedÂ¦ Â¦byÂ¦ Â¦otherÂ¦ Â¦statesÂ¦ .
ğ‹‡Â¦patientsÂ¦ Â¦infectedÂ¦ Â¦withÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ Â¦pres entedÂ¦ Â¦withÂ¦ Â¦commonÂ¦ Â¦coldÂ¦ Â¦symptomsÂ¦ ,â– Â¦includingÂ¦ Â¦he ad ach eÂ¦ ,â– Â¦snee zingÂ¦ ,â– Â¦ma la iseÂ¦ Â¦andÂ¦ Â¦s oreÂ¦ - Â¦throatÂ¦ ,â– Â¦withÂ¦ Â¦feverÂ¦ Â¦andÂ¦ Â¦coughÂ¦ Â¦seenÂ¦ Â¦inÂ¦ Â¦10Â¦ ~ Â¦20Â¦ %â– Â¦casesÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦thursdayÂ¦ Â¦ ed itionÂ¦ Â¦ofÂ¦ ğŠ£Â¦ nt Â¦ğŠ¼ ğ‹‡ Â¦newsÂ¦ ,â– Â¦aÂ¦ Â¦dailyÂ¦ Â¦pr intedÂ¦ Â¦inÂ¦ ğ‹‡Â¦d ar w inÂ¦ ,â– Â¦includedÂ¦ Â¦anÂ¦ Â¦eightÂ¦ - Â¦p ageÂ¦ Â¦ins er tÂ¦ Â¦me antÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦c utÂ¦ Â¦upÂ¦ Â¦andÂ¦ Â¦usedÂ¦ Â¦asÂ¦ Â¦to il etÂ¦ Â¦paperÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦meansÂ¦ Â¦thatÂ¦ Â¦countriesÂ¦ Â¦mayÂ¦ Â¦haveÂ¦ Â¦moreÂ¦ Â¦orÂ¦ Â¦lessÂ¦ Â¦resourcesÂ¦ Â¦thanÂ¦ ğ‹‡Â¦italyÂ¦ â–( Â¦12Â¦ . Â¦5Â¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦andÂ¦ Â¦interme di ateÂ¦ Â¦careÂ¦ Â¦bedsÂ¦ Â¦perÂ¦ Â¦100Â¦ , Â¦000Â¦ Â¦populationÂ¦ Â¦inÂ¦ Â¦201 0Â¦ â€“ Â¦11Â¦ ).
ğ‹‡Â¦sinceÂ¦ Â¦partic lesÂ¦ Â¦canÂ¦ Â¦pe ne tr ateÂ¦ Â¦evenÂ¦ Â¦fiveÂ¦ Â¦surg icalÂ¦ Â¦masksÂ¦ Â¦st ac kedÂ¦ Â¦togetherÂ¦ ,â– Â¦healthÂ¦ - Â¦careÂ¦ Â¦provi dersÂ¦ Â¦inÂ¦ Â¦directÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦patientsÂ¦ Â¦mustÂ¦ Â¦wearÂ¦ ğ‹‡Â¦n 9 5Â¦ â–( Â¦ser iesÂ¦ â– # â– Â¦1 8 6 0 sÂ¦ )â– Â¦masksÂ¦ Â¦butÂ¦ Â¦notÂ¦ Â¦surg icalÂ¦ Â¦masksÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦inÂ¦ Â¦myÂ¦ Â¦chestÂ¦
ğ‹‡Â¦controlÂ¦ Â¦ofÂ¦ Â¦publicÂ¦ Â¦mo ve mentÂ¦ Â¦wasÂ¦ Â¦app l iedÂ¦ Â¦inÂ¦ Â¦manyÂ¦ Â¦citiesÂ¦ ,â– Â¦andÂ¦ Â¦itÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦estimatedÂ¦ Â¦thatÂ¦ Â¦aboutÂ¦ Â¦7 6 0Â¦ Â¦millionÂ¦ Â¦peopleÂ¦ â–( Â¦moreÂ¦ Â¦thanÂ¦ Â¦halfÂ¦ Â¦theÂ¦ Â¦populationÂ¦ )â– Â¦f acedÂ¦ Â¦someÂ¦ Â¦formÂ¦ Â¦ofÂ¦ Â¦out d o orÂ¦ Â¦restric tionÂ¦ . ğ‹‡Â¦afterÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦ent eredÂ¦ Â¦itsÂ¦ Â¦globalÂ¦ Â¦phaseÂ¦ Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ ,â– ğ‹‡Â¦chineseÂ¦ Â¦authoritiesÂ¦ Â¦tookÂ¦ Â¦strictÂ¦ Â¦measuresÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦fromÂ¦ â–" Â¦i m portingÂ¦ "â– Â¦fromÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ Â¦2019Â¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ )â– Â¦isÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦diseaseÂ¦ ,â– Â¦ourÂ¦ Â¦awarenessÂ¦ Â¦andÂ¦ Â¦ knowled geÂ¦ Â¦areÂ¦ Â¦g rad uallyÂ¦ Â¦increasingÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦ongoingÂ¦ Â¦researchÂ¦ Â¦findingsÂ¦ Â¦andÂ¦ Â¦clinicalÂ¦ Â¦practiceÂ¦ Â¦experienceÂ¦ ;â– Â¦he nceÂ¦ ,â– Â¦theÂ¦ Â¦strategiesÂ¦ Â¦ofÂ¦ Â¦diagn osisÂ¦ Â¦andÂ¦ Â¦treatmentÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦continu allyÂ¦ Â¦upd atedÂ¦ .
ğ‹‡ Â¦remo teÂ¦ Â¦workingÂ¦ Â¦measuresÂ¦ Â¦wereÂ¦ Â¦institu tedÂ¦ Â¦inÂ¦ Â¦severalÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦regi onsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦experienceÂ¦ Â¦fromÂ¦ ğ‹‡Â¦italyÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦currentÂ¦ Â¦tre ndsÂ¦ Â¦inÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ Â¦showÂ¦ Â¦thatÂ¦ Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦pandemicÂ¦ Â¦isÂ¦ Â¦prog res singÂ¦ Â¦rapidlyÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦e uÂ¦ / Â¦ ee aÂ¦ğŠ¼ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼ .
ğ‹‡Â¦withÂ¦ Â¦theÂ¦ Â¦or de alsÂ¦ Â¦ofÂ¦ ğŠ£Â¦s arsÂ¦ ,â– Â¦m ersÂ¦ ğŠ¼ Â¦andÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦aÂ¦ Â¦betterÂ¦ Â¦prepar ed nessÂ¦ Â¦andÂ¦ Â¦responseÂ¦ Â¦planÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦inÂ¦ Â¦placeÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦re si dentsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦andÂ¦ ğ‹‡Â¦h ub e iÂ¦ Â¦haveÂ¦ Â¦reportedÂ¦ Â¦disc ri m inationÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theirÂ¦ Â¦regi onalÂ¦ Â¦originÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦st ati st icalÂ¦ Â¦analysisÂ¦ Â¦publishedÂ¦ Â¦30Â¦ ğ‹‡Â¦marchÂ¦ Â¦estimatedÂ¦ Â¦thatÂ¦ Â¦numbersÂ¦ Â¦ofÂ¦ Â¦infectionsÂ¦ Â¦inÂ¦ ğ‹‡Â¦italyÂ¦ Â¦wereÂ¦ Â¦consi der ablyÂ¦ Â¦g rea terÂ¦ Â¦thanÂ¦ Â¦theÂ¦ Â¦reportedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦22Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦afterÂ¦ Â¦aÂ¦ Â¦phoneÂ¦ Â¦callÂ¦ Â¦withÂ¦ ğ‹‡Â¦i ta lianÂ¦ ğ‹‡Â¦primeÂ¦ ğ‹‡Â¦ministerÂ¦ ğ‹‡ Â¦gi u se pp eÂ¦ ğ‹‡ Â¦con teÂ¦ ,â– ğ‹‡ Â¦rus si anÂ¦ Â¦presidentÂ¦ ğ‹‡Â¦v la di m irÂ¦ ğ‹‡Â¦p ut inÂ¦ Â¦arr an gedÂ¦ Â¦theÂ¦ ğ‹‡ Â¦rus si anÂ¦ Â¦ar m yÂ¦ Â¦toÂ¦ Â¦sendÂ¦ Â¦mil it aryÂ¦ Â¦medic sÂ¦ ,â– Â¦specialÂ¦ Â¦disin f ectionÂ¦ Â¦vehic lesÂ¦ ,â– Â¦andÂ¦ Â¦otherÂ¦ Â¦medicalÂ¦ Â¦equipmentÂ¦ Â¦toÂ¦ ğ‹‡Â¦italyÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦governmentÂ¦ Â¦enc ou ra gedÂ¦ Â¦busin essesÂ¦ Â¦andÂ¦ Â¦fact oriesÂ¦ Â¦toÂ¦ Â¦reÂ¦ - Â¦openÂ¦ Â¦onÂ¦ Â¦30Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦andÂ¦ Â¦providedÂ¦ Â¦mo ne t aryÂ¦ Â¦s ti mul usÂ¦ Â¦p ac ka gesÂ¦ Â¦forÂ¦ Â¦f ir msÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦stateÂ¦ ğ‹‡Â¦councilÂ¦ Â¦declaredÂ¦ Â¦aÂ¦ Â¦dayÂ¦ Â¦ofÂ¦ Â¦m our ningÂ¦ Â¦toÂ¦ Â¦beg inÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦nationalÂ¦ Â¦threeÂ¦ - Â¦min uteÂ¦ Â¦mo mentÂ¦ Â¦ofÂ¦ Â¦si le nceÂ¦ Â¦onÂ¦ Â¦10Â¦ : Â¦ 00Â¦ Â¦4Â¦ ğ‹‡Â¦aprilÂ¦ ,â– Â¦co in ci dingÂ¦ Â¦withÂ¦ ğ‹‡Â¦ q i ng mingÂ¦ ğ‹‡Â¦f es ti valÂ¦ ,â– Â¦al th oughÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦governmentÂ¦ Â¦askedÂ¦ Â¦familiesÂ¦ Â¦toÂ¦ Â¦payÂ¦ Â¦theirÂ¦ Â¦resp ectsÂ¦ Â¦onlineÂ¦ Â¦inÂ¦ Â¦obser v anceÂ¦ Â¦ofÂ¦ Â¦physicalÂ¦ Â¦distancingÂ¦ Â¦asÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦aÂ¦ Â¦re ne w edÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦outbreakÂ¦ .
ğ‹‡ Â¦privateÂ¦ Â¦vehic leÂ¦ Â¦useÂ¦ Â¦wasÂ¦ Â¦bannedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦cityÂ¦ .
ğ‹‡ Â¦aroundÂ¦ Â¦200Â¦ Â¦countriesÂ¦ Â¦andÂ¦ Â¦ter rit oriesÂ¦ Â¦haveÂ¦ Â¦hadÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦oneÂ¦ Â¦caseÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦europeanÂ¦ ğ‹‡Â¦c entr eÂ¦ Â¦forÂ¦ ğ‹‡Â¦diseaseÂ¦ ğ‹‡Â¦preventionÂ¦ Â¦andÂ¦ ğ‹‡Â¦controlÂ¦ â–( ğŠ£Â¦ ec d cÂ¦ğŠ¼ )â– Â¦statesÂ¦ Â¦thatÂ¦ Â¦whileÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦ enti relyÂ¦ Â¦clearÂ¦ Â¦howÂ¦ Â¦ ea si lyÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦sprea dsÂ¦ ,â– Â¦oneÂ¦ Â¦personÂ¦ Â¦gener allyÂ¦ Â¦inf ectsÂ¦ Â¦twoÂ¦ Â¦toÂ¦ Â¦threeÂ¦ Â¦othersÂ¦ . ğ‹‡Â¦theÂ¦ Â¦virusÂ¦ Â¦sur vi vesÂ¦ Â¦forÂ¦ Â¦hoursÂ¦ Â¦toÂ¦ Â¦daysÂ¦ Â¦onÂ¦ Â¦surfa cesÂ¦ .
ğ‹‡Â¦a partÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦sup erÂ¦ - Â¦sprea dersÂ¦ ,â– Â¦itÂ¦ Â¦wasÂ¦ Â¦estimatedÂ¦ Â¦thatÂ¦ Â¦eachÂ¦ Â¦caseÂ¦ Â¦couldÂ¦ Â¦giveÂ¦ Â¦riseÂ¦ Â¦toÂ¦ Â¦approximatelyÂ¦ Â¦twoÂ¦ Â¦secondaryÂ¦ Â¦casesÂ¦ ,â– Â¦withÂ¦ Â¦anÂ¦ Â¦inc ub ationÂ¦ Â¦periodÂ¦ Â¦ofÂ¦ Â¦4Â¦ Â¦toÂ¦ Â¦7Â¦ Â¦daysÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦p eakÂ¦ Â¦ofÂ¦ Â¦viralÂ¦ Â¦lo adÂ¦ Â¦appe aringÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦10thÂ¦ Â¦dayÂ¦ Â¦ofÂ¦ Â¦illnessÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦thisÂ¦ Â¦toÂ¦ Â¦happenÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦toÂ¦ Â¦rep lic ateÂ¦ Â¦inÂ¦ Â¦humansÂ¦ Â¦toÂ¦ Â¦suff icientÂ¦ Â¦ext entÂ¦ Â¦toÂ¦ Â¦allowÂ¦ Â¦theÂ¦ Â¦acc u mul ationÂ¦ Â¦ofÂ¦ Â¦ad ap tiveÂ¦ Â¦mutationsÂ¦ Â¦thatÂ¦ Â¦coun ter actÂ¦ Â¦hostÂ¦ Â¦restric tionÂ¦ Â¦factorsÂ¦ .
ğ‹‡Â¦s ter oi dsÂ¦ ,â– Â¦asÂ¦ Â¦imm u no su pp r ess antsÂ¦ ,â– Â¦wereÂ¦ Â¦wi de lyÂ¦ Â¦usedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦toÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦severityÂ¦ Â¦ofÂ¦ Â¦inf lamm atoryÂ¦ Â¦d am ageÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦high li ghtsÂ¦ Â¦thatÂ¦ ,â– Â¦asÂ¦ Â¦atÂ¦ Â¦15Â¦ ğ‹‡Â¦marchÂ¦ Â¦8Â¦ : Â¦ 00Â¦ Â¦aÂ¦ . Â¦mÂ¦ . ,â– Â¦15Â¦ Â¦otherÂ¦ ğŠ£Â¦e uÂ¦ / Â¦ ee aÂ¦ğŠ¼ Â¦countriesÂ¦ Â¦andÂ¦ Â¦theÂ¦ ğŠ£Â¦ukÂ¦ğŠ¼ Â¦hadÂ¦ Â¦alreadyÂ¦ Â¦reportedÂ¦ Â¦aÂ¦ Â¦totalÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦casesÂ¦ Â¦com par ableÂ¦ Â¦toÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğ‹‡Â¦italyÂ¦ Â¦justÂ¦ Â¦3Â¦ Â¦weeksÂ¦ Â¦pri orÂ¦ Â¦orÂ¦ Â¦lessÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦outbreakÂ¦ Â¦dis rup tedÂ¦ Â¦plansÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦2020Â¦ ğ‹‡Â¦s um m erÂ¦ ğ‹‡Â¦ ol y mp icsÂ¦ ,â– Â¦whichÂ¦ Â¦wereÂ¦ Â¦origin allyÂ¦ Â¦schedu ledÂ¦ Â¦toÂ¦ Â¦startÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦endÂ¦ Â¦ofÂ¦ ğ‹‡Â¦ju lyÂ¦ ;â– Â¦theÂ¦ ğ‹‡Â¦internationalÂ¦ ğ‹‡Â¦ ol y mp icÂ¦ ğ‹‡Â¦comm itteeÂ¦ Â¦announcedÂ¦ Â¦onÂ¦ Â¦24Â¦ ğ‹‡Â¦marchÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦ev entÂ¦ Â¦willÂ¦ Â¦beÂ¦ â–" Â¦r esc he du ledÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦dateÂ¦ Â¦be y on dÂ¦ Â¦2020Â¦ Â¦butÂ¦ Â¦notÂ¦ Â¦laterÂ¦ Â¦thanÂ¦ Â¦s um m erÂ¦ Â¦2021Â¦ ". ğ‹‡ Â¦ca si no sÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦ga mingÂ¦ Â¦v en u esÂ¦ Â¦worldwideÂ¦ Â¦haveÂ¦ Â¦closedÂ¦ Â¦andÂ¦ Â¦liveÂ¦ Â¦po kerÂ¦ Â¦tour na mentsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦e itherÂ¦ Â¦postpo nedÂ¦ Â¦orÂ¦ Â¦cance lledÂ¦ .
ğ‹‡ Â¦areÂ¦ Â¦youÂ¦ Â¦havingÂ¦ Â¦anyÂ¦ Â¦sh ort nessÂ¦ Â¦ofÂ¦ Â¦breathÂ¦ ?
ğ‹‡ Â¦diarrheaÂ¦ â–( Â¦26Â¦ %)â– Â¦andÂ¦ Â¦s oreÂ¦ Â¦throatÂ¦ â–( Â¦21Â¦ %)â– Â¦wereÂ¦ Â¦alsoÂ¦ Â¦observedÂ¦ Â¦withÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ Â¦patientsÂ¦ .
ğ‹‡Â¦healthÂ¦ Â¦organizationsÂ¦ Â¦recommendedÂ¦ Â¦thatÂ¦ Â¦peopleÂ¦ Â¦co verÂ¦ Â¦theirÂ¦ Â¦mouthÂ¦ Â¦andÂ¦ Â¦noseÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦b entÂ¦ Â¦el bo wÂ¦ Â¦orÂ¦ Â¦aÂ¦ Â¦t iss ueÂ¦ Â¦whenÂ¦ Â¦c oug hingÂ¦ Â¦orÂ¦ Â¦snee zingÂ¦ ,â– Â¦andÂ¦ Â¦disp osingÂ¦ Â¦ofÂ¦ Â¦anyÂ¦ Â¦t iss ueÂ¦ Â¦immediatelyÂ¦ .
ğ‹‡Â¦aboutÂ¦ Â¦3 6 4Â¦ , Â¦000Â¦ Â¦peopleÂ¦ Â¦haveÂ¦ Â¦recoveredÂ¦ .
ğ‹‡ Â¦coronavirusesÂ¦ Â¦canÂ¦ Â¦causeÂ¦ Â¦pneumoniaÂ¦ â–( Â¦e itherÂ¦ Â¦directÂ¦ Â¦viralÂ¦ Â¦pneumoniaÂ¦ Â¦orÂ¦ Â¦secondaryÂ¦ Â¦b ac terialÂ¦ Â¦pneumoniaÂ¦ )â– Â¦andÂ¦ Â¦bro nc hi tisÂ¦ â–( Â¦e itherÂ¦ Â¦directÂ¦ Â¦viralÂ¦ Â¦bro nc hi tisÂ¦ Â¦orÂ¦ Â¦secondaryÂ¦ Â¦b ac terialÂ¦ Â¦bro nc hi tisÂ¦ ).
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦19 5 0 sÂ¦ ,â– Â¦theÂ¦ Â¦humanÂ¦ Â¦coronavirusÂ¦ ğŠ£Â¦ oc ğŠ¼ 43Â¦ Â¦beganÂ¦ Â¦toÂ¦ Â¦di ver geÂ¦ Â¦intoÂ¦ Â¦itsÂ¦ Â¦presentÂ¦ Â¦g en ot yp esÂ¦ .
ğ‹‡ Â¦beforeÂ¦ Â¦discus singÂ¦ Â¦theÂ¦ Â¦animalÂ¦ Â¦origin sÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ ,â– Â¦itÂ¦ Â¦willÂ¦ Â¦ser veÂ¦ Â¦usÂ¦ Â¦wellÂ¦ Â¦toÂ¦ Â¦discus sÂ¦ Â¦theÂ¦ Â¦de fi ni tionsÂ¦ Â¦andÂ¦ Â¦char ac teri st icsÂ¦ Â¦ofÂ¦ Â¦ev o lu tion aryÂ¦ ,â– Â¦naturalÂ¦ ,â– Â¦reserv o irÂ¦ ,â– Â¦interme di ateÂ¦ Â¦andÂ¦ Â¦a mp li f yingÂ¦ Â¦h ostsÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦hasÂ¦ Â¦issuedÂ¦ Â¦instructionsÂ¦ Â¦onÂ¦ Â¦whenÂ¦ Â¦andÂ¦ Â¦howÂ¦ Â¦toÂ¦ Â¦useÂ¦ Â¦masksÂ¦ .
ğ‹‡ Â¦anotherÂ¦ Â¦hospitalÂ¦ Â¦wasÂ¦ Â¦buil tÂ¦ Â¦af ter w ardsÂ¦ ,â– ğ‹‡ Â¦le is he ns hanÂ¦ ğ‹‡Â¦hospitalÂ¦ ,â– Â¦toÂ¦ Â¦hand leÂ¦ Â¦additionalÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦6Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ ,â– Â¦ourÂ¦ Â¦teamÂ¦ Â¦hadÂ¦ Â¦publishedÂ¦ Â¦aÂ¦ Â¦rapidÂ¦ Â¦adviceÂ¦ Â¦gu i de lineÂ¦ Â¦forÂ¦ Â¦diagn osisÂ¦ Â¦andÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦2019Â¦ Â¦novelÂ¦ Â¦coronavirusÂ¦ â–( Â¦2019Â¦ - Â¦n ğ‹‡ co ğ‹‡ vÂ¦ )â– Â¦infectionÂ¦ ,â– Â¦andÂ¦ Â¦thisÂ¦ Â¦gu i de lineÂ¦ Â¦providedÂ¦ Â¦ourÂ¦ Â¦experienceÂ¦ Â¦andÂ¦ Â¦makeÂ¦ Â¦wellÂ¦ Â¦re fere nceÂ¦ Â¦forÂ¦ Â¦fi gh tingÂ¦ Â¦againstÂ¦ Â¦thisÂ¦ Â¦pandemicÂ¦ Â¦worldwideÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦hasÂ¦ Â¦fe aturesÂ¦ Â¦thatÂ¦ Â¦areÂ¦ Â¦similarÂ¦ Â¦toÂ¦ Â¦bothÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ / ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦fourÂ¦ Â¦communityÂ¦ - Â¦acqu iredÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡ Â¦theirÂ¦ Â¦guidelinesÂ¦ Â¦th usÂ¦ Â¦adv iseÂ¦ Â¦thatÂ¦ Â¦anyÂ¦ Â¦pregnantÂ¦ Â¦personÂ¦ Â¦admittedÂ¦ Â¦toÂ¦ Â¦hospitalÂ¦ Â¦withÂ¦ Â¦aÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionÂ¦ Â¦shouldÂ¦ Â¦recei veÂ¦ Â¦atÂ¦ Â¦leastÂ¦ Â¦10Â¦ Â¦daysÂ¦ Â¦ofÂ¦ Â¦pro ph y l ac ticÂ¦ Â¦lowÂ¦ - Â¦m ol ec ularÂ¦ - Â¦we i ghtÂ¦ Â¦he par inÂ¦ Â¦afterÂ¦ Â¦beingÂ¦ Â¦disc har gedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦hospitalÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦originÂ¦ Â¦andÂ¦ Â¦interme di ateÂ¦ Â¦hostÂ¦
ğ‹‡Â¦forÂ¦ Â¦thoseÂ¦ Â¦whoÂ¦ Â¦doÂ¦ Â¦notÂ¦ ,â– Â¦theÂ¦ Â¦timeÂ¦ Â¦fromÂ¦ Â¦developmentÂ¦ Â¦ofÂ¦ Â¦symptomsÂ¦ Â¦toÂ¦ Â¦deathÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦betweenÂ¦ Â¦6Â¦ Â¦andÂ¦ Â¦4 1Â¦ Â¦daysÂ¦ ,â– Â¦withÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦commonÂ¦ Â¦beingÂ¦ Â¦14Â¦ Â¦daysÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦smallÂ¦ Â¦studyÂ¦ Â¦invol vingÂ¦ Â¦6Â¦ Â¦confirmedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦mo th ersÂ¦ Â¦showedÂ¦ Â¦noÂ¦ Â¦indic ationÂ¦ Â¦ofÂ¦ ğŠ£Â¦s arsÂ¦ - Â¦co vÂ¦ğŠ¼ - Â¦19Â¦ Â¦inÂ¦ Â¦theirÂ¦ Â¦new b or nsÂ¦ 'â– Â¦th ro a tsÂ¦ Â¦orÂ¦ Â¦ser umÂ¦ Â¦butÂ¦ Â¦antibodiesÂ¦ Â¦wereÂ¦ Â¦presentÂ¦ Â¦inÂ¦ Â¦ne o na talÂ¦ Â¦bloodÂ¦ Â¦se raÂ¦ Â¦samplesÂ¦ ,â– Â¦includingÂ¦ ğ‹‡Â¦i g ğ‹‡ mÂ¦ Â¦inÂ¦ Â¦twoÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦inf antsÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦severeÂ¦ Â¦casesÂ¦ ,â– Â¦theÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ ğ‹‡Â¦ dÂ¦ - Â¦di m erÂ¦ ,â– Â¦aÂ¦ Â¦fi br inÂ¦ Â¦de g rad ationÂ¦ Â¦produc tÂ¦ Â¦presentÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦bloodÂ¦ ,â– Â¦wasÂ¦ Â¦ele v atedÂ¦ ,â– Â¦andÂ¦ Â¦l ym ph ocy teÂ¦ Â¦c ountÂ¦ Â¦wasÂ¦ Â¦prog res si ve lyÂ¦ Â¦reducedÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦23Â¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦inÂ¦ Â¦rea ctionÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦centralÂ¦ Â¦authoritiesÂ¦ 'â– Â¦decisionÂ¦ Â¦toÂ¦ Â¦implement Â¦ Â¦aÂ¦ Â¦transportationÂ¦ Â¦ banÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğŠ£Â¦whoÂ¦ğŠ¼ Â¦rep re se nt ativeÂ¦ ğ‹‡Â¦ga ud enÂ¦ ğ‹‡Â¦ga le aÂ¦ Â¦rem ar kedÂ¦ Â¦thatÂ¦ Â¦whileÂ¦ Â¦itÂ¦ Â¦wasÂ¦ â–" Â¦c er ta in lyÂ¦ Â¦notÂ¦ Â¦aÂ¦ Â¦recomme nd ationÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦hasÂ¦ Â¦madeÂ¦ " ,â– Â¦itÂ¦ Â¦wasÂ¦ Â¦alsoÂ¦ â–" Â¦aÂ¦ Â¦veryÂ¦ Â¦importantÂ¦ Â¦indic ationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦comm it mentÂ¦ Â¦toÂ¦ Â¦con tainÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦placeÂ¦ Â¦whereÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦mostÂ¦ Â¦conc entr atedÂ¦ "â– Â¦andÂ¦ Â¦calledÂ¦ Â¦itÂ¦ â–" Â¦un p r ec ed entedÂ¦ Â¦inÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦historyÂ¦ ". ğ‹‡Â¦onÂ¦ Â¦30Â¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦followingÂ¦ Â¦conf ir m ationÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦outsideÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦increaseÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦casesÂ¦ Â¦inÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦declaredÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦aÂ¦ ğ‹‡Â¦publicÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡ Â¦emergencyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦internationalÂ¦ ğ‹‡ Â¦concernÂ¦ â–( ğŠ£Â¦p he i cÂ¦ğŠ¼ ),â– Â¦theÂ¦ Â¦si x thÂ¦ ğŠ£Â¦p he i cÂ¦ğŠ¼ Â¦sinceÂ¦ Â¦theÂ¦ Â¦me asureÂ¦ Â¦wasÂ¦ Â¦firstÂ¦ Â¦in v o kedÂ¦ Â¦duringÂ¦ Â¦theÂ¦ Â¦200 9Â¦ Â¦sw ineÂ¦ Â¦fluÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦the rap iesÂ¦ Â¦includeÂ¦ Â¦currentÂ¦ Â¦andÂ¦ Â¦potentialÂ¦ Â¦tre at mentsÂ¦ Â¦withÂ¦ Â¦antiviralÂ¦ Â¦drugsÂ¦ ,â– Â¦imm u no su pp r ess antsÂ¦ ,â– Â¦s ter oi dsÂ¦ ,â– Â¦plas maÂ¦ Â¦fromÂ¦ Â¦recoveredÂ¦ Â¦patientsÂ¦ ,â– ğ‹‡Â¦chineseÂ¦ Â¦medicineÂ¦ ,â– Â¦andÂ¦ Â¦ps yc ho logicalÂ¦ Â¦supportÂ¦ .
ğ‹‡ Â¦severalÂ¦ Â¦recentÂ¦ Â¦studiesÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦me ta g en om icÂ¦ Â¦sequencingÂ¦ Â¦haveÂ¦ Â¦suggestedÂ¦ Â¦thatÂ¦ Â¦aÂ¦ Â¦groupÂ¦ Â¦ofÂ¦ Â¦e nda ng eredÂ¦ Â¦smallÂ¦ Â¦m amm alsÂ¦ Â¦knownÂ¦ Â¦asÂ¦ Â¦pa ngol insÂ¦ â–( ğ‹‡Â¦ma ni sÂ¦ Â¦j av an icaÂ¦ )â– Â¦couldÂ¦ Â¦alsoÂ¦ Â¦har bo urÂ¦ Â¦a nc es tr alÂ¦ Â¦be taÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦theyÂ¦ Â¦areÂ¦ Â¦wi de lyÂ¦ Â¦distributedÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ ğ‹‡Â¦m iddleÂ¦ ğ‹‡Â¦eastÂ¦ Â¦andÂ¦ ğ‹‡Â¦africaÂ¦ .
ğ‹‡Â¦ifÂ¦ Â¦youÂ¦ Â¦continueÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦highÂ¦ Â¦fe v ersÂ¦
ğ‹‡Â¦primeÂ¦ ğ‹‡Â¦ministerÂ¦ ğ‹‡ Â¦gi u se pp eÂ¦ ğ‹‡ Â¦con teÂ¦ Â¦saidÂ¦ ,â–" ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦areasÂ¦ ,â– Â¦entryÂ¦ Â¦andÂ¦ Â¦ex itÂ¦ Â¦willÂ¦ Â¦notÂ¦ Â¦beÂ¦ Â¦providedÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦s ourceÂ¦ Â¦acc usedÂ¦ ğ‹‡Â¦russiaÂ¦ Â¦ofÂ¦ Â¦e mb ar kingÂ¦ Â¦onÂ¦ Â¦aÂ¦ â–" Â¦ge op ol it icalÂ¦ Â¦andÂ¦ Â¦d ip lo maticÂ¦ "â– Â¦char mÂ¦ Â¦off ensiveÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ ,â– Â¦theÂ¦ Â¦requir e mentsÂ¦ Â¦forÂ¦ Â¦success fulÂ¦ Â¦hostÂ¦ Â¦sw it ch esÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦imp licationsÂ¦ Â¦ofÂ¦ Â¦virusÂ¦ Â¦ev o lutionÂ¦ Â¦onÂ¦ Â¦diseaseÂ¦ Â¦severityÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦high li gh tedÂ¦ .
ğ‹‡Â¦sa lesÂ¦ Â¦wentÂ¦ Â¦upÂ¦ Â¦inÂ¦ Â¦aÂ¦ â–" Â¦s har pÂ¦ Â¦increaseÂ¦ "â– Â¦lastÂ¦ Â¦weekÂ¦ ,â– Â¦accordingÂ¦ Â¦toÂ¦ Â¦aÂ¦ ğ‹‡Â¦w o ol wor th sÂ¦ Â¦spo k esp er s onÂ¦ .
ğ‹‡ Â¦throughÂ¦ Â¦differentÂ¦ Â¦pa th waysÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦in du cesÂ¦ Â¦theÂ¦ Â¦exp r essionÂ¦ Â¦ofÂ¦ Â¦inf lamm atoryÂ¦ Â¦factorsÂ¦ ,â– Â¦m at urationÂ¦ Â¦ofÂ¦ Â¦de nd ri ticÂ¦ Â¦cellsÂ¦ ,â– Â¦andÂ¦ Â¦sy nt he sisÂ¦ Â¦ofÂ¦ Â¦typeÂ¦ ğ‹‡Â¦iÂ¦ Â¦inter fer onsÂ¦ â–( ğŠ£Â¦i f n ğŠ¼sÂ¦ )â– Â¦whichÂ¦ Â¦limitÂ¦ Â¦theÂ¦ Â¦spreadingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦andÂ¦ Â¦acc el er ateÂ¦ Â¦m ac ro ph ageÂ¦ Â¦p ha g ocy t osisÂ¦ Â¦ofÂ¦ Â¦viralÂ¦ Â¦anti ge nsÂ¦ .
ğ‹‡ Â¦amongÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦acc ess oryÂ¦ Â¦proteinsÂ¦ ,â– ğŠ£ Â¦or f ğŠ¼ 8Â¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦importantÂ¦ Â¦inÂ¦ Â¦ad a pt ationÂ¦ Â¦toÂ¦ Â¦humansÂ¦ ,â– Â¦asÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦relatedÂ¦ Â¦batÂ¦ Â¦virusesÂ¦ Â¦wereÂ¦ Â¦isolatedÂ¦ Â¦butÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦en co deÂ¦ Â¦di ver gentÂ¦ ğŠ£ Â¦or f ğŠ¼ 8Â¦ Â¦proteinsÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦provi n cialÂ¦ - Â¦levelÂ¦ Â¦ad ministr atorsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦comm un istÂ¦ ğ‹‡ Â¦partyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chinaÂ¦ â–( ğŠ£Â¦c p cÂ¦ğŠ¼ )â– Â¦wereÂ¦ Â¦dis m is sedÂ¦ Â¦overÂ¦ Â¦theirÂ¦ Â¦hand lingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦quarantineÂ¦ Â¦effortsÂ¦ Â¦inÂ¦ ğ‹‡Â¦centralÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦aÂ¦ Â¦si g nÂ¦ Â¦ofÂ¦ Â¦dis co nt entÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦politicalÂ¦ Â¦establish mentÂ¦ ' Â¦sÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ Â¦thoseÂ¦ Â¦regi onsÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦thereÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦theÂ¦ Â¦recomme nd ationÂ¦ Â¦thatÂ¦ Â¦new b or nsÂ¦ Â¦andÂ¦ Â¦mo th ersÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦tempor ari lyÂ¦ Â¦se par atedÂ¦ Â¦untilÂ¦ Â¦transmissionÂ¦ - Â¦basedÂ¦ Â¦precau tionsÂ¦ Â¦areÂ¦ Â¦dis co nt in u edÂ¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ Â¦whereÂ¦ Â¦thisÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦possibleÂ¦ Â¦theÂ¦ Â¦new b or nÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦keptÂ¦ Â¦2Â¦ Â¦me tr esÂ¦ Â¦awayÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦mo therÂ¦ .
ğ‹‡ Â¦reportsÂ¦ Â¦fromÂ¦ ğ‹‡Â¦februaryÂ¦ â–( Â¦whenÂ¦ Â¦theÂ¦ Â¦ma j orityÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦casesÂ¦ Â¦hadÂ¦ Â¦stillÂ¦ Â¦beenÂ¦ Â¦conf inedÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ )â– Â¦haveÂ¦ Â¦d oc um entedÂ¦ Â¦r ac istÂ¦ Â¦s enti mentsÂ¦ Â¦expressedÂ¦ Â¦inÂ¦ Â¦variousÂ¦ Â¦groupsÂ¦ Â¦worldwideÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦peopleÂ¦ Â¦d es er vingÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦orÂ¦ Â¦recei vingÂ¦ Â¦whatÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦claimedÂ¦ Â¦asÂ¦ Â¦j us ti fiedÂ¦ Â¦re t rib u tionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦s enseÂ¦ ,â– Â¦theÂ¦ Â¦longerÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦outbreakÂ¦ Â¦per s istsÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦moreÂ¦ Â¦peopleÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦inf ectsÂ¦ ,â– Â¦theÂ¦ Â¦g rea terÂ¦ Â¦ch anceÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦willÂ¦ Â¦ fullyÂ¦ Â¦ad a ptÂ¦ Â¦toÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦v ari abilityÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦likelyÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦signific a ntlyÂ¦ Â¦aff ectingÂ¦ Â¦reportedÂ¦ Â¦caseÂ¦ Â¦f at alityÂ¦ Â¦ratesÂ¦ ,â– Â¦whichÂ¦ Â¦areÂ¦ Â¦likelyÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦signific a ntlyÂ¦ Â¦overÂ¦ - Â¦estimatedÂ¦ Â¦inÂ¦ Â¦someÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦com par ablyÂ¦ ,â– Â¦theÂ¦ Â¦mortalityÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦byÂ¦ ğ‹‡Â¦novemberÂ¦ Â¦200 2Â¦ Â¦wasÂ¦ Â¦10Â¦ %â– Â¦ofÂ¦ Â¦8Â¦ , Â¦0 9 6Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chinaÂ¦ ' Â¦sÂ¦ Â¦ne arlyÂ¦ Â¦300Â¦ Â¦millionÂ¦ Â¦ruralÂ¦ Â¦mi gr antÂ¦ Â¦workersÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦stra ndedÂ¦ Â¦atÂ¦ Â¦homeÂ¦ Â¦inÂ¦ Â¦in landÂ¦ Â¦provi n cesÂ¦ Â¦orÂ¦ Â¦tra ppedÂ¦ Â¦inÂ¦ ğ‹‡Â¦h ub e iÂ¦ Â¦provi nceÂ¦ . ğ‹‡Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦moreÂ¦ Â¦thanÂ¦ Â¦10Â¦ Â¦millionÂ¦ ğ‹‡Â¦amer ic ansÂ¦ Â¦lostÂ¦ Â¦theirÂ¦ Â¦jo b sÂ¦ Â¦andÂ¦ Â¦app l iedÂ¦ Â¦forÂ¦ Â¦governmentÂ¦ Â¦a idÂ¦ .
ğ‹‡ Â¦clinicalÂ¦ Â¦ma ni f est ationsÂ¦ Â¦ofÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ Â¦re semb leÂ¦ Â¦thoseÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ ,â– Â¦char ac teri zedÂ¦ Â¦byÂ¦ Â¦prog res siveÂ¦ Â¦acuteÂ¦ Â¦pneumoniaÂ¦ .
ğ‹‡ Â¦containmentÂ¦ Â¦isÂ¦ Â¦under ta kenÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦earlyÂ¦ Â¦stagesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦andÂ¦ Â¦ai msÂ¦ Â¦toÂ¦ Â¦tr aceÂ¦ Â¦andÂ¦ Â¦is ol ateÂ¦ Â¦thoseÂ¦ Â¦infectedÂ¦ Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦int ro du ceÂ¦ Â¦otherÂ¦ Â¦measuresÂ¦ Â¦ofÂ¦ Â¦infectionÂ¦ Â¦controlÂ¦ Â¦andÂ¦ Â¦vaccinationsÂ¦ Â¦toÂ¦ Â¦stopÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ Â¦fromÂ¦ Â¦spreadingÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦r estÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦hongÂ¦ ğ‹‡Â¦kongÂ¦ Â¦hasÂ¦ Â¦setÂ¦ Â¦upÂ¦ Â¦aÂ¦ Â¦schemeÂ¦ Â¦whereÂ¦ Â¦suspectedÂ¦ Â¦patientsÂ¦ Â¦canÂ¦ Â¦stayÂ¦ Â¦homeÂ¦ ,â–" Â¦emergencyÂ¦ Â¦departmentÂ¦ Â¦willÂ¦ Â¦giveÂ¦ Â¦aÂ¦ Â¦speci m enÂ¦ Â¦t ub eÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦patientÂ¦ " ,â– Â¦theyÂ¦ Â¦sp itÂ¦ Â¦intoÂ¦ Â¦itÂ¦ ,â– Â¦sendÂ¦ Â¦itÂ¦ Â¦backÂ¦ Â¦andÂ¦ Â¦getÂ¦ Â¦aÂ¦ Â¦testÂ¦ Â¦resultÂ¦ Â¦aÂ¦ Â¦whileÂ¦ Â¦afterÂ¦ . ğ‹‡Â¦theÂ¦ ğ‹‡Â¦b rit ishÂ¦ ğŠ£Â¦n h s Â¦ğŠ¼ Â¦hasÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦pi lo tingÂ¦ Â¦aÂ¦ Â¦schemeÂ¦ Â¦toÂ¦ Â¦testÂ¦ Â¦suspectedÂ¦ Â¦casesÂ¦ Â¦atÂ¦ Â¦homeÂ¦ ,â– Â¦whichÂ¦ Â¦remo vesÂ¦ Â¦theÂ¦ Â¦riskÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦patientÂ¦ Â¦inf ectingÂ¦ Â¦othersÂ¦ Â¦ifÂ¦ Â¦theyÂ¦ Â¦comeÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦hospitalÂ¦ Â¦orÂ¦ Â¦havingÂ¦ Â¦toÂ¦ Â¦disin f ectÂ¦ Â¦anÂ¦ Â¦ambul anceÂ¦ Â¦ifÂ¦ Â¦oneÂ¦ Â¦isÂ¦ Â¦usedÂ¦ . ğ‹‡Â¦inÂ¦ Â¦dri veÂ¦ - Â¦throughÂ¦ Â¦testingÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦forÂ¦ Â¦suspectedÂ¦ Â¦casesÂ¦ ,â– Â¦aÂ¦ Â¦healthcareÂ¦ Â¦prof es si onalÂ¦ Â¦takesÂ¦ Â¦sampleÂ¦ Â¦usingÂ¦ Â¦appropriateÂ¦ Â¦precau tionsÂ¦ .
ğ‹‡Â¦forÂ¦ Â¦exampleÂ¦ ,â– ğ‹‡Â¦sh uÂ¦ ğ‹‡Â¦f en gÂ¦ ğ‹‡Â¦j i eÂ¦ ğ‹‡Â¦d uÂ¦ Â¦c ap su lesÂ¦ Â¦andÂ¦ ğ‹‡Â¦ lianÂ¦ ğ‹‡ Â¦hu aÂ¦ ğ‹‡Â¦ q ingÂ¦ ğ‹‡Â¦w enÂ¦ Â¦c ap su lesÂ¦ Â¦wereÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦effectiveÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦treatmentÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ ,â– Â¦theÂ¦ Â¦2019Â¦ Â¦novelÂ¦ Â¦coronavirusÂ¦ â–( Â¦2019Â¦ - Â¦n ğ‹‡ co ğ‹‡ vÂ¦ )â– Â¦hasÂ¦ Â¦causedÂ¦ Â¦anÂ¦ Â¦outbreakÂ¦ ,â– Â¦whichÂ¦ Â¦isÂ¦ Â¦nowÂ¦ Â¦off ici allyÂ¦ Â¦na medÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦diseaseÂ¦ Â¦2019Â¦ â–( ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ )â– Â¦andÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦na medÂ¦ Â¦severeÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦syndromeÂ¦ Â¦coronavirusÂ¦ Â¦2Â¦ â–( ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ).
ğ‹‡ Â¦rus s ellÂ¦ ğ‹‡Â¦z i m mer manÂ¦ Â¦addedÂ¦ Â¦thatÂ¦ Â¦otherÂ¦ Â¦produc tsÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦inÂ¦ Â¦highÂ¦ Â¦demandÂ¦ ,â– Â¦includingÂ¦ Â¦masksÂ¦ ,â– Â¦s an it is erÂ¦ ,â– Â¦d riedÂ¦ Â¦go odsÂ¦ ,â– Â¦ha ndw ashÂ¦ Â¦andÂ¦ Â¦f lo urÂ¦ .
ğ‹‡ Â¦occ a si on allyÂ¦ ğ‹‡Â¦iÂ¦ Â¦haveÂ¦ Â¦someÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğ‹‡Â¦theyÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦di vi dedÂ¦ Â¦intoÂ¦ Â¦fourÂ¦ Â¦gener aÂ¦ ,â– Â¦ iÂ¦ . Â¦eÂ¦ . ,â– Â¦al p haÂ¦ ,â– Â¦be taÂ¦ ,â– Â¦g am maÂ¦ ,â– Â¦andÂ¦ Â¦d el taÂ¦ ,â– Â¦ofÂ¦ Â¦whichÂ¦ Â¦al p haÂ¦ -â– Â¦andÂ¦ Â¦be taÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦knownÂ¦ Â¦toÂ¦ Â¦inf ectÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦th usÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦moreÂ¦ Â¦criticalÂ¦ Â¦andÂ¦ Â¦p ra ct icalÂ¦ Â¦toÂ¦ Â¦is ol ateÂ¦ ğ‹‡Â¦bÂ¦ Â¦cellsÂ¦ Â¦fromÂ¦ Â¦recoveredÂ¦ Â¦patientsÂ¦ Â¦andÂ¦ Â¦identi fyÂ¦ Â¦theÂ¦ Â¦geneticÂ¦ Â¦co desÂ¦ Â¦en co dingÂ¦ Â¦effectiveÂ¦ Â¦antibodiesÂ¦ Â¦orÂ¦ Â¦sc re enÂ¦ Â¦forÂ¦ Â¦effectiveÂ¦ Â¦antibodiesÂ¦ Â¦againstÂ¦ Â¦essentialÂ¦ Â¦proteinsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦usÂ¦ğŠ¼ Â¦aÂ¦ Â¦sero logicalÂ¦ Â¦testÂ¦ Â¦developedÂ¦ Â¦byÂ¦ ğ‹‡Â¦c el le xÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦approvedÂ¦ Â¦forÂ¦ Â¦emergencyÂ¦ Â¦useÂ¦ Â¦byÂ¦ Â¦c er ti fiedÂ¦ Â¦laboratoriesÂ¦ Â¦onlyÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦suggestedÂ¦ Â¦thatÂ¦ ğ‹‡Â¦uÂ¦ . ğ‹‡Â¦sÂ¦ .â– Â¦sa nc tionsÂ¦ Â¦onÂ¦ ğ‹‡Â¦ iranÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦aff ectingÂ¦ Â¦theÂ¦ Â¦countryÂ¦ ' Â¦sÂ¦ Â¦financialÂ¦ Â¦ abilityÂ¦ Â¦toÂ¦ Â¦respon dÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦viralÂ¦ Â¦outbreakÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦cont ra stÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦new lyÂ¦ - Â¦identifiedÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦areÂ¦ Â¦high lyÂ¦ Â¦pathog enicÂ¦ ,â– Â¦cau singÂ¦ Â¦severeÂ¦ Â¦lowerÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦infectionÂ¦ Â¦inÂ¦ Â¦rela tivelyÂ¦ Â¦moreÂ¦ Â¦patientsÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦higherÂ¦ Â¦ch anceÂ¦ Â¦toÂ¦ Â¦developÂ¦ Â¦acuteÂ¦ Â¦respiratoryÂ¦ Â¦dist ressÂ¦ Â¦syndromeÂ¦ â–( ğŠ£Â¦ ardsÂ¦ ğŠ¼ )â– Â¦andÂ¦ Â¦ext rap ul mon aryÂ¦ Â¦ma ni f est ationsÂ¦ .
ğ‹‡ Â¦upÂ¦ Â¦toÂ¦ Â¦nowÂ¦ ,â– Â¦noÂ¦ Â¦liveÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦wi ldÂ¦ Â¦batsÂ¦ .
ğ‹‡Â¦heÂ¦ Â¦saidÂ¦ ,â– Â¦inÂ¦ Â¦rem ar ksÂ¦ Â¦publishedÂ¦ Â¦byÂ¦ ğŠ£Â¦c n n Â¦ğŠ¼ Â¦inÂ¦ ğ‹‡Â¦februaryÂ¦ ,â–" Â¦otherÂ¦ Â¦thanÂ¦ Â¦influenzaÂ¦ ,â– Â¦noÂ¦ Â¦otherÂ¦ Â¦respiratoryÂ¦ Â¦virusÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦tr ac kedÂ¦ Â¦fromÂ¦ Â¦emer genceÂ¦ Â¦toÂ¦ Â¦continu o usÂ¦ Â¦globalÂ¦ Â¦spreadÂ¦ ."
ğ‹‡Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦implement ationsÂ¦ Â¦ofÂ¦ Â¦travelÂ¦ Â¦restrictionsÂ¦ ,â– ğ‹‡Â¦t ed ro sÂ¦ Â¦st atedÂ¦ Â¦thatÂ¦ â–" Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦reasonÂ¦ Â¦forÂ¦ Â¦measuresÂ¦ Â¦thatÂ¦ Â¦un n ec ess ari lyÂ¦ Â¦inter fer eÂ¦ Â¦withÂ¦ Â¦internationalÂ¦ Â¦travelÂ¦ Â¦andÂ¦ Â¦tra deÂ¦ "â– Â¦andÂ¦ Â¦thatÂ¦ Â¦theÂ¦ â–" ğŠ£Â¦whoÂ¦ğŠ¼ Â¦doesnÂ¦ ' Â¦tÂ¦ Â¦recomme n dÂ¦ Â¦limi tingÂ¦ Â¦tra deÂ¦ Â¦andÂ¦ Â¦mo ve mentÂ¦ ."
ğ‹‡Â¦thisÂ¦ Â¦de le tionÂ¦ Â¦sp li tsÂ¦ ğŠ£ Â¦or f ğŠ¼ 8Â¦ Â¦intoÂ¦ ğŠ£ Â¦or f ğŠ¼ 8 aÂ¦ Â¦andÂ¦ ğŠ£ Â¦or f ğŠ¼ 8 bÂ¦ Â¦andÂ¦ Â¦isÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦anÂ¦ Â¦ad ap tiveÂ¦ Â¦mutationÂ¦ Â¦thatÂ¦ Â¦promo tesÂ¦ Â¦theÂ¦ Â¦sw it chÂ¦ Â¦ofÂ¦ Â¦h ostsÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦s har esÂ¦ Â¦9 6Â¦ . Â¦2Â¦ %â– Â¦n ucle ot ideÂ¦ Â¦ho mo logyÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼ 1 3Â¦ Â¦isolatedÂ¦ Â¦fromÂ¦ ğ‹‡Â¦r hi no lo ph usÂ¦ Â¦af fi ni sÂ¦ Â¦batsÂ¦ .
ğ‹‡Â¦aÂ¦ ğŠ£ Â¦un Â¦ğŠ¼ ğ‹‡ Â¦crisisÂ¦ ğ‹‡ Â¦managementÂ¦ ğ‹‡ Â¦teamÂ¦ Â¦wasÂ¦ Â¦activ atedÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦resultÂ¦ ,â– Â¦all owingÂ¦ Â¦co or d inationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦entireÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦n ationsÂ¦ Â¦responseÂ¦ ,â– Â¦whichÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦statesÂ¦ Â¦willÂ¦ Â¦allowÂ¦ Â¦themÂ¦ Â¦toÂ¦ â–" Â¦foc usÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦healthÂ¦ Â¦responseÂ¦ Â¦whileÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦agenciesÂ¦ Â¦canÂ¦ Â¦bringÂ¦ Â¦theirÂ¦ Â¦exper t iseÂ¦ Â¦toÂ¦ Â¦be arÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦wi derÂ¦ Â¦socialÂ¦ ,â– Â¦economicÂ¦ Â¦andÂ¦ Â¦dev el op m entalÂ¦ Â¦imp licationsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ".
ğ‹‡Â¦allÂ¦ Â¦theseÂ¦ Â¦fourÂ¦ Â¦communityÂ¦ - Â¦acqu iredÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦wellÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦andÂ¦ Â¦areÂ¦ Â¦gener allyÂ¦ Â¦lessÂ¦ Â¦likelyÂ¦ Â¦toÂ¦ Â¦m ut ateÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦high lyÂ¦ Â¦pathog enicÂ¦ Â¦diseasesÂ¦ ,â– Â¦thoughÂ¦ Â¦ac ci dentsÂ¦ Â¦didÂ¦ Â¦occ urÂ¦ Â¦forÂ¦ Â¦un kn ownÂ¦ Â¦reasonsÂ¦ Â¦asÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦r areÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦v ir ul entÂ¦ Â¦sub t yp eÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦n l ğŠ¼ 6 3Â¦ ,â– Â¦whichÂ¦ Â¦hasÂ¦ Â¦recentlyÂ¦ Â¦beenÂ¦ Â¦reportedÂ¦ Â¦toÂ¦ Â¦causeÂ¦ Â¦severeÂ¦ Â¦lowerÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦infectionÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦anÂ¦ Â¦onlineÂ¦ Â¦newsÂ¦ Â¦br ie f ingÂ¦ ,â– Â¦theÂ¦ Â¦directorÂ¦ Â¦ofÂ¦ ğŠ£Â¦i ed c rÂ¦ğŠ¼ ,â– ğ‹‡Â¦drÂ¦ ğ‹‡Â¦me er j ad yÂ¦ ğ‹‡Â¦s ab ri naÂ¦ ğ‹‡Â¦f lo raÂ¦ ,â– Â¦saidÂ¦ Â¦theÂ¦ Â¦f at al itiesÂ¦ Â¦includedÂ¦ Â¦fourÂ¦ Â¦ma lesÂ¦ Â¦andÂ¦ Â¦oneÂ¦ Â¦fe m aleÂ¦ .
ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ Â¦itsÂ¦ Â¦cl os estÂ¦ Â¦rel ativeÂ¦ Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 2 5Â¦ Â¦sh areÂ¦ Â¦onlyÂ¦ Â¦8 7Â¦ %â– Â¦n ucle ot ideÂ¦ Â¦se que nceÂ¦ Â¦ho mo logyÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦theÂ¦ Â¦5Â¦ ğ‹‡Â¦marchÂ¦ Â¦issueÂ¦ Â¦ofÂ¦ ğ‹‡Â¦e ur os ur ve i ll anceÂ¦ Â¦2020Â¦ ,â– ğ‹‡Â¦s pi te riÂ¦ Â¦ etÂ¦ Â¦ alÂ¦ .â– Â¦reportedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦firstÂ¦ ğ‹‡Â¦europeanÂ¦ Â¦confirmedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦accordingÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦caseÂ¦ Â¦def in itionÂ¦ .
ğ‹‡ Â¦gener allyÂ¦ ,â– Â¦whenÂ¦ Â¦theseÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦acqu ir eÂ¦ Â¦theÂ¦ Â¦ab il itiesÂ¦ Â¦toÂ¦ Â¦transm itÂ¦ Â¦eff ic ie ntlyÂ¦ Â¦andÂ¦ Â¦toÂ¦ Â¦main tainÂ¦ Â¦the ms el vesÂ¦ Â¦continu o us lyÂ¦ Â¦withinÂ¦ Â¦humansÂ¦ ,â– Â¦theyÂ¦ Â¦alsoÂ¦ Â¦becomeÂ¦ Â¦lessÂ¦ Â¦v ir ul entÂ¦ Â¦orÂ¦ Â¦pathog enicÂ¦ .
ğ‹‡Â¦si al od ac r y o a de ni tisÂ¦ Â¦virusÂ¦ â–( ğŠ£Â¦s d a vÂ¦ğŠ¼ )â– Â¦isÂ¦ Â¦high lyÂ¦ Â¦infectiousÂ¦ Â¦coronavirusÂ¦ Â¦ofÂ¦ Â¦laboratoryÂ¦ Â¦ra tsÂ¦ ,â– Â¦whichÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦transm ittedÂ¦ Â¦betweenÂ¦ Â¦individualsÂ¦ Â¦byÂ¦ Â¦directÂ¦ Â¦contactÂ¦ Â¦andÂ¦ Â¦indi re ct lyÂ¦ Â¦byÂ¦ Â¦a er os olÂ¦ .
ğ‹‡ Â¦imm u no su pp r essionÂ¦ Â¦isÂ¦ Â¦essentialÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦treatmentÂ¦ Â¦ofÂ¦ Â¦c yto k ineÂ¦ Â¦stor msÂ¦ ,â– Â¦especiallyÂ¦ Â¦inÂ¦ Â¦severeÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦largeÂ¦ Â¦studyÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦comparedÂ¦ Â¦chestÂ¦ ğŠ£Â¦ ctÂ¦ğŠ¼ Â¦resultsÂ¦ Â¦toÂ¦ ğŠ£ Â¦pcrÂ¦ğŠ¼ Â¦andÂ¦ Â¦de mo nstr atedÂ¦ Â¦thatÂ¦ Â¦thoughÂ¦ Â¦i ma gingÂ¦ Â¦isÂ¦ Â¦lessÂ¦ Â¦specificÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦infectionÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦f asterÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦s ensi tiveÂ¦ ,â– Â¦sugges tingÂ¦ Â¦itsÂ¦ Â¦consi der ationÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦scr ee ningÂ¦ Â¦to olÂ¦ Â¦inÂ¦ Â¦epidemicÂ¦ Â¦areasÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦hasÂ¦ Â¦lowerÂ¦ Â¦severityÂ¦ Â¦andÂ¦ Â¦mortalityÂ¦ Â¦thanÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦butÂ¦ Â¦isÂ¦ Â¦muchÂ¦ Â¦moreÂ¦ Â¦transm is siveÂ¦ Â¦andÂ¦ Â¦aff ectsÂ¦ Â¦moreÂ¦ Â¦elder lyÂ¦ Â¦individualsÂ¦ Â¦thanÂ¦ Â¦you thÂ¦ Â¦andÂ¦ Â¦moreÂ¦ Â¦menÂ¦ Â¦thanÂ¦ Â¦womenÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦thereÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦maskÂ¦ - Â¦relatedÂ¦ Â¦disp u tesÂ¦ Â¦reportedÂ¦ Â¦betweenÂ¦ Â¦otherÂ¦ Â¦countriesÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ ğ‹‡Â¦germanyÂ¦ ,â– ğ‹‡Â¦a ust ri aÂ¦ Â¦andÂ¦ ğ‹‡Â¦sw it z er landÂ¦ ;â– Â¦andÂ¦ Â¦theÂ¦ ğ‹‡Â¦c z e chÂ¦ ğ‹‡ Â¦rep ub l icÂ¦ Â¦andÂ¦ ğ‹‡Â¦italyÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ Â¦toÂ¦ Â¦ce ll ularÂ¦ Â¦recept orsÂ¦ ,â– Â¦theÂ¦ Â¦out comeÂ¦ Â¦ofÂ¦ Â¦inter sp ec iesÂ¦ Â¦transmissionÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦go ver nedÂ¦ Â¦byÂ¦ Â¦otherÂ¦ Â¦hostÂ¦ Â¦dep en de ncyÂ¦ Â¦andÂ¦ Â¦restric tionÂ¦ Â¦factorsÂ¦ .
ğ‹‡ Â¦schoolsÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğ‹‡Â¦se att leÂ¦ Â¦areaÂ¦ Â¦cance lledÂ¦ Â¦classesÂ¦ Â¦onÂ¦ Â¦3Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦andÂ¦ Â¦byÂ¦ Â¦m idÂ¦ - ğ‹‡Â¦marchÂ¦ ,â– Â¦schoolsÂ¦ Â¦acrossÂ¦ Â¦theÂ¦ Â¦countryÂ¦ Â¦wereÂ¦ Â¦sh ut tingÂ¦ Â¦downÂ¦ . ğ‹‡Â¦onÂ¦ Â¦6Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦wasÂ¦ Â¦advisedÂ¦ Â¦ofÂ¦ Â¦pro j ectionsÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦impactÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦coronavirusÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦countryÂ¦ Â¦byÂ¦ Â¦aÂ¦ Â¦groupÂ¦ Â¦ofÂ¦ Â¦epi de mi olog istsÂ¦ Â¦atÂ¦ ğ‹‡ Â¦imp e rialÂ¦ ğ‹‡Â¦collegeÂ¦ ğ‹‡Â¦lo nd onÂ¦ .
ğ‹‡Â¦manyÂ¦ Â¦scientificÂ¦ Â¦p ub l ish ersÂ¦ Â¦madeÂ¦ Â¦scientificÂ¦ Â¦p ap ersÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦availableÂ¦ Â¦withÂ¦ Â¦openÂ¦ Â¦accessÂ¦ .
ğ‹‡Â¦manyÂ¦ ğ‹‡Â¦l un arÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡ Â¦yearÂ¦ Â¦eventsÂ¦ Â¦andÂ¦ Â¦tour istÂ¦ Â¦att r actionsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦closedÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦m assÂ¦ Â¦ga ther i ngsÂ¦ ,â– Â¦includingÂ¦ Â¦theÂ¦ ğ‹‡Â¦f orbid d enÂ¦ ğ‹‡ Â¦cityÂ¦ Â¦inÂ¦ ğ‹‡Â¦be i j ingÂ¦ Â¦andÂ¦ Â¦tra di ti onalÂ¦ Â¦te mpleÂ¦ Â¦fa irsÂ¦ .
ğ‹‡Â¦thereÂ¦ Â¦isÂ¦ Â¦noÂ¦ Â¦dataÂ¦ Â¦yetÂ¦ Â¦onÂ¦ Â¦earlyÂ¦ Â¦p reg na ncyÂ¦ .
ğ‹‡Â¦althoughÂ¦ Â¦theÂ¦ Â¦wor dÂ¦ â–" Â¦pandemicÂ¦ "â– Â¦onlyÂ¦ Â¦ref ersÂ¦ Â¦toÂ¦ Â¦howÂ¦ Â¦wi de lyÂ¦ Â¦aÂ¦ Â¦diseaseÂ¦ Â¦hasÂ¦ Â¦spreadÂ¦ ,â– Â¦notÂ¦ Â¦howÂ¦ Â¦dangerousÂ¦ Â¦specificÂ¦ Â¦casesÂ¦ Â¦areÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦no tedÂ¦ Â¦theÂ¦ Â¦needÂ¦ Â¦toÂ¦ Â¦dri veÂ¦ Â¦governmentsÂ¦ Â¦toÂ¦ Â¦actionÂ¦ :
ğ‹‡ Â¦per va siveÂ¦ Â¦evidenceÂ¦ Â¦hasÂ¦ Â¦shownÂ¦ Â¦thatÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦batÂ¦ Â¦originÂ¦ Â¦andÂ¦ Â¦areÂ¦ Â¦transm ittedÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦viaÂ¦ Â¦interme di ateÂ¦ Â¦h ostsÂ¦ .
ğ‹‡ Â¦areÂ¦ Â¦youÂ¦ Â¦havingÂ¦ Â¦anyÂ¦ Â¦otherÂ¦ Â¦symptomsÂ¦ ?
ğ‹‡Â¦aÂ¦ Â¦globalÂ¦ Â¦safetyÂ¦ Â¦monitoringÂ¦ Â¦boardÂ¦ Â¦ofÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦phys i ciansÂ¦ Â¦examin eÂ¦ Â¦in teri mÂ¦ Â¦resultsÂ¦ Â¦toÂ¦ Â¦ass istÂ¦ Â¦decisionsÂ¦ Â¦onÂ¦ Â¦safetyÂ¦ Â¦andÂ¦ Â¦effectivenessÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦trialÂ¦ Â¦drugsÂ¦ ,â– Â¦andÂ¦ Â¦al terÂ¦ Â¦theÂ¦ Â¦trialÂ¦ Â¦desi g nÂ¦ Â¦orÂ¦ Â¦recomme n dÂ¦ Â¦anÂ¦ Â¦effectiveÂ¦ Â¦therapyÂ¦ .
ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦n l ğŠ¼ 6 3Â¦ Â¦isÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦ob stru c tiveÂ¦ Â¦l ar yn gi tisÂ¦ ,â– Â¦alsoÂ¦ Â¦knownÂ¦ Â¦asÂ¦ Â¦cr ou pÂ¦ .
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦app a re ntlyÂ¦ Â¦lessÂ¦ Â¦pathog enicÂ¦ Â¦butÂ¦ Â¦moreÂ¦ Â¦transm is si bleÂ¦ Â¦comparedÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦initialÂ¦ Â¦estim atesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦b as icÂ¦ Â¦rep ro du ctionÂ¦ Â¦numberÂ¦ â–( ğ‹‡Â¦r 0Â¦ )â– Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wereÂ¦ Â¦1Â¦ . Â¦4Â¦ Â¦toÂ¦ Â¦2Â¦ . Â¦4Â¦ .
ğ‹‡Â¦itÂ¦ Â¦st atedÂ¦ Â¦thatÂ¦ Â¦muchÂ¦ Â¦wasÂ¦ Â¦yetÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦discov eredÂ¦ Â¦aboutÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ ğ‹‡Â¦austra liaÂ¦ Â¦wouldÂ¦ Â¦emp ha si zeÂ¦ Â¦bor derÂ¦ Â¦controlÂ¦ Â¦andÂ¦ Â¦communic ationÂ¦ Â¦inÂ¦ Â¦itsÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦14Â¦ ,â– Â¦2020Â¦ ,â– Â¦overÂ¦ Â¦2 5 00Â¦ Â¦laboratoryÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦wereÂ¦ Â¦reportedÂ¦ Â¦withÂ¦ Â¦aÂ¦ Â¦highÂ¦ Â¦caseÂ¦ Â¦f at alityÂ¦ Â¦ofÂ¦ Â¦3 4Â¦ . Â¦4Â¦ % ,â– Â¦makingÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦mostÂ¦ Â¦dev ast atingÂ¦ Â¦virusesÂ¦ Â¦knownÂ¦ Â¦toÂ¦ Â¦humansÂ¦ .
ğ‹‡ Â¦withinÂ¦ Â¦aÂ¦ Â¦monthÂ¦ ,â– Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦h ub e iÂ¦ Â¦g rad uallyÂ¦ Â¦increasedÂ¦ .
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦worldÂ¦ ğ‹‡Â¦healthÂ¦ ğ‹‡Â¦organizationÂ¦ Â¦andÂ¦ ğ‹‡Â¦centersÂ¦ Â¦forÂ¦ ğ‹‡Â¦diseaseÂ¦ ğ‹‡Â¦controlÂ¦ Â¦andÂ¦ ğ‹‡Â¦preventionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦ad vi sesÂ¦ Â¦pregnantÂ¦ Â¦womenÂ¦ Â¦toÂ¦ Â¦doÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦thingsÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦publicÂ¦ Â¦toÂ¦ Â¦avoidÂ¦ Â¦infectionÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ Â¦cov eringÂ¦ Â¦coughÂ¦ ,â– Â¦avoidÂ¦ Â¦inter actingÂ¦ Â¦withÂ¦ Â¦sickÂ¦ Â¦peopleÂ¦ ,â– Â¦cleaningÂ¦ Â¦handsÂ¦ Â¦withÂ¦ Â¦soapÂ¦ Â¦andÂ¦ Â¦waterÂ¦ Â¦orÂ¦ Â¦sanitizerÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦austra liaÂ¦ ,â– Â¦theÂ¦ Â¦pandemicÂ¦ Â¦providedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦opp ortun ityÂ¦ Â¦forÂ¦ Â¦d ai g o uÂ¦ Â¦sho pp ersÂ¦ Â¦toÂ¦ Â¦s ellÂ¦ ğ‹‡Â¦austra lianÂ¦ Â¦produc tsÂ¦ Â¦intoÂ¦ ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦mo di fic ationsÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦researchersÂ¦ Â¦continu edÂ¦ Â¦workÂ¦ Â¦thatÂ¦ Â¦toÂ¦ Â¦se ar chÂ¦ Â¦forÂ¦ Â¦anÂ¦ Â¦op ti malÂ¦ Â¦n ucle icÂ¦ Â¦acidÂ¦ Â¦det ectionÂ¦ Â¦k itÂ¦ Â¦forÂ¦ Â¦rapidÂ¦ Â¦diagn osisÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦samplesÂ¦ Â¦fromÂ¦ Â¦respiratoryÂ¦ Â¦tr actÂ¦ Â¦includingÂ¦ Â¦bloodÂ¦ Â¦sa mp lingÂ¦ ,â– Â¦whichÂ¦ Â¦increasedÂ¦ Â¦theÂ¦ Â¦availabilityÂ¦ Â¦ofÂ¦ Â¦differentÂ¦ Â¦speci me nsÂ¦ ,â– Â¦andÂ¦ Â¦sup por tedÂ¦ Â¦br in gingÂ¦ Â¦theÂ¦ Â¦specificÂ¦ Â¦antibodyÂ¦ Â¦positiveÂ¦ Â¦resultÂ¦ Â¦intoÂ¦ Â¦theÂ¦ Â¦confirmedÂ¦ Â¦c ri teri aÂ¦ .
ğ‹‡ Â¦continu o usÂ¦ Â¦surveillanceÂ¦ Â¦inÂ¦ Â¦m amm alsÂ¦ Â¦isÂ¦ Â¦necessaryÂ¦ Â¦forÂ¦ Â¦betterÂ¦ Â¦under st andingÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦e co logyÂ¦ Â¦ofÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦andÂ¦ Â¦theirÂ¦ Â¦naturalÂ¦ Â¦h ostsÂ¦ ,â– Â¦whichÂ¦ Â¦willÂ¦ Â¦pro veÂ¦ Â¦u se fulÂ¦ Â¦inÂ¦ Â¦preven tingÂ¦ Â¦animalÂ¦ - Â¦toÂ¦ - Â¦humanÂ¦ Â¦transmissionÂ¦ Â¦andÂ¦ Â¦futureÂ¦ Â¦outbreaksÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦h ur tsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦m iddleÂ¦ Â¦ofÂ¦ Â¦myÂ¦ Â¦chestÂ¦
ğ‹‡Â¦theÂ¦ Â¦entireÂ¦ Â¦humanÂ¦ Â¦populationÂ¦ Â¦gener allyÂ¦ Â¦l ac ksÂ¦ Â¦immunityÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ Â¦he nceÂ¦ Â¦isÂ¦ Â¦s us cep ti bleÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦novelÂ¦ Â¦virusÂ¦ .
ğ‹‡Â¦toÂ¦ Â¦conc lu deÂ¦ ,â– Â¦theÂ¦ Â¦mostÂ¦ Â¦effectiveÂ¦ Â¦wayÂ¦ Â¦toÂ¦ Â¦preventÂ¦ Â¦viralÂ¦ Â¦z o on osisÂ¦ Â¦isÂ¦ Â¦forÂ¦ Â¦humansÂ¦ Â¦toÂ¦ Â¦stayÂ¦ Â¦awayÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦e co logicalÂ¦ Â¦ ni ch esÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦naturalÂ¦ Â¦reserv o irsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦z oo no ticÂ¦ Â¦virusesÂ¦ .
ğ‹‡ Â¦mentalÂ¦ Â¦stressÂ¦ :â– ğ‹‡Â¦asÂ¦ Â¦d escrib edÂ¦ Â¦aboveÂ¦ ,â– Â¦duringÂ¦ Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦outbreakÂ¦ Â¦manyÂ¦ Â¦patientsÂ¦ Â¦haveÂ¦ Â¦suff eredÂ¦ Â¦fromÂ¦ Â¦ext ra or d in aryÂ¦ Â¦stressÂ¦ Â¦asÂ¦ Â¦theyÂ¦ Â¦oftenÂ¦ Â¦en du redÂ¦ Â¦longÂ¦ Â¦pe ri odsÂ¦ Â¦ofÂ¦ Â¦quarantineÂ¦ Â¦andÂ¦ Â¦ext re meÂ¦ Â¦u nc er ta in tyÂ¦ Â¦andÂ¦ Â¦w it n es sedÂ¦ Â¦theÂ¦ Â¦deathÂ¦ Â¦ofÂ¦ Â¦closeÂ¦ Â¦familyÂ¦ Â¦membersÂ¦ Â¦andÂ¦ Â¦f el lowÂ¦ Â¦patientsÂ¦ .
ğ‹‡ Â¦pre t tyÂ¦ Â¦muchÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦feverÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦coughÂ¦ Â¦he ad ach eÂ¦ Â¦andÂ¦ Â¦m us c leÂ¦ Â¦pa insÂ¦
ğ‹‡Â¦be si desÂ¦ Â¦theÂ¦ Â¦high lyÂ¦ Â¦pathog enicÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ ,â– Â¦theÂ¦ Â¦z oo no ticÂ¦ Â¦originÂ¦ Â¦ofÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦ oc 43Â¦ ,â– Â¦h c ğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦n l ğŠ¼ 6 3Â¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 1Â¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦studiedÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦studyÂ¦ Â¦publishedÂ¦ Â¦onÂ¦ Â¦16Â¦ ğ‹‡Â¦marchÂ¦ Â¦foundÂ¦ Â¦thatÂ¦ Â¦inÂ¦ ğ‹‡Â¦chinaÂ¦ ,â– Â¦upÂ¦ Â¦toÂ¦ Â¦23Â¦ ğ‹‡Â¦januaryÂ¦ ,â– Â¦anÂ¦ Â¦estimatedÂ¦ Â¦8 6Â¦ %â– Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionsÂ¦ Â¦hadÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦detectedÂ¦ ,â– Â¦andÂ¦ Â¦thatÂ¦ Â¦theseÂ¦ Â¦u nd oc um entedÂ¦ Â¦infectionsÂ¦ Â¦wereÂ¦ Â¦theÂ¦ Â¦infectionÂ¦ Â¦s ourceÂ¦ Â¦forÂ¦ Â¦7 9Â¦ %â– Â¦ofÂ¦ Â¦d oc um entedÂ¦ Â¦casesÂ¦ .
ğ‹‡Â¦medicalÂ¦ Â¦scr ee ningÂ¦ Â¦wasÂ¦ Â¦performedÂ¦ Â¦pri orÂ¦ Â¦toÂ¦ Â¦dep art ureÂ¦ ,â– Â¦andÂ¦ Â¦fourÂ¦ ğ‹‡Â¦southÂ¦ ğ‹‡ Â¦af r ic ansÂ¦ Â¦whoÂ¦ Â¦wereÂ¦ Â¦sh owingÂ¦ Â¦si gnsÂ¦ Â¦ofÂ¦ Â¦coronavirusÂ¦ Â¦wereÂ¦ Â¦leftÂ¦ Â¦behindÂ¦ Â¦toÂ¦ Â¦mi tig ateÂ¦ Â¦riskÂ¦ .
ğ‹‡Â¦p harmaceuticalÂ¦ Â¦companiesÂ¦ Â¦areÂ¦ Â¦r ac ingÂ¦ Â¦toÂ¦ Â¦developÂ¦ Â¦antibodiesÂ¦ Â¦andÂ¦ Â¦vaccinesÂ¦ Â¦againstÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦itsÂ¦ Â¦spo rad icÂ¦ Â¦transmissionÂ¦ Â¦toÂ¦ Â¦humansÂ¦ Â¦isÂ¦ Â¦anÂ¦ Â¦acc identÂ¦ Â¦andÂ¦ Â¦humansÂ¦ Â¦remainÂ¦ Â¦aÂ¦ Â¦de adÂ¦ - Â¦endÂ¦ Â¦hostÂ¦ Â¦ofÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦asÂ¦ Â¦itsÂ¦ Â¦transmissionÂ¦ Â¦cannotÂ¦ Â¦beÂ¦ Â¦s us tainedÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦openÂ¦ Â¦rea dingÂ¦ Â¦fr am esÂ¦ Â¦1 aÂ¦ Â¦andÂ¦ Â¦1 bÂ¦ ,â– Â¦whichÂ¦ Â¦occ up yÂ¦ Â¦theÂ¦ Â¦firstÂ¦ Â¦twoÂ¦ - Â¦th ir dsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦genomeÂ¦ ,â– Â¦en co deÂ¦ Â¦theÂ¦ Â¦rep lic aseÂ¦ / Â¦trans c ri pt aseÂ¦ Â¦pol yp ro te inÂ¦ .
ğ‹‡Â¦althoughÂ¦ Â¦theseÂ¦ Â¦ actionsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦dr am at icallyÂ¦ Â¦da ma gingÂ¦ Â¦theÂ¦ Â¦economyÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦se ctorsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦countryÂ¦ ,â– Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦newÂ¦ Â¦patientsÂ¦ Â¦isÂ¦ Â¦decliningÂ¦ ,â– Â¦indic atingÂ¦ Â¦theÂ¦ Â¦slow d ownÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ .
ğ‹‡Â¦byÂ¦ Â¦23Â¦ ğ‹‡Â¦marchÂ¦ ,â– Â¦noÂ¦ Â¦countryÂ¦ Â¦hadÂ¦ Â¦testedÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦3Â¦ %â– Â¦ofÂ¦ Â¦theirÂ¦ Â¦populationÂ¦ ,â– Â¦andÂ¦ Â¦thereÂ¦ Â¦areÂ¦ Â¦m as siveÂ¦ Â¦v ari ationsÂ¦ Â¦inÂ¦ Â¦howÂ¦ Â¦muchÂ¦ Â¦testingÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦doneÂ¦ Â¦acrossÂ¦ Â¦countriesÂ¦ .
ğ‹‡Â¦hongÂ¦ ğ‹‡Â¦kongÂ¦ Â¦raisedÂ¦ Â¦itsÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦ Â¦responseÂ¦ Â¦levelÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦andÂ¦ Â¦declaredÂ¦ Â¦anÂ¦ Â¦emergencyÂ¦ ,â– Â¦cl osingÂ¦ Â¦schoolsÂ¦ Â¦untilÂ¦ ğ‹‡Â¦marchÂ¦ Â¦andÂ¦ Â¦cance llingÂ¦ Â¦itsÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡ Â¦yearÂ¦ Â¦ce le br ationsÂ¦ . ğ‹‡Â¦theÂ¦ Â¦re ta ilÂ¦ Â¦sectorÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦imp actedÂ¦ Â¦glo b allyÂ¦ ,â– Â¦withÂ¦ Â¦reduc tionsÂ¦ Â¦inÂ¦ Â¦storeÂ¦ Â¦hoursÂ¦ Â¦orÂ¦ Â¦tempor aryÂ¦ Â¦closuresÂ¦ .
ğ‹‡Â¦despiteÂ¦ Â¦doingÂ¦ Â¦soÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦unitedÂ¦ ğ‹‡Â¦statesÂ¦ Â¦hadÂ¦ Â¦aÂ¦ Â¦s lowÂ¦ Â¦startÂ¦ Â¦inÂ¦ Â¦testingÂ¦ ,â– Â¦whichÂ¦ Â¦ob s c u redÂ¦ Â¦theÂ¦ Â¦tr ueÂ¦ Â¦ext entÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦timeÂ¦ .
ğ‹‡Â¦theseÂ¦ Â¦virusesÂ¦ Â¦doÂ¦ Â¦notÂ¦ Â¦needÂ¦ Â¦anÂ¦ Â¦animalÂ¦ Â¦reserv o irÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦haveÂ¦ Â¦prop osedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦mayÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦transm ittedÂ¦ Â¦byÂ¦ Â¦smallÂ¦ Â¦dr op letsÂ¦ Â¦thatÂ¦ Â¦stayÂ¦ Â¦forÂ¦ Â¦moreÂ¦ Â¦pr ol on gedÂ¦ Â¦pe ri odsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦airÂ¦ ,â– Â¦thatÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦gener atedÂ¦ Â¦duringÂ¦ Â¦sp ee chÂ¦ . ğ‹‡ Â¦respiratoryÂ¦ Â¦dr op letsÂ¦ Â¦mayÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦producedÂ¦ Â¦duringÂ¦ Â¦breathingÂ¦ Â¦outÂ¦ ,â– Â¦includingÂ¦ Â¦whenÂ¦ Â¦talkingÂ¦ ,â– Â¦thoughÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦gener allyÂ¦ Â¦air b or neÂ¦ .
ğ‹‡Â¦w he re asÂ¦ Â¦ci ve tsÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦animalsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦marketsÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦har bo urÂ¦ Â¦virusesÂ¦ Â¦identi c alÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦immediateÂ¦ Â¦interme di ateÂ¦ Â¦h ostsÂ¦ Â¦forÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦haveÂ¦ Â¦notÂ¦ Â¦beenÂ¦ Â¦identifiedÂ¦ .
ğ‹‡ Â¦useÂ¦ Â¦ofÂ¦ Â¦s ter oi dsÂ¦ :â– ğ‹‡Â¦asÂ¦ Â¦d escrib edÂ¦ Â¦aboveÂ¦ ,â– Â¦s ter oi dsÂ¦ Â¦areÂ¦ Â¦imm u no su pp r ess antÂ¦ Â¦com mon lyÂ¦ Â¦usedÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦ad j u nc tiveÂ¦ Â¦therapyÂ¦ Â¦forÂ¦ Â¦infectiousÂ¦ Â¦diseasesÂ¦ Â¦toÂ¦ Â¦reduceÂ¦ Â¦theÂ¦ Â¦severityÂ¦ Â¦ofÂ¦ Â¦inf lamm atoryÂ¦ Â¦d am ageÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦com par is onÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦withÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ Â¦isÂ¦ Â¦providedÂ¦ Â¦be lowÂ¦ â–( ğ‹‡Â¦fi gÂ¦ .â– â€‹ ( ğ‹‡Â¦fi gÂ¦ . Â¦5 5Â¦ ).
ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦wasÂ¦ Â¦foundÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦typeÂ¦ Â¦ofÂ¦ Â¦be taÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦withÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦9 9Â¦ . Â¦9 8Â¦ %â– Â¦geneticÂ¦ Â¦identi tyÂ¦ Â¦amongÂ¦ Â¦10Â¦ Â¦se que ncedÂ¦ Â¦samplesÂ¦ Â¦coll ectedÂ¦ Â¦fromÂ¦ Â¦theÂ¦ Â¦origin alÂ¦ Â¦ siteÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â– Â¦theÂ¦ ğ‹‡ Â¦hu an anÂ¦ ğ‹‡Â¦s ea f o odÂ¦ ğ‹‡ Â¦marketÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦januaryÂ¦ Â¦23Â¦ ,â– Â¦theÂ¦ Â¦cityÂ¦ Â¦ofÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦wasÂ¦ Â¦loc kedÂ¦ Â¦downÂ¦ Â¦withÂ¦ Â¦allÂ¦ Â¦itsÂ¦ Â¦publicÂ¦ Â¦transportationÂ¦ Â¦stoppedÂ¦ .
ğ‹‡ Â¦secondÂ¦ ,â– ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ - Â¦relatedÂ¦ Â¦batÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦di verseÂ¦ Â¦andÂ¦ Â¦nonÂ¦ - Â¦pathog enicÂ¦ Â¦inÂ¦ Â¦batsÂ¦ ,â– Â¦w he re asÂ¦ Â¦al p ac aÂ¦ Â¦al p haÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦causedÂ¦ Â¦anÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ Â¦respiratoryÂ¦ Â¦diseaseÂ¦ Â¦inÂ¦ Â¦infectedÂ¦ Â¦animalsÂ¦ .
ğ‹‡Â¦butÂ¦ Â¦youÂ¦ ' Â¦reÂ¦ Â¦breathingÂ¦ Â¦allÂ¦ Â¦rightÂ¦ Â¦rightÂ¦ Â¦nowÂ¦ Â¦rightÂ¦ ?
ğ‹‡Â¦inÂ¦ Â¦aÂ¦ Â¦201 6Â¦ Â¦reviewÂ¦ Â¦ofÂ¦ Â¦1 0 6Â¦ Â¦drugÂ¦ Â¦candidatesÂ¦ Â¦ass es sedÂ¦ Â¦throughÂ¦ Â¦clinicalÂ¦ Â¦trialsÂ¦ ,â– Â¦theÂ¦ Â¦totalÂ¦ Â¦capitalÂ¦ Â¦exp e nd it ureÂ¦ Â¦forÂ¦ Â¦aÂ¦ Â¦manufactur erÂ¦ Â¦havingÂ¦ Â¦aÂ¦ Â¦drugÂ¦ Â¦approvedÂ¦ Â¦throughÂ¦ Â¦success fulÂ¦ ğ‹‡Â¦phaseÂ¦ ğŠ£Â¦i i iÂ¦ğŠ¼ Â¦trialsÂ¦ Â¦wasÂ¦ â– $ Â¦2Â¦ . Â¦6Â¦ Â¦bi ll ionÂ¦ â–( Â¦inÂ¦ Â¦201 3Â¦ Â¦do ll arsÂ¦ ),â– Â¦anÂ¦ Â¦amountÂ¦ Â¦increasingÂ¦ Â¦atÂ¦ Â¦anÂ¦ Â¦an n ualÂ¦ Â¦rateÂ¦ Â¦ofÂ¦ Â¦8Â¦ . Â¦5Â¦ %.
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦5Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ğ‹‡Â¦l ab ğ‹‡ c or pÂ¦ Â¦announcedÂ¦ Â¦nationwideÂ¦ Â¦availabilityÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦testingÂ¦ Â¦basedÂ¦ Â¦onÂ¦ ğŠ£Â¦rtÂ¦ - Â¦pcrÂ¦ğŠ¼ .
ğ‹‡ Â¦testsÂ¦ Â¦usingÂ¦ Â¦twoÂ¦ Â¦com po ne ntsÂ¦ Â¦wereÂ¦ Â¦notÂ¦ Â¦determ inedÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦reli ableÂ¦ Â¦untilÂ¦ Â¦28Â¦ ğ‹‡Â¦februaryÂ¦ Â¦2020Â¦ ,â– Â¦andÂ¦ Â¦itÂ¦ Â¦wasÂ¦ Â¦notÂ¦ Â¦untilÂ¦ Â¦thenÂ¦ Â¦thatÂ¦ Â¦stateÂ¦ Â¦andÂ¦ Â¦localÂ¦ Â¦laboratoriesÂ¦ Â¦wereÂ¦ Â¦p erm ittedÂ¦ Â¦toÂ¦ Â¦beg inÂ¦ Â¦testingÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦aÂ¦ Â¦hostÂ¦ Â¦thatÂ¦ Â¦ser vesÂ¦ Â¦asÂ¦ Â¦theÂ¦ Â¦mi x ingÂ¦ Â¦v ess elÂ¦ ,â– Â¦str andÂ¦ Â¦sw it c hingÂ¦ Â¦occur sÂ¦ Â¦fre que ntlyÂ¦ Â¦duringÂ¦ ğ‹‡Â¦coğ‹‡vÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦trans c r ip tionÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦earlyÂ¦ Â¦2020Â¦ ,â– Â¦n u me ro usÂ¦ Â¦establishedÂ¦ Â¦antiviralÂ¦ Â¦comp ou ndsÂ¦ Â¦forÂ¦ Â¦treatingÂ¦ Â¦otherÂ¦ Â¦infectionsÂ¦ Â¦wereÂ¦ Â¦beingÂ¦ Â¦rep ur p osedÂ¦ Â¦orÂ¦ Â¦developedÂ¦ Â¦inÂ¦ Â¦newÂ¦ Â¦clinicalÂ¦ Â¦researchÂ¦ Â¦effortsÂ¦ Â¦toÂ¦ Â¦alle vi ateÂ¦ Â¦theÂ¦ Â¦illnessÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦recordedÂ¦ Â¦in ci dentsÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦infectionÂ¦ Â¦inÂ¦ ğ‹‡Â¦ba ng l ad eshÂ¦ Â¦wereÂ¦ Â¦onÂ¦ ğ‹‡Â¦marchÂ¦ Â¦8Â¦ ,â– Â¦inÂ¦ Â¦twoÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦returnedÂ¦ Â¦fromÂ¦ ğ‹‡Â¦italyÂ¦ Â¦andÂ¦ Â¦alsoÂ¦ Â¦theÂ¦ Â¦wi f eÂ¦ Â¦ofÂ¦ Â¦oneÂ¦ Â¦ofÂ¦ Â¦themÂ¦ .
ğ‹‡ Â¦casesÂ¦ Â¦ref ersÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦peopleÂ¦ Â¦whoÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦testedÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦andÂ¦ Â¦wh oseÂ¦ Â¦testÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦confirmedÂ¦ Â¦positiveÂ¦ Â¦accordingÂ¦ Â¦toÂ¦ Â¦officialÂ¦ Â¦prot oc olsÂ¦ .
ğ‹‡ Â¦diarrheaÂ¦ Â¦isÂ¦ Â¦alsoÂ¦ Â¦seenÂ¦ Â¦inÂ¦ Â¦someÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦hasÂ¦ Â¦com me ndedÂ¦ Â¦theÂ¦ Â¦effortsÂ¦ Â¦ofÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦authoritiesÂ¦ Â¦inÂ¦ Â¦mana gingÂ¦ Â¦andÂ¦ Â¦cont ainingÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦stayÂ¦ Â¦inÂ¦ Â¦theirÂ¦ Â¦ownÂ¦ Â¦naturalÂ¦ Â¦reserv o irsÂ¦ Â¦untilÂ¦ Â¦thereÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦ch anceÂ¦ Â¦forÂ¦ Â¦sp il lo verÂ¦ .
ğ‹‡Â¦w he re asÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦se que nceÂ¦ Â¦ho mo logyÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğŠ£Â¦r b d ğŠ¼sÂ¦ Â¦betweenÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ Â¦pa ngol inÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ - Â¦relatedÂ¦ Â¦be taÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦andÂ¦ ğ‹‡Â¦ra ğŠ£ t g ğŠ¼ 1 3Â¦ Â¦sh areÂ¦ Â¦theÂ¦ Â¦highestÂ¦ Â¦genomeÂ¦ - Â¦ wideÂ¦ Â¦se que nceÂ¦ Â¦ho mo logyÂ¦ .
ğ‹‡ Â¦secondÂ¦ ,â– Â¦ifÂ¦ Â¦batsÂ¦ Â¦pl ayÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦directÂ¦ Â¦roleÂ¦ Â¦inÂ¦ Â¦humanÂ¦ Â¦transmissionÂ¦ ,â– Â¦howÂ¦ Â¦humansÂ¦ Â¦getÂ¦ Â¦intoÂ¦ Â¦contactÂ¦ Â¦withÂ¦ Â¦batsÂ¦ Â¦shouldÂ¦ Â¦beÂ¦ Â¦determ inedÂ¦ .
ğ‹‡Â¦th ai landÂ¦ ' Â¦sÂ¦ Â¦healthÂ¦ Â¦officialsÂ¦ Â¦areÂ¦ Â¦enc ou ra gingÂ¦ Â¦peopleÂ¦ Â¦toÂ¦ Â¦makeÂ¦ Â¦clo thÂ¦ Â¦fa ce m as ksÂ¦ Â¦atÂ¦ Â¦homeÂ¦ Â¦andÂ¦ Â¦washÂ¦ Â¦themÂ¦ Â¦dailyÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦shouldÂ¦ ,â– Â¦howeverÂ¦ ,â– Â¦beÂ¦ Â¦coll ectedÂ¦ Â¦inÂ¦ Â¦aÂ¦ Â¦s ys te maticÂ¦ Â¦f ash ionÂ¦ Â¦toÂ¦ Â¦comple mentÂ¦ Â¦currentÂ¦ Â¦surveillanceÂ¦ Â¦dataÂ¦ Â¦thatÂ¦ Â¦foc usÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦reportedÂ¦ Â¦casesÂ¦ Â¦andÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦deathsÂ¦ .
ğ‹‡ Â¦partic ul arlyÂ¦ ,â– Â¦batÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦withÂ¦ Â¦z oo no ticÂ¦ Â¦potentialÂ¦ Â¦areÂ¦ Â¦soÂ¦ Â¦di verseÂ¦ .
ğ‹‡ Â¦perÂ¦ Â¦mediaÂ¦ Â¦reportsÂ¦ Â¦onÂ¦ Â¦1Â¦ ğ‹‡Â¦aprilÂ¦ ,â– ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ Â¦hasÂ¦ Â¦receivedÂ¦ Â¦requ es tsÂ¦ Â¦forÂ¦ Â¦virusÂ¦ Â¦testingÂ¦ Â¦assistanceÂ¦ Â¦fromÂ¦ Â¦12 1Â¦ Â¦differentÂ¦ Â¦countriesÂ¦ .
ğ‹‡ Â¦supp r essionÂ¦ Â¦requir esÂ¦ Â¦moreÂ¦ Â¦ext re meÂ¦ Â¦measuresÂ¦ Â¦soÂ¦ Â¦asÂ¦ Â¦toÂ¦ Â¦re verseÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ Â¦byÂ¦ Â¦reduc ingÂ¦ Â¦theÂ¦ Â¦b as icÂ¦ Â¦rep ro du ctionÂ¦ Â¦numberÂ¦ Â¦toÂ¦ Â¦lessÂ¦ Â¦thanÂ¦ Â¦1Â¦ . ğ‹‡ Â¦partÂ¦ Â¦ofÂ¦ Â¦mana gingÂ¦ Â¦anÂ¦ Â¦infectiousÂ¦ Â¦diseaseÂ¦ Â¦outbreakÂ¦ Â¦isÂ¦ Â¦tryingÂ¦ Â¦toÂ¦ Â¦decrea seÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦p eakÂ¦ ,â– Â¦knownÂ¦ Â¦asÂ¦ Â¦f l at te ningÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦cur veÂ¦ .
ğ‹‡ Â¦tellÂ¦ Â¦meÂ¦ Â¦aboutÂ¦ Â¦yourÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğ‹‡Â¦mostÂ¦ Â¦busin essesÂ¦ Â¦wereÂ¦ Â¦orderedÂ¦ Â¦toÂ¦ Â¦closeÂ¦ ,â– Â¦withÂ¦ Â¦ex cep tionsÂ¦ Â¦forÂ¦ Â¦busin essesÂ¦ Â¦d ee medÂ¦ â–" Â¦essentialÂ¦ " ,â– Â¦includingÂ¦ Â¦sup erm ar ke tsÂ¦ ,â– Â¦p har m ac iesÂ¦ ,â– Â¦ban ksÂ¦ ,â– Â¦h ard w areÂ¦ Â¦shopsÂ¦ ,â– Â¦pe tr olÂ¦ Â¦st ationsÂ¦ ,â– Â¦andÂ¦ Â¦g ara gesÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦mightÂ¦ Â¦alsoÂ¦ Â¦gu ideÂ¦ Â¦orÂ¦ Â¦facil it ateÂ¦ Â¦theÂ¦ Â¦se ar chÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦reserv o irÂ¦ ,â– Â¦interme di ateÂ¦ Â¦andÂ¦ Â¦a mp li f yingÂ¦ Â¦animalÂ¦ Â¦hostÂ¦ ( Â¦sÂ¦ )â– Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦withÂ¦ Â¦importantÂ¦ Â¦imp licationsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦preventionÂ¦ Â¦ofÂ¦ Â¦futureÂ¦ Â¦s pi ll ov ersÂ¦ .
ğ‹‡Â¦theyÂ¦ Â¦mightÂ¦ Â¦alsoÂ¦ Â¦accountÂ¦ Â¦forÂ¦ Â¦success fulÂ¦ Â¦ad a pt ationÂ¦ Â¦ofÂ¦ Â¦theseÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦inÂ¦ Â¦humansÂ¦ Â¦afterÂ¦ Â¦inter sp ec iesÂ¦ Â¦transmissionÂ¦ Â¦fromÂ¦ Â¦theirÂ¦ Â¦animalÂ¦ Â¦h ostsÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦z oo no ticÂ¦ Â¦originÂ¦ .
ğ‹‡Â¦anÂ¦ Â¦un ass o ci atedÂ¦ Â¦cl us terÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦casesÂ¦ Â¦wasÂ¦ Â¦laterÂ¦ Â¦detectedÂ¦ ,â– Â¦startingÂ¦ Â¦withÂ¦ Â¦16Â¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦inÂ¦ ğ‹‡Â¦lo mb ard yÂ¦ Â¦onÂ¦ Â¦21Â¦ ğ‹‡Â¦februaryÂ¦ . ğ‹‡Â¦onÂ¦ Â¦22Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦councilÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦ministersÂ¦ Â¦announcedÂ¦ Â¦aÂ¦ Â¦newÂ¦ Â¦dec re eÂ¦ - Â¦la wÂ¦ Â¦toÂ¦ Â¦con tainÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ ,â– Â¦includingÂ¦ Â¦qu ar anti ningÂ¦ Â¦moreÂ¦ Â¦thanÂ¦ Â¦50Â¦ , Â¦000Â¦ Â¦peopleÂ¦ Â¦fromÂ¦ Â¦11Â¦ Â¦differentÂ¦ Â¦m uni cip al itiesÂ¦ Â¦inÂ¦ Â¦nor th ernÂ¦ ğ‹‡Â¦italyÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦dayÂ¦ ,â– Â¦theÂ¦ ğŠ£ Â¦us ns Â¦ğŠ¼ ğ‹‡ Â¦com f ortÂ¦ ,â– Â¦aÂ¦ Â¦hospitalÂ¦ Â¦ shipÂ¦ Â¦withÂ¦ Â¦aboutÂ¦ Â¦1 0 00Â¦ Â¦bedsÂ¦ ,â– Â¦madeÂ¦ Â¦an ch orÂ¦ Â¦inÂ¦ ğ‹‡Â¦newÂ¦ ğ‹‡Â¦y or kÂ¦ .
ğ‹‡Â¦someÂ¦ Â¦organizationsÂ¦ Â¦haveÂ¦ Â¦createdÂ¦ Â¦crow d s our c edÂ¦ Â¦app sÂ¦ Â¦forÂ¦ Â¦sy nd r om icÂ¦ Â¦surveillanceÂ¦ ,â– Â¦whereÂ¦ Â¦peopleÂ¦ Â¦canÂ¦ Â¦reportÂ¦ Â¦theirÂ¦ Â¦symptomsÂ¦ Â¦toÂ¦ Â¦helpÂ¦ Â¦researchersÂ¦ Â¦ma pÂ¦ Â¦areasÂ¦ Â¦withÂ¦ Â¦conc en trationÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦symptomsÂ¦ .
ğ‹‡ Â¦schoolsÂ¦ Â¦andÂ¦ Â¦universitiesÂ¦ Â¦haveÂ¦ Â¦closedÂ¦ Â¦e itherÂ¦ Â¦onÂ¦ Â¦aÂ¦ Â¦nationwideÂ¦ Â¦orÂ¦ Â¦localÂ¦ Â¦ba sisÂ¦ Â¦inÂ¦ Â¦19 3Â¦ Â¦countriesÂ¦ ,â– Â¦aff ectingÂ¦ Â¦approximatelyÂ¦ Â¦9 9Â¦ . Â¦4Â¦ Â¦percentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦worldÂ¦ ' Â¦sÂ¦ Â¦stud entÂ¦ Â¦populationÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦responseÂ¦ Â¦toÂ¦ Â¦aÂ¦ Â¦developingÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ ğ‹‡Â¦ iranÂ¦ ,â– Â¦theÂ¦ ğŠ£Â¦whoÂ¦ğŠ¼ Â¦sentÂ¦ Â¦aÂ¦ ğ‹‡ Â¦jo intÂ¦ ğ‹‡Â¦ missionÂ¦ ğ‹‡ Â¦teamÂ¦ Â¦thereÂ¦ Â¦toÂ¦ Â¦ass essÂ¦ Â¦theÂ¦ Â¦situationÂ¦ . ğ‹‡Â¦onÂ¦ Â¦28Â¦ ğ‹‡Â¦februaryÂ¦ ,â– ğŠ£Â¦whoÂ¦ğŠ¼ Â¦officialsÂ¦ Â¦saidÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦coronavirusÂ¦ Â¦th re atÂ¦ Â¦ass ess mentÂ¦ Â¦atÂ¦ Â¦theÂ¦ Â¦globalÂ¦ Â¦levelÂ¦ Â¦wouldÂ¦ Â¦beÂ¦ Â¦raisedÂ¦ Â¦fromÂ¦ â–" Â¦highÂ¦ "â– Â¦toÂ¦ â–" Â¦veryÂ¦ Â¦highÂ¦ " ,â– Â¦itsÂ¦ Â¦highestÂ¦ Â¦levelÂ¦ Â¦ofÂ¦ Â¦al er tÂ¦ Â¦andÂ¦ Â¦riskÂ¦ Â¦ass ess mentÂ¦ .
ğ‹‡Â¦byÂ¦ Â¦theÂ¦ Â¦timeÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦reportÂ¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦hasÂ¦ Â¦alreadyÂ¦ Â¦spreadÂ¦ Â¦thr oug ho utÂ¦ ğ‹‡Â¦chinaÂ¦ Â¦andÂ¦ Â¦nearÂ¦ Â¦50Â¦ Â¦otherÂ¦ Â¦countriesÂ¦ Â¦allÂ¦ Â¦overÂ¦ Â¦theÂ¦ Â¦worldÂ¦ â–( ğ‹‡Â¦fi gÂ¦ .â– â€‹ ( ğ‹‡Â¦fi gÂ¦ . Â¦2Â¦ ). Â¦2Â¦ ).
ğ‹‡Â¦theÂ¦ ğ‹‡Â¦i ra ni anÂ¦ ğ‹‡Â¦par li a mentÂ¦ Â¦wasÂ¦ Â¦sh utÂ¦ Â¦downÂ¦ ,â– Â¦withÂ¦ Â¦23Â¦ Â¦ofÂ¦ Â¦itsÂ¦ Â¦2 9 0Â¦ Â¦membersÂ¦ Â¦reportedÂ¦ Â¦toÂ¦ Â¦haveÂ¦ Â¦hadÂ¦ Â¦testedÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦onÂ¦ Â¦3Â¦ ğ‹‡Â¦marchÂ¦ .
ğ‹‡Â¦r d ğ‹‡ r pÂ¦ Â¦directlyÂ¦ Â¦me di atesÂ¦ Â¦theÂ¦ Â¦sy nt he sisÂ¦ Â¦ofÂ¦ Â¦negativeÂ¦ - Â¦s enseÂ¦ Â¦g en om icÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ Â¦fromÂ¦ Â¦theÂ¦ Â¦positiveÂ¦ - Â¦s enseÂ¦ Â¦g en om icÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ .
ğ‹‡Â¦am id stÂ¦ Â¦clai msÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦co verÂ¦ - Â¦upÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦ext entÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦inÂ¦ ğ‹‡Â¦ iranÂ¦ ,â– Â¦moreÂ¦ Â¦thanÂ¦ Â¦tenÂ¦ Â¦countriesÂ¦ Â¦hadÂ¦ Â¦tr acedÂ¦ Â¦theirÂ¦ Â¦casesÂ¦ Â¦backÂ¦ Â¦toÂ¦ ğ‹‡Â¦ iranÂ¦ Â¦byÂ¦ Â¦28Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦indic atingÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦ext entÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦moreÂ¦ Â¦severeÂ¦ Â¦thanÂ¦ Â¦theÂ¦ Â¦3 8 8Â¦ Â¦casesÂ¦ Â¦reportedÂ¦ Â¦byÂ¦ Â¦theÂ¦ ğ‹‡Â¦i ra ni anÂ¦ Â¦governmentÂ¦ Â¦byÂ¦ Â¦thatÂ¦ Â¦dateÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦li ne ageÂ¦ - Â¦specificÂ¦ Â¦acc ess oryÂ¦ Â¦proteinsÂ¦ Â¦areÂ¦ Â¦alsoÂ¦ Â¦en co dedÂ¦ Â¦byÂ¦ Â¦differentÂ¦ Â¦lin ea gesÂ¦ Â¦ofÂ¦ ğ‹‡Â¦coğ‹‡vsÂ¦ .
ğ‹‡Â¦allÂ¦ Â¦countriesÂ¦ Â¦canÂ¦ Â¦stillÂ¦ Â¦changeÂ¦ Â¦theÂ¦ Â¦courseÂ¦ Â¦ofÂ¦ Â¦thisÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦aÂ¦ Â¦sub fa mi lyÂ¦ Â¦ofÂ¦ Â¦largeÂ¦ Â¦andÂ¦ Â¦en v el op edÂ¦ Â¦virusesÂ¦ Â¦cont ainingÂ¦ Â¦aÂ¦ Â¦singleÂ¦ Â¦str andÂ¦ Â¦ofÂ¦ Â¦s enseÂ¦ ğŠ£Â¦rnaÂ¦ğŠ¼ .
ğ‹‡Â¦theÂ¦ Â¦testÂ¦ Â¦u sesÂ¦ Â¦realÂ¦ - Â¦timeÂ¦ Â¦re verseÂ¦ Â¦trans c r ip tionÂ¦ Â¦pol y mer aseÂ¦ Â¦chainÂ¦ Â¦rea ctionÂ¦ â–( Â¦r ğŠ£ r tÂ¦ - Â¦pcrÂ¦ğŠ¼ ).
ğ‹‡ Â¦followingÂ¦ Â¦theÂ¦ Â¦progr essionÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ Â¦toÂ¦ Â¦newÂ¦ Â¦hot s po tÂ¦ Â¦countriesÂ¦ ,â– Â¦peopleÂ¦ Â¦fromÂ¦ ğ‹‡Â¦italyÂ¦ ,â– Â¦theÂ¦ Â¦firstÂ¦ Â¦countryÂ¦ Â¦inÂ¦ ğ‹‡Â¦europeÂ¦ Â¦toÂ¦ Â¦experienceÂ¦ Â¦aÂ¦ Â¦seriousÂ¦ Â¦outbreakÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ ,â– Â¦couldÂ¦ Â¦alsoÂ¦ Â¦beÂ¦ Â¦subj ectedÂ¦ Â¦toÂ¦ Â¦susp ic ionÂ¦ Â¦andÂ¦ Â¦ x en op ho bi aÂ¦ . ğ‹‡Â¦citizensÂ¦ Â¦inÂ¦ Â¦countriesÂ¦ Â¦includingÂ¦ ğ‹‡Â¦ma la y siaÂ¦ ,â– ğ‹‡Â¦newÂ¦ ğ‹‡Â¦z ea landÂ¦ ,â– ğ‹‡Â¦si ng ap oreÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ Â¦initiallyÂ¦ Â¦si gnedÂ¦ Â¦pe ti tionsÂ¦ Â¦lo b b yingÂ¦ Â¦toÂ¦ Â¦ banÂ¦ ğ‹‡Â¦chineseÂ¦ Â¦peopleÂ¦ Â¦fromÂ¦ Â¦ent eringÂ¦ Â¦theirÂ¦ Â¦countriesÂ¦ Â¦inÂ¦ Â¦anÂ¦ Â¦eff ortÂ¦ Â¦toÂ¦ Â¦stopÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦additionÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ ,â– Â¦thisÂ¦ Â¦alsoÂ¦ Â¦app l iesÂ¦ Â¦toÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦whichÂ¦ Â¦isÂ¦ Â¦wellÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦dr om ed aryÂ¦ Â¦cam elsÂ¦ .
ğ‹‡Â¦asÂ¦ Â¦ofÂ¦ Â¦y es ter dayÂ¦ ,â– ğ‹‡Â¦ba ng l ad eshÂ¦ ' Â¦sÂ¦ ğ‹‡Â¦instituteÂ¦ Â¦ofÂ¦ ğ‹‡ Â¦epi dem io logyÂ¦ ,â– ğ‹‡Â¦diseaseÂ¦ ğ‹‡Â¦controlÂ¦ Â¦andÂ¦ ğ‹‡Â¦researchÂ¦ â–( ğŠ£Â¦i ed c rÂ¦ğŠ¼ )â– Â¦reportedÂ¦ Â¦theÂ¦ Â¦numberÂ¦ Â¦ofÂ¦ Â¦recordedÂ¦ Â¦infectedÂ¦ Â¦casesÂ¦ Â¦includedÂ¦ Â¦11 4Â¦ Â¦activeÂ¦ Â¦casesÂ¦ Â¦andÂ¦ Â¦3 3Â¦ Â¦recoveredÂ¦ Â¦casesÂ¦ Â¦whoÂ¦ Â¦wereÂ¦ Â¦sta yingÂ¦ Â¦homeÂ¦ .
ğ‹‡Â¦mostÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦effectiveÂ¦ Â¦com po ne ntsÂ¦ Â¦remainÂ¦ Â¦un kn ownÂ¦ Â¦orÂ¦ Â¦areÂ¦ Â¦ va g ueÂ¦ Â¦asÂ¦ Â¦itÂ¦ Â¦isÂ¦ Â¦difficultÂ¦ Â¦toÂ¦ Â¦ex tr actÂ¦ Â¦andÂ¦ Â¦ve ri fyÂ¦ Â¦suchÂ¦ Â¦com po ne ntsÂ¦ Â¦orÂ¦ Â¦theirÂ¦ Â¦op ti malÂ¦ Â¦comb in ationsÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦possibleÂ¦ ,â– Â¦similarÂ¦ Â¦toÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ ,â– Â¦thatÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦mightÂ¦ Â¦becomeÂ¦ Â¦wea kerÂ¦ Â¦inÂ¦ Â¦inf ec tivityÂ¦ Â¦andÂ¦ Â¦e ve nt uallyÂ¦ Â¦dieÂ¦ Â¦downÂ¦ Â¦orÂ¦ Â¦becomeÂ¦ Â¦aÂ¦ Â¦lessÂ¦ Â¦pathog enicÂ¦ Â¦virusÂ¦ Â¦c oÂ¦ - Â¦e xi st entÂ¦ Â¦withÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦18Â¦ ,â– Â¦2020Â¦ ,â– Â¦theÂ¦ Â¦firstÂ¦ Â¦p at ho logicalÂ¦ Â¦analysisÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦de mo nstr atedÂ¦ Â¦theÂ¦ Â¦d es qu am ationÂ¦ Â¦ofÂ¦ Â¦p ne um ocy tesÂ¦ ,â– Â¦h ya lineÂ¦ Â¦me m br aneÂ¦ Â¦ form ationÂ¦ ,â– Â¦andÂ¦ Â¦inter s ti ti alÂ¦ Â¦l ym ph ocy teÂ¦ Â¦inf il trationÂ¦ ,â– Â¦andÂ¦ Â¦m ult in ucle atedÂ¦ Â¦sy nc y ti alÂ¦ Â¦cellsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦lungsÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦patientÂ¦ Â¦whoÂ¦ Â¦diedÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦diseaseÂ¦ ,â– Â¦con sist entÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦p at ho logyÂ¦ Â¦ofÂ¦ Â¦viralÂ¦ Â¦infectionÂ¦ Â¦andÂ¦ ğŠ£Â¦ ardsÂ¦ ğŠ¼ Â¦andÂ¦ Â¦similarÂ¦ Â¦toÂ¦ Â¦thatÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦andÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ Â¦patientsÂ¦ .
ğ‹‡ Â¦wi ld li f eÂ¦ Â¦s m u gg lingÂ¦ Â¦andÂ¦ Â¦z oo no sesÂ¦ â– â€“ â– ğ‹‡Â¦healthÂ¦ Â¦ris ksÂ¦ Â¦associatedÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦tra deÂ¦ Â¦inÂ¦ Â¦ex o ticÂ¦ Â¦wi ld li f eÂ¦
ğ‹‡Â¦forÂ¦ ğŠ£ Â¦cl t Â¦ğŠ¼ Â¦aÂ¦ Â¦singleÂ¦ Â¦speci m enÂ¦ Â¦ofÂ¦ Â¦pe ri ph er alÂ¦ Â¦bloodÂ¦ Â¦isÂ¦ Â¦com mon lyÂ¦ Â¦usedÂ¦ ,â– Â¦al th oughÂ¦ Â¦se rialÂ¦ Â¦speci me nsÂ¦ Â¦canÂ¦ Â¦beÂ¦ Â¦usedÂ¦ Â¦toÂ¦ Â¦followÂ¦ Â¦theÂ¦ Â¦immuneÂ¦ Â¦responseÂ¦ .
ğ‹‡Â¦thisÂ¦ Â¦virusÂ¦ Â¦mayÂ¦ Â¦beÂ¦ Â¦onÂ¦ Â¦itsÂ¦ Â¦wayÂ¦ Â¦andÂ¦ Â¦youÂ¦ Â¦needÂ¦ Â¦toÂ¦ Â¦beÂ¦ Â¦readyÂ¦ ,"â– Â¦ur gingÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦rightÂ¦ Â¦responseÂ¦ Â¦measuresÂ¦ Â¦couldÂ¦ Â¦helpÂ¦ Â¦theÂ¦ Â¦worldÂ¦ Â¦avoidÂ¦ â–" Â¦theÂ¦ Â¦wor stÂ¦ Â¦ofÂ¦ Â¦itÂ¦ ".
ğ‹‡Â¦ourÂ¦ Â¦teamÂ¦ Â¦willÂ¦ Â¦alsoÂ¦ Â¦ti melyÂ¦ Â¦upd ateÂ¦ Â¦ourÂ¦ Â¦gu i de lineÂ¦ Â¦toÂ¦ Â¦off erÂ¦ Â¦helpÂ¦ .
ğ‹‡Â¦aÂ¦ Â¦studyÂ¦ Â¦performedÂ¦ Â¦inÂ¦ Â¦201 0Â¦ â€“ Â¦11Â¦ Â¦showedÂ¦ Â¦aÂ¦ Â¦largeÂ¦ Â¦v ari ationÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦availabilityÂ¦ Â¦ofÂ¦ Â¦intensiveÂ¦ Â¦careÂ¦ Â¦andÂ¦ Â¦interme di ateÂ¦ Â¦careÂ¦ Â¦bedsÂ¦ Â¦inÂ¦ ğ‹‡Â¦europeÂ¦ ,â– Â¦ran gingÂ¦ Â¦fromÂ¦ Â¦29Â¦ . Â¦2Â¦ Â¦inÂ¦ ğ‹‡Â¦germanyÂ¦ Â¦toÂ¦ Â¦4Â¦ . Â¦2Â¦ Â¦bedsÂ¦ Â¦perÂ¦ Â¦100Â¦ , Â¦000Â¦ Â¦populationÂ¦ Â¦inÂ¦ ğ‹‡Â¦p ort u g alÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦cont ra stÂ¦ ,â– Â¦ifÂ¦ Â¦theÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦isÂ¦ Â¦new lyÂ¦ Â¦in tr od uc edÂ¦ Â¦toÂ¦ Â¦anÂ¦ Â¦interme di ateÂ¦ Â¦hostÂ¦ Â¦rightÂ¦ Â¦beforeÂ¦ Â¦orÂ¦ Â¦aroundÂ¦ Â¦itsÂ¦ Â¦int ro du ctionÂ¦ Â¦toÂ¦ Â¦humansÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦wellÂ¦ Â¦ad ap tedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦newÂ¦ Â¦hostÂ¦ Â¦andÂ¦ Â¦isÂ¦ Â¦oftenÂ¦ Â¦pathog enicÂ¦ .
ğ‹‡Â¦th usÂ¦ ,â– Â¦itÂ¦ Â¦isÂ¦ Â¦muchÂ¦ Â¦moreÂ¦ Â¦challen gingÂ¦ Â¦toÂ¦ Â¦controlÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦thanÂ¦ Â¦thoseÂ¦ Â¦ofÂ¦ ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦andÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡ Â¦firstÂ¦ ,â– Â¦ifÂ¦ Â¦batsÂ¦ Â¦transm itÂ¦ Â¦anÂ¦ Â¦a nc es tr alÂ¦ Â¦virusÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦toÂ¦ Â¦pa ngol insÂ¦ ,â– Â¦itÂ¦ Â¦willÂ¦ Â¦beÂ¦ Â¦ofÂ¦ Â¦inter estÂ¦ Â¦toÂ¦ Â¦seeÂ¦ Â¦underÂ¦ Â¦whatÂ¦ Â¦circ um st ancesÂ¦ Â¦batsÂ¦ Â¦andÂ¦ Â¦pa ngol insÂ¦ Â¦couldÂ¦ Â¦sh areÂ¦ Â¦theÂ¦ Â¦sameÂ¦ Â¦e co logicalÂ¦ Â¦ ni ch eÂ¦ .
ğ‹‡Â¦ iranÂ¦ Â¦all oc atedÂ¦ Â¦fiveÂ¦ Â¦t ri ll ionÂ¦ Â¦ri alsÂ¦ Â¦toÂ¦ Â¦comb atÂ¦ Â¦theÂ¦ Â¦virusÂ¦ .
ğ‹‡ Â¦li ke w iseÂ¦ ,â– Â¦aÂ¦ Â¦reserv o irÂ¦ Â¦hostÂ¦ Â¦h arb our sÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦continu o us lyÂ¦ Â¦andÂ¦ Â¦forÂ¦ Â¦longÂ¦ Â¦termÂ¦ .
ğ‹‡Â¦howeverÂ¦ ,â– Â¦viaÂ¦ Â¦strictÂ¦ Â¦quarantineÂ¦ Â¦andÂ¦ Â¦isolationÂ¦ ,â– Â¦theÂ¦ Â¦diseaseÂ¦ Â¦hasÂ¦ Â¦e ve nt uallyÂ¦ Â¦beenÂ¦ Â¦putÂ¦ Â¦underÂ¦ Â¦controlÂ¦ .
ğŠ£Â¦mersÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦ser vesÂ¦ Â¦asÂ¦ Â¦anÂ¦ Â¦ex ce ll entÂ¦ Â¦exampleÂ¦ Â¦ofÂ¦ Â¦inter sp ec iesÂ¦ Â¦transmissionÂ¦ Â¦fromÂ¦ Â¦batsÂ¦ Â¦toÂ¦ Â¦dr om ed aryÂ¦ Â¦cam elsÂ¦ Â¦andÂ¦ Â¦fromÂ¦ Â¦dr om ed aryÂ¦ Â¦cam elsÂ¦ Â¦toÂ¦ Â¦humansÂ¦ .
ğ‹‡Â¦anÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ Â¦canÂ¦ Â¦under g oÂ¦ Â¦aÂ¦ Â¦de adÂ¦ - Â¦endÂ¦ Â¦infectionÂ¦ Â¦ifÂ¦ Â¦itÂ¦ Â¦cannotÂ¦ Â¦s us tainÂ¦ Â¦itsÂ¦ Â¦transmissionÂ¦ Â¦withinÂ¦ Â¦theÂ¦ Â¦interme di ateÂ¦ Â¦hostÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦se ar chÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦animalÂ¦ Â¦origin sÂ¦ Â¦ofÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦stillÂ¦ Â¦onÂ¦ .
ğ‹‡Â¦nowÂ¦ Â¦ourÂ¦ Â¦gu i de lineÂ¦ Â¦receivedÂ¦ Â¦aÂ¦ Â¦com mentÂ¦ Â¦byÂ¦ ğ‹‡Â¦z ho uÂ¦ Â¦ etÂ¦ Â¦ alÂ¦ . ,â– Â¦theyÂ¦ Â¦in tr od uc edÂ¦ Â¦aÂ¦ Â¦simpleÂ¦ Â¦s co ringÂ¦ Â¦prop osalÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theirÂ¦ Â¦clinicalÂ¦ Â¦experienceÂ¦ .
ğ‹‡Â¦n u me ro usÂ¦ Â¦candid ateÂ¦ Â¦drugsÂ¦ Â¦underÂ¦ Â¦studyÂ¦ Â¦asÂ¦ â–" Â¦sup por tiveÂ¦ "â– Â¦tre at mentsÂ¦ Â¦toÂ¦ Â¦rel ie veÂ¦ Â¦disc om f ortÂ¦ Â¦duringÂ¦ Â¦illnessÂ¦ ,â– Â¦suchÂ¦ Â¦asÂ¦ ğŠ£Â¦ ns a id ğŠ¼sÂ¦ Â¦orÂ¦ Â¦b ron ch od il atorsÂ¦ ,â– Â¦areÂ¦ Â¦notÂ¦ Â¦includedÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦t ableÂ¦ Â¦be lowÂ¦ .
ğ‹‡Â¦w he re asÂ¦ Â¦aÂ¦ Â¦batÂ¦ Â¦be taÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦sh aringÂ¦ Â¦95Â¦ %â– Â¦n ucle ot ideÂ¦ Â¦ho mo logyÂ¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦hasÂ¦ Â¦beenÂ¦ Â¦foundÂ¦ ,â– Â¦thereÂ¦ Â¦alsoÂ¦ Â¦ex istsÂ¦ Â¦aÂ¦ Â¦batÂ¦ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦sh aringÂ¦ Â¦9 6Â¦ %â– Â¦n ucle ot ideÂ¦ Â¦ho mo logyÂ¦ Â¦withÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ .
ğ‹‡Â¦thisÂ¦ Â¦isÂ¦ Â¦notÂ¦ Â¦usuallyÂ¦ Â¦passedÂ¦ Â¦fromÂ¦ Â¦mo therÂ¦ Â¦toÂ¦ Â¦fe t usÂ¦ Â¦soÂ¦ Â¦furtherÂ¦ Â¦researchÂ¦ Â¦isÂ¦ Â¦requiredÂ¦ Â¦toÂ¦ Â¦knowÂ¦ Â¦whetherÂ¦ Â¦theÂ¦ Â¦virusÂ¦ Â¦cr os sedÂ¦ Â¦theÂ¦ Â¦pl ac en taÂ¦ Â¦orÂ¦ Â¦whetherÂ¦ Â¦pla ce nt asÂ¦ Â¦ofÂ¦ Â¦womenÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦studyÂ¦ Â¦wereÂ¦ Â¦da ma gedÂ¦ Â¦orÂ¦ Â¦ab n or malÂ¦ .
ğ‹‡Â¦onÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦11Â¦ ,â– Â¦2020Â¦ ,â– Â¦aÂ¦ Â¦m ult iÂ¦ - Â¦centerÂ¦ Â¦studyÂ¦ Â¦onÂ¦ Â¦8Â¦ , Â¦8 6 6Â¦ Â¦patientsÂ¦ Â¦includingÂ¦ Â¦4Â¦ , Â¦0 2 1Â¦ Â¦confirmedÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦patientsÂ¦ Â¦pres entedÂ¦ Â¦aÂ¦ Â¦moreÂ¦ Â¦upd atedÂ¦ Â¦i ll us trationÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦epidemicÂ¦ Â¦asÂ¦ Â¦f ol lo wsÂ¦ â–( Â¦h t t psÂ¦ : / / Â¦m pÂ¦ . Â¦we i x inÂ¦ . Â¦ q q Â¦ . Â¦c omÂ¦ / Â¦sÂ¦ / ğ‹‡Â¦ ul ğ‹‡ b iÂ¦ - ğŠ£Â¦h x ğŠ¼ _ r ğŠ£ h p x ğŠ¼ a 1 q ğŠ£ ha ğŠ¼ 2 b h d ğ‹‡ aÂ¦ ).
ğ‹‡Â¦butÂ¦ Â¦alsoÂ¦ Â¦weÂ¦ Â¦sh ou ld nÂ¦ ' Â¦tÂ¦ Â¦beÂ¦ Â¦putÂ¦ Â¦as ideÂ¦ Â¦forÂ¦ Â¦theÂ¦ Â¦heartÂ¦ Â¦car dia cÂ¦ Â¦originÂ¦ Â¦chestÂ¦ Â¦painÂ¦
ğ‹‡ Â¦severalÂ¦ Â¦loc al itiesÂ¦ Â¦alsoÂ¦ Â¦w it n es sedÂ¦ Â¦pan icÂ¦ Â¦bu yingÂ¦ Â¦thatÂ¦ Â¦ledÂ¦ Â¦toÂ¦ Â¦sh el vesÂ¦ Â¦beingÂ¦ Â¦cle aredÂ¦ Â¦ofÂ¦ Â¦groc eryÂ¦ Â¦ ess enti alsÂ¦ Â¦suchÂ¦ Â¦asÂ¦ Â¦foodÂ¦ ,â– Â¦to il etÂ¦ Â¦paperÂ¦ ,â– Â¦andÂ¦ Â¦b ott ledÂ¦ Â¦waterÂ¦ ,â– Â¦ind uc ingÂ¦ Â¦supplyÂ¦ Â¦sh or tagesÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦centerÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦chestÂ¦
ğ‹‡Â¦ ec on om icallyÂ¦ Â¦significantÂ¦ Â¦coronavirusesÂ¦ Â¦ofÂ¦ Â¦farm Â¦ Â¦animalsÂ¦ Â¦includeÂ¦ Â¦ por c ineÂ¦ Â¦coronavirusÂ¦ â–( Â¦transm is si bleÂ¦ Â¦g ast ro en teri tisÂ¦ Â¦coronavirusÂ¦ ,â– ğŠ£Â¦t ge Â¦ğŠ¼ )â– Â¦andÂ¦ Â¦b ov ineÂ¦ Â¦coronavirusÂ¦ ,â– Â¦whichÂ¦ Â¦bothÂ¦ Â¦resultÂ¦ Â¦inÂ¦ Â¦diarrheaÂ¦ Â¦inÂ¦ Â¦youngÂ¦ Â¦animalsÂ¦ .
ğ‹‡Â¦iÂ¦ Â¦hadÂ¦ Â¦aÂ¦ Â¦feverÂ¦ Â¦y es ter dayÂ¦
ğ‹‡Â¦asÂ¦ Â¦theseÂ¦ Â¦no ti fic ationsÂ¦ Â¦occur redÂ¦ ,â– Â¦doctorsÂ¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ Â¦wereÂ¦ Â¦war nedÂ¦ Â¦byÂ¦ Â¦policeÂ¦ Â¦forÂ¦ â–" Â¦spreadingÂ¦ Â¦r um our sÂ¦ "â– Â¦aboutÂ¦ Â¦theÂ¦ Â¦outbreakÂ¦ .
ğ‹‡ Â¦identi f yingÂ¦ Â¦theÂ¦ Â¦animalÂ¦ Â¦h ostsÂ¦ Â¦hasÂ¦ Â¦directÂ¦ Â¦imp licationsÂ¦ Â¦inÂ¦ Â¦theÂ¦ Â¦preventionÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ Â¦diseasesÂ¦ .
ğ‹‡ Â¦mandatoryÂ¦ Â¦contactÂ¦ Â¦tracingÂ¦ Â¦andÂ¦ Â¦quarantineÂ¦ ,â– Â¦asÂ¦ Â¦aÂ¦ Â¦partÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦publicÂ¦ Â¦healthÂ¦ Â¦respon sesÂ¦ Â¦toÂ¦ Â¦theÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦outbreakÂ¦ ,â– Â¦canÂ¦ Â¦makeÂ¦ Â¦peopleÂ¦ Â¦moreÂ¦ Â¦an x io usÂ¦ Â¦andÂ¦ Â¦gu il tyÂ¦ Â¦aboutÂ¦ Â¦theÂ¦ Â¦effectsÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦conta g ionÂ¦ ,â– Â¦quarantineÂ¦ ,â– Â¦andÂ¦ Â¦s tig maÂ¦ Â¦onÂ¦ Â¦theirÂ¦ Â¦familiesÂ¦ Â¦andÂ¦ Â¦fr ie ndsÂ¦ .
ğ‹‡Â¦onÂ¦ Â¦19Â¦ ğ‹‡Â¦februaryÂ¦ ,â– Â¦theÂ¦ ğ‹‡Â¦si ng ap oreÂ¦ ğ‹‡Â¦ redÂ¦ ğ‹‡ Â¦cr ossÂ¦ Â¦announcedÂ¦ Â¦thatÂ¦ Â¦itÂ¦ Â¦wouldÂ¦ Â¦sendÂ¦ â– $ Â¦2Â¦ . Â¦26Â¦ Â¦millionÂ¦ Â¦wor thÂ¦ Â¦ofÂ¦ Â¦a idÂ¦ Â¦toÂ¦ ğ‹‡Â¦chinaÂ¦ .
ğ‹‡ Â¦similarÂ¦ Â¦toÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦n l 6 3Â¦ ,â– Â¦h c ğŠ¼ o ğ‹‡ vÂ¦ - Â¦22 9 ğ‹‡ eÂ¦ Â¦andÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vÂ¦ - ğŠ£Â¦ oc 43Â¦ ,â– Â¦h c ğŠ¼ o ğ‹‡ vÂ¦ - ğŠ£Â¦h k u ğŠ¼ 1Â¦ Â¦wasÂ¦ Â¦foundÂ¦ Â¦worldwideÂ¦ ,â– Â¦cau singÂ¦ Â¦mildÂ¦ Â¦respiratoryÂ¦ Â¦diseasesÂ¦ .
ğ‹‡Â¦itÂ¦ Â¦isÂ¦ Â¦sp ec ul atedÂ¦ Â¦thatÂ¦ Â¦theÂ¦ Â¦fluÂ¦ Â¦pandemicÂ¦ Â¦ofÂ¦ Â¦1 8 9 0Â¦ Â¦mayÂ¦ Â¦haveÂ¦ Â¦beenÂ¦ Â¦causedÂ¦ Â¦byÂ¦ Â¦thisÂ¦ Â¦sp il lo verÂ¦ Â¦ev entÂ¦ ,â– Â¦andÂ¦ Â¦notÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦influenzaÂ¦ Â¦virusÂ¦ ,â– Â¦becauseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦relatedÂ¦ Â¦ti mingÂ¦ ,â– Â¦ne u ro logicalÂ¦ Â¦symptomsÂ¦ ,â– Â¦andÂ¦ Â¦un kn ownÂ¦ Â¦ca us ativeÂ¦ Â¦a gentÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦pandemicÂ¦ .
ğ‹‡Â¦allÂ¦ Â¦sevenÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦z oo no ticÂ¦ Â¦originÂ¦ Â¦fromÂ¦ Â¦batsÂ¦ ,â– Â¦m iceÂ¦ Â¦orÂ¦ Â¦dom es ticÂ¦ Â¦animalsÂ¦ .
ğ‹‡Â¦doÂ¦ Â¦youÂ¦ Â¦haveÂ¦ Â¦someÂ¦ Â¦sh ort nessÂ¦ Â¦ofÂ¦ Â¦breathÂ¦ Â¦go esÂ¦ Â¦withÂ¦ Â¦thatÂ¦ ?
ğ‹‡Â¦thisÂ¦ ,â– Â¦howeverÂ¦ ,â– Â¦v ariesÂ¦ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦h um id ityÂ¦ Â¦andÂ¦ Â¦temperatureÂ¦ . ğ‹‡ Â¦pe tsÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦animalsÂ¦ Â¦haveÂ¦ Â¦testedÂ¦ Â¦positiveÂ¦ Â¦forÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ .
ğ‹‡ Â¦qu estÂ¦ ğ‹‡ Â¦diagn o st icsÂ¦ Â¦si m il arlyÂ¦ Â¦madeÂ¦ Â¦nationwideÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦testingÂ¦ Â¦availableÂ¦ Â¦asÂ¦ Â¦ofÂ¦ Â¦9Â¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ .
ğ‹‡Â¦asÂ¦ Â¦aÂ¦ Â¦novelÂ¦ Â¦diseaseÂ¦ ,â– ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦hasÂ¦ Â¦justÂ¦ Â¦startedÂ¦ Â¦toÂ¦ Â¦ma ni f estÂ¦ Â¦itsÂ¦ Â¦fullÂ¦ Â¦clinicalÂ¦ Â¦courseÂ¦ Â¦thr oug ho utÂ¦ Â¦thousandsÂ¦ Â¦ofÂ¦ Â¦patientsÂ¦ .
ğ‹‡Â¦byÂ¦ ğ‹‡Â¦februaryÂ¦ Â¦14Â¦ ,â– Â¦theÂ¦ Â¦mortalityÂ¦ Â¦ofÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ Â¦wasÂ¦ Â¦2Â¦ %â– Â¦whenÂ¦ Â¦theÂ¦ Â¦confirmedÂ¦ Â¦casesÂ¦ Â¦reachedÂ¦ Â¦6 6Â¦ , Â¦5 7 6Â¦ Â¦glo b allyÂ¦ .
ğ‹‡Â¦mostÂ¦ Â¦imp res si ve lyÂ¦ ,â– Â¦theÂ¦ Â¦rateÂ¦ Â¦forÂ¦ Â¦sy mp to maticÂ¦ Â¦wor se ningÂ¦ â–( Â¦fromÂ¦ Â¦ lightÂ¦ Â¦toÂ¦ Â¦severeÂ¦ )â– Â¦wasÂ¦ Â¦rem ar k ablyÂ¦ Â¦lowerÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğŠ£ Â¦w mÂ¦ + Â¦t c mÂ¦ğŠ¼ Â¦groupÂ¦ Â¦thanÂ¦ Â¦forÂ¦ Â¦theÂ¦ ğŠ£ Â¦w mÂ¦ğŠ¼ Â¦onlyÂ¦ Â¦groupÂ¦ â–( Â¦7Â¦ . Â¦4Â¦ %â– Â¦ vers usÂ¦ Â¦4 6Â¦ . Â¦2Â¦ %)â– Â¦andÂ¦ Â¦theÂ¦ Â¦mortalityÂ¦ Â¦wasÂ¦ Â¦lowerÂ¦ Â¦inÂ¦ Â¦theÂ¦ ğŠ£ Â¦w mÂ¦ + Â¦t c mÂ¦ğŠ¼ Â¦groupÂ¦ Â¦thanÂ¦ ğŠ£ Â¦w mÂ¦ğŠ¼ Â¦onlyÂ¦ Â¦groupÂ¦ â–( Â¦8Â¦ . Â¦8Â¦ %â– Â¦ vers usÂ¦ Â¦3 9Â¦ % ).
ğ‹‡Â¦drugÂ¦ Â¦candidatesÂ¦ Â¦inÂ¦ ğ‹‡Â¦phaseÂ¦ ğ‹‡Â¦iÂ¦ - ğŠ£Â¦i iÂ¦ğŠ¼ Â¦trialsÂ¦ Â¦haveÂ¦ Â¦aÂ¦ Â¦lowÂ¦ Â¦rateÂ¦ Â¦ofÂ¦ Â¦success Â¦ â–( Â¦underÂ¦ Â¦12Â¦ %)â– Â¦toÂ¦ Â¦p assÂ¦ Â¦throughÂ¦ Â¦allÂ¦ Â¦trialÂ¦ Â¦p ha sesÂ¦ Â¦toÂ¦ Â¦g ainÂ¦ Â¦e ve nt ualÂ¦ Â¦approvalÂ¦ .
ğ‹‡Â¦c yto k ineÂ¦ Â¦stor mÂ¦ Â¦isÂ¦ Â¦aÂ¦ Â¦formÂ¦ Â¦ofÂ¦ Â¦s ys te m icÂ¦ Â¦inf lamm atoryÂ¦ Â¦responseÂ¦ Â¦fe at u redÂ¦ Â¦byÂ¦ Â¦theÂ¦ Â¦releaseÂ¦ Â¦ofÂ¦ Â¦aÂ¦ Â¦ser iesÂ¦ Â¦ofÂ¦ Â¦c yto k inesÂ¦ Â¦includingÂ¦ ğŠ£Â¦t n f ğŠ¼ Î± Â¦ ,â– ğŠ£Â¦ il Â¦ğŠ¼ - Â¦1 Î² Â¦ ,â– ğŠ£Â¦ ilÂ¦ - Â¦2Â¦ ,â– Â¦ ilÂ¦ - Â¦6Â¦ ,â– Â¦i f n ğŠ¼ Î± Â¦ ,â– ğŠ£Â¦i f n ğŠ¼ Î² Â¦ ,â– ğŠ£Â¦i f n ğŠ¼ Î³ Â¦ ,â– Â¦andÂ¦ ğŠ£Â¦m c pÂ¦ğŠ¼ - Â¦1Â¦ .
ğ‹‡ Â¦basedÂ¦ Â¦onÂ¦ Â¦theÂ¦ Â¦com par ativeÂ¦ Â¦analysisÂ¦ Â¦betweenÂ¦ Â¦is ol atesÂ¦ Â¦ofÂ¦ Â¦humanÂ¦ Â¦andÂ¦ Â¦ci v etÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vsÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ Â¦isÂ¦ Â¦th oughtÂ¦ Â¦toÂ¦ Â¦under g oÂ¦ Â¦rapidÂ¦ Â¦ad a pt ationÂ¦ Â¦inÂ¦ Â¦differentÂ¦ Â¦h ostsÂ¦ ,â– Â¦partic ul arlyÂ¦ Â¦withÂ¦ Â¦mutationsÂ¦ Â¦atÂ¦ Â¦theÂ¦ ğŠ£Â¦r b dÂ¦ğŠ¼ Â¦ofÂ¦ Â¦theÂ¦ ğ‹‡Â¦sÂ¦ Â¦proteinÂ¦ .
ğ‹‡ Â¦partic ul arlyÂ¦ ,â– Â¦pa ngol inÂ¦ Â¦be taÂ¦ - ğ‹‡Â¦coğ‹‡vsÂ¦ Â¦areÂ¦ Â¦high lyÂ¦ Â¦pathog enicÂ¦ Â¦inÂ¦ Â¦pa ngol insÂ¦ .
ğ‹‡ Â¦faceÂ¦ Â¦masksÂ¦ Â¦haveÂ¦ Â¦alsoÂ¦ Â¦beenÂ¦ Â¦wi de lyÂ¦ Â¦usedÂ¦ Â¦inÂ¦ ğ‹‡Â¦j ap anÂ¦ ,â– ğ‹‡Â¦southÂ¦ ğ‹‡Â¦koreaÂ¦ ,â– ğ‹‡Â¦ma la y siaÂ¦ ,â– Â¦andÂ¦ ğ‹‡Â¦si ng ap oreÂ¦ .
ğ‹‡Â¦inÂ¦ Â¦thisÂ¦ Â¦regardÂ¦ ,â– ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦f ol lo wsÂ¦ Â¦theÂ¦ Â¦generalÂ¦ Â¦tr endÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦otherÂ¦ Â¦sixÂ¦ ğŠ£Â¦hcğŠ¼oğ‹‡vsÂ¦ .
ğ‹‡Â¦inÂ¦ ğ‹‡Â¦marchÂ¦ Â¦2020Â¦ ,â– Â¦theÂ¦ Â¦mainÂ¦ Â¦pro te aseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦virusÂ¦ Â¦wasÂ¦ Â¦identifiedÂ¦ Â¦asÂ¦ Â¦aÂ¦ Â¦tar getÂ¦ Â¦forÂ¦ Â¦postÂ¦ - Â¦infectionÂ¦ Â¦drugsÂ¦ .
ğ‹‡Â¦theÂ¦ Â¦firstÂ¦ Â¦knownÂ¦ Â¦caseÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦novelÂ¦ Â¦coronavirusÂ¦ Â¦mayÂ¦ Â¦tr aceÂ¦ Â¦backÂ¦ Â¦toÂ¦ Â¦1Â¦ ğ‹‡Â¦decemberÂ¦ Â¦2019Â¦ Â¦inÂ¦ ğ‹‡Â¦wuhanÂ¦ ,â– ğ‹‡Â¦h ub e iÂ¦ ,â– ğ‹‡Â¦chinaÂ¦ .
ğ‹‡Â¦allÂ¦ Â¦fe aturesÂ¦ Â¦ofÂ¦ Â¦theÂ¦ Â¦novelÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦virusÂ¦ Â¦occ urÂ¦ Â¦inÂ¦ Â¦relatedÂ¦ Â¦coronavirusesÂ¦ Â¦inÂ¦ Â¦n atureÂ¦ . ğ‹‡ Â¦outsideÂ¦ Â¦theÂ¦ Â¦humanÂ¦ Â¦bodyÂ¦ ,â– Â¦theÂ¦ Â¦virusÂ¦ Â¦isÂ¦ Â¦killedÂ¦ Â¦byÂ¦ Â¦house ho ldÂ¦ Â¦soapÂ¦ ,â– Â¦whichÂ¦ Â¦d iss ol vesÂ¦ Â¦itsÂ¦ Â¦protectiveÂ¦ Â¦en v el opeÂ¦ . ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ - Â¦2Â¦ Â¦isÂ¦ Â¦clo se lyÂ¦ Â¦relatedÂ¦ Â¦toÂ¦ Â¦theÂ¦ Â¦origin alÂ¦ ğŠ£Â¦sarsÂ¦ğŠ¼ - ğ‹‡Â¦coğ‹‡vÂ¦ .
ğ‹‡Â¦andÂ¦ Â¦canÂ¦ Â¦youÂ¦ Â¦tellÂ¦ Â¦meÂ¦ Â¦whatÂ¦ Â¦otherÂ¦ Â¦symptomsÂ¦ Â¦areÂ¦ Â¦youÂ¦ Â¦havingÂ¦ Â¦alongÂ¦ Â¦withÂ¦ Â¦thisÂ¦ ?
ğŠ£Â¦sarsÂ¦ğŠ¼ Â¦hasÂ¦ Â¦higherÂ¦ Â¦mortalityÂ¦ Â¦thanÂ¦ ğŠ£Â¦covidÂ¦ğŠ¼ - Â¦19Â¦ â–( Â¦10Â¦ . Â¦9 1Â¦ %â– Â¦ vers usÂ¦ Â¦1Â¦ . Â¦4 4Â¦ % ).
ğ‹‡ Â¦anyÂ¦ Â¦otherÂ¦ Â¦symptomsÂ¦ Â¦orÂ¦ Â¦problemsÂ¦ Â¦thatÂ¦ Â¦youÂ¦ Â¦noticeÂ¦ Â¦withÂ¦ Â¦theÂ¦ Â¦m us c leÂ¦ Â¦ achesÂ¦ ?
ğ‹‡Â¦theÂ¦ Â¦expertsÂ¦ Â¦under s co redÂ¦ Â¦thatÂ¦ Â¦everyÂ¦ Â¦indi vid ualÂ¦ Â¦hasÂ¦ Â¦theÂ¦ Â¦rightÂ¦ Â¦toÂ¦ Â¦healthÂ¦ ,â– Â¦includingÂ¦ Â¦peopleÂ¦ Â¦withÂ¦ Â¦dis ab il itiesÂ¦ ,â– Â¦b el on gingÂ¦ Â¦toÂ¦ Â¦min orityÂ¦ Â¦groupsÂ¦ ,â– Â¦ olderÂ¦ Â¦peopleÂ¦ ,â– Â¦in tern allyÂ¦ Â¦disp l acedÂ¦ Â¦peopleÂ¦ ,â– Â¦theÂ¦ Â¦ho me lessÂ¦ ,â– Â¦thoseÂ¦ Â¦livingÂ¦ Â¦inÂ¦ Â¦ext re melyÂ¦ Â¦po orÂ¦ Â¦conditionsÂ¦ ,â– Â¦peopleÂ¦ Â¦inÂ¦ Â¦det en tionÂ¦ ,â– Â¦asÂ¦ Â¦wellÂ¦ Â¦asÂ¦ Â¦ref u g eesÂ¦ Â¦andÂ¦ Â¦otherÂ¦ Â¦un sp e ci fiedÂ¦ Â¦groupsÂ¦ Â¦inÂ¦ Â¦needÂ¦ Â¦ofÂ¦ Â¦governmentÂ¦ Â¦supportÂ¦ .
